<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Desmopressin use for minimising perioperative blood transfusion - Desborough, MJ - 2017 | Cochrane Library</title> <meta content="Desmopressin use for minimising perioperative blood transfusion - Desborough, MJ - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001884.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Desmopressin use for minimising perioperative blood transfusion - Desborough, MJ - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001884.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD001884.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Desmopressin use for minimising perioperative blood transfusion" name="citation_title"/> <meta content="Michael J Desborough" name="citation_author"/> <meta content="NHS Blood and Transplant" name="citation_author_institution"/> <meta content="Kathryn Oakland" name="citation_author"/> <meta content="NHS Blood and Transplant" name="citation_author_institution"/> <meta content="Charlotte Brierley" name="citation_author"/> <meta content="John Radcliffe Hospital" name="citation_author_institution"/> <meta content="Sean Bennett" name="citation_author"/> <meta content="University of Ottawa" name="citation_author_institution"/> <meta content="Carolyn Doree" name="citation_author"/> <meta content="NHS Blood and Transplant" name="citation_author_institution"/> <meta content="Marialena Trivella" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Sally Hopewell" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Simon J Stanworth" name="citation_author"/> <meta content="Oxford University Hospitals NHS Foundation Trust and University of Oxford" name="citation_author_institution"/> <meta content="Lise J Estcourt" name="citation_author"/> <meta content="NHS Blood and Transplant" name="citation_author_institution"/> <meta content="lise.estcourt@nhsbt.nhs.uk" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD001884.pub3" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/07/10" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001884.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001884.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001884.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Antifibrinolytic Agents [administration &amp; dosage]; Aprotinin [administration &amp; dosage]; Blood Loss, Surgical [*prevention &amp; control]; Cardiac Surgical Procedures [statistics &amp; numerical data]; Deamino Arginine Vasopressin [*administration &amp; dosage]; Erythrocyte Transfusion [*statistics &amp; numerical data]; Hemostatics [*administration &amp; dosage]; Orthopedic Procedures [statistics &amp; numerical data]; Randomized Controlled Trials as Topic; Tranexamic Acid [administration &amp; dosage]; Transplantation, Homologous; Vascular Surgical Procedures [statistics &amp; numerical data]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001884.pub3&amp;doi=10.1002/14651858.CD001884.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="dLyXbLct";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD001884\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD001884\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001884\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001884\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ru","fr","ms","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD001884.pub3",title:"Desmopressin use for minimising perioperative blood transfusion",firstPublishedDate:"Jul 10, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Injuries Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=dLyXbLct&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001884.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001884.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD001884.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD001884.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001884.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD001884.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD001884.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD001884.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD001884.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD001884.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3722 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD001884.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-sec-0252"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-sec-0039"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-sec-0040"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-sec-0066"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-sec-0242"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/appendices#CD001884-sec-0257"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/table_n/CD001884StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/table_n/CD001884StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Desmopressin use for minimising perioperative blood transfusion</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/information#CD001884-cr-0002">Michael J Desborough</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/information#CD001884-cr-0003">Kathryn Oakland</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/information#CD001884-cr-0004">Charlotte Brierley</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/information#CD001884-cr-0005">Sean Bennett</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/information#CD001884-cr-0006">Carolyn Doree</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/information#CD001884-cr-0007">Marialena Trivella</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/information#CD001884-cr-0008">Sally Hopewell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/information#CD001884-cr-0009">Simon J Stanworth</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001884.pub3/information#CD001884-cr-0010"><i class="icon corresponding-author fa fa-envelope"></i>Lise J Estcourt</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/information/en#CD001884-sec-0262">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 10 July 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD001884.pub3">https://doi.org/10.1002/14651858.CD001884.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD001884-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001884-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001884-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001884-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001884-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001884-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD001884-abs-0001" lang="en"> <section id="CD001884-sec-0001"> <h3 class="title" id="CD001884-sec-0001">Background</h3> <p>Blood transfusion is administered during many types of surgery, but its efficacy and safety are increasingly questioned. Evaluation of the efficacy of agents, such as desmopressin (DDAVP; 1‐deamino‐8‐D‐arginine‐vasopressin), that may reduce perioperative blood loss is needed. </p> </section> <section id="CD001884-sec-0002"> <h3 class="title" id="CD001884-sec-0002">Objectives</h3> <p>To examine the evidence for the efficacy of DDAVP in reducing perioperative blood loss and the need for red cell transfusion in people who do not have inherited bleeding disorders. </p> </section> <section id="CD001884-sec-0003"> <h3 class="title" id="CD001884-sec-0003">Search methods</h3> <p>We searched for randomised controlled trials (RCTs) in the Cochrane Central Register of Controlled Trials (2017, issue 3) in the Cochrane Library, MEDLINE (from 1946), Embase (from 1974), the Cumulative Index to Nursing and Allied Health Literature (CINAHL) (from 1937), the Transfusion Evidence Library (from 1980), and ongoing trial databases (all searches to 3 April 2017). </p> </section> <section id="CD001884-sec-0004"> <h3 class="title" id="CD001884-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials comparing DDAVP to placebo or an active comparator (e.g. tranexamic acid, aprotinin) before, during, or immediately after surgery or after invasive procedures in adults or children. </p> </section> <section id="CD001884-sec-0005"> <h3 class="title" id="CD001884-sec-0005">Data collection and analysis</h3> <p>We used the standard methodological procedures expected by Cochrane.</p> </section> <section id="CD001884-sec-0006"> <h3 class="title" id="CD001884-sec-0006">Main results</h3> <p>We identified 65 completed trials (3874 participants) and four ongoing trials. Of the 65 completed trials, 39 focused on adult cardiac surgery, three on paediatric cardiac surgery, 12 on orthopaedic surgery, two on plastic surgery, and two on vascular surgery; seven studies were conducted in surgery for other conditions. These trials were conducted between 1986 and 2016, and 11 were funded by pharmaceutical companies or by a party with a commercial interest in the outcome of the trial. </p> <p>The GRADE quality of evidence was very low to moderate across all outcomes. No trial reported quality of life. </p> <p><b>DDAVP versus placebo or no treatment</b> </p> <p>Trial results showed considerable heterogeneity between surgical settings for total volume of red cells transfused (<i>low‐quality evidence</i> ) and for total blood loss (<i>very low‐quality evidence</i>) due to large differences in baseline blood loss. Consequently, these outcomes were not pooled and were reported in subgroups. </p> <p>Compared with placebo, DDAVP may slightly decrease the total volume of red cells transfused in adult cardiac surgery (mean difference (MD) ‐0.52 units, 95% confidence interval (CI) ‐0.96 to ‐0.08 units; 14 trials, 957 participants), but may lead to little or no difference in orthopaedic surgery (MD ‐0.02, 95% CI ‐0.67 to 0.64 units; 6 trials, 303 participants), vascular surgery (MD 0.06, 95% CI ‐0.60 to 0.73 units; 2 trials, 135 participants), or hepatic surgery (MD ‐0.47, 95% CI ‐1.27 to 0.33 units; 1 trial, 59 participants). </p> <p>DDAVP probably leads to little or no difference in the total number of participants transfused with blood (risk ratio (RR) 0.96, 95% CI 0.86 to 1.06; 25 trials; 1806 participants) (<i>moderate‐quality evidence</i>). </p> <p>Whether DDAVP decreases total blood loss in adult cardiac surgery (MD ‐135.24 mL, 95% CI ‐210.80 mL to ‐59.68 mL; 22 trials, 1358 participants), orthopaedic surgery (MD ‐285.76 mL, 95% CI ‐514.99 mL to ‐56.53 mL; 5 trials, 241 participants), or vascular surgery (MD ‐582.00 mL, 95% CI ‐1264.07 mL to 100.07 mL; 1 trial, 44 participants) is uncertain because the quality of evidence is very low. </p> <p>DDAVP probably leads to little or no difference in all‐cause mortality (Peto odds ratio (pOR) 1.09, 95% CI 0.51 to 2.34; 22 trials, 1631 participants) or in thrombotic events (pOR 1.36, 95% CI, 0.85 to 2.16; 29 trials, 1984 participants) (<i>both low‐quality evidence</i>). </p> <p><b>DDAVP versus placebo or no treatment for people with platelet dysfunction</b> </p> <p>Compared with placebo, DDAVP may lead to a reduction in the total volume of red cells transfused (MD ‐0.65 units, 95% CI ‐1.16 to ‐0.13 units; 6 trials, 388 participants) (<i>low‐quality evidence</i> ) and in total blood loss (MD ‐253.93 mL, 95% CI ‐408.01 mL to ‐99.85 mL; 7 trials, 422 participants) (<i>low‐quality evidence</i>). </p> <p>DDAVP probably leads to little or no difference in the total number of participants receiving a red cell transfusion (RR 0.83, 95% CI 0.66 to 1.04; 5 trials, 258 participants) (<i>moderate‐quality evidence</i>). </p> <p>Whether DDAVP leads to a difference in all‐cause mortality (pOR 0.72, 95% CI 0.12 to 4.22; 7 trials; 422 participants) or in thrombotic events (pOR 1.58, 95% CI 0.60 to 4.17; 7 trials, 422 participants) is uncertain because the quality of evidence is very low<i>.</i> </p> <p><b>DDAVP versus tranexamic acid</b> </p> <p>Compared with tranexamic acid, DDAVP may increase the volume of blood transfused (MD 0.6 units, 95% CI 0.09 to 1.11 units; 1 trial, 40 participants) and total blood loss (MD 142.81 mL, 95% CI 79.78 mL to 205.84 mL; 2 trials, 115 participants) (<i>both low‐quality evidence</i>). </p> <p>Whether DDAVP increases or decreases the total number of participants transfused with blood is uncertain because the quality of evidence is very low (RR 2.42, 95% CI 1.04 to 5.64; 3 trials, 135 participants). </p> <p>No trial reported all‐cause mortality.</p> <p>Whether DDAVP leads to a difference in thrombotic events is uncertain because the quality of evidence is very low (pOR 2.92, 95% CI 0.32 to 26.83; 2 trials, 115 participants). </p> <p><b>DDAVP versus aprotinin</b> </p> <p>Compared with aprotinin, DDAVP probably increases the total number of participants transfused with blood (RR 2.41, 95% CI 1.45 to 4.02; 1 trial, 99 participants) (<i>moderate‐quality evidence</i>). </p> <p>No trials reported volume of blood transfused or total blood loss and the single trial that included mortality as an outcome reported no deaths. </p> <p>Whether DDAVP leads to a difference in thrombotic events is uncertain because the quality of evidence is very low (pOR 0.98, 95% CI 0.06 to 15.89; 2 trials, 152 participants). </p> </section> <section id="CD001884-sec-0007"> <h3 class="title" id="CD001884-sec-0007">Authors' conclusions</h3> <p>Most of the evidence derived by comparing DDAVP versus placebo was obtained in cardiac surgery, where DDAVP was administered after cardiopulmonary bypass. In adults undergoing cardiac surgery, the reduction in volume of red cells transfused and total blood loss was small and was unlikely to be clinically important. It is less clear whether DDAVP may be of benefit for children and for those undergoing non‐cardiac surgery. A key area for researchers is examining the effects of DDAVP for people with platelet dysfunction. Few trials have compared DDAVP versus tranexamic acid or aprotinin; consequently, we are uncertain of the relative efficacy of these interventions. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD001884-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001884-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001884-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001884-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001884-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD001884-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD001884-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001884-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD001884-abs-0005" lang="en"> <h3>Desmopressin use for reducing the need for blood transfusion for people having an operation </h3> <p><b>Review question</b> </p> <p>Could desmopressin (a medicine that can be used to prevent bleeding) reduce the need for blood transfusion when people have surgery? </p> <p><b>Background</b> </p> <p>Blood loss is common during major surgery. Blood transfusions can replace blood that has been lost. Risks associated with blood transfusion include reactions against the blood, and – particularly in low‐ and middle‐income countries – infection. </p> <p>Desmopressin is a medicine commonly known as DDAVP (an abbreviation of its chemical name: 1‐deamino‐8‐D‐arginine vasopressin). It is used for people born with problems that put them at risk of bleeding, and may help people who do not have bleeding disorders. DDAVP may have side effects; for instance, it might increase risk of heart attack or stroke, or cause low blood pressure when it is given. </p> <p><b>Study characteristics</b> </p> <p>We investigated whether giving DDAVP reduced the need for blood transfusion in people having surgery. </p> <p>We searched the medical literature to 3 April 2017. We identified 65 relevant trials with 3874 participants (adults and children). All trials assessed the effects of giving DDAVP before, during, or immediately after surgery or more minor procedures like biopsies. Most trials focused on adult heart surgery, or bone and joint surgery. Fewer trials focused on heart surgery for children, plastic surgery, surgery on blood vessels, or liver surgery. The trials were conducted between 1986 and 2016. Eleven were funded by pharmaceutical companies or by a party with a commercial interest in the trial’s outcome. </p> <p><b>Key results</b> </p> <p>Compared with placebo (an inactive substance that looks the same as the substance being tested, i.e. DDAVP) or no treatment, DDAVP may slightly reduce the amount of blood transfused in adult heart surgery. DDAVP may lead to little or no difference in the amount of blood transfused in heart surgery for children, bone and joint surgery, surgery on major blood vessels, or liver surgery. DDAVP probably leads to little or no difference in the total number of people who receive a blood transfusion. Whether DDAVP increases or reduces total blood loss is uncertain because the quality of evidence is very low. DDAVP may lead to little or no difference in the risk of death, heart attack, or stroke. </p> <p>For people who are more vulnerable to bleeding because they are taking an antiplatelet medicine that stops their blood from clotting normally, DDAVP may lead to a reduction in the total volume of red cells transfused and in total blood loss. It probably leads to little or no difference in the number of people receiving a red cell transfusion. Whether DDAVP increases or reduces the risk of death, heart attack, or stroke is uncertain because the quality of evidence is very low. </p> <p>Compared with tranexamic acid (a medication used to treat or prevent excessive blood loss) DDAVP may be less effective in reducing the volume of blood transfused and total blood loss. Whether DDAVP increases or reduces the number of people who receive a blood transfusion, or risk of death, heart attack, or stroke is uncertain because the quality of evidence is very low. </p> <p>Compared with aprotinin (another medication used to reduce bleeding) DDAVP probably increases the number of people who receive a blood transfusion. Whether it increases or decreases the risk of a heart attack or stroke is uncertain because the quality of evidence is very low. No trials comparing DDAVP against aprotinin reported the volume of blood transfused, total blood loss, or risk of death. </p> <p>None of the 65 trials assessed quality of life.</p> <p><b>Quality of the evidence</b> </p> <p>We rated the quality of evidence as very low to moderate for the outcomes above. We considered many of the trials to be at high risk of bias and noted inconsistency and imprecision in their results. </p> <p><b>Conclusion</b> </p> <p>Overall, differences in transfusion and blood loss when people were treated with DDAVP or placebo were small and unlikely to be clinically important. It is possible that people who are more vulnerable to bleeding, such as those taking antiplatelet agents, may gain more benefit from DDAVP. Few trials compared DDAVP against tranexamic acid or aprotinin; consequently, we are uncertain whether DDAVP is better or worse than these agents. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD001884-sec-0252" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD001884-sec-0252"></div> <h3 class="title" id="CD001884-sec-0253">Implications for practice</h3> <section id="CD001884-sec-0253"> <p>Findings from 65 trials conducted worldwide show no benefit of DDAVP (1‐deamino‐8‐D‐arginine‐vasopressin) for unselected patients. Small reductions in blood loss and in total volume of red cells transfused were noted in cardiac surgery, but these are unlikely to be clinically important. No difference was found in mortality or adverse events (such as thrombotic events) with the use of DDAVP, as there were so few events. </p> </section> <h3 class="title" id="CD001884-sec-0254">Implications for research</h3> <section id="CD001884-sec-0254"> <p>The quality of the evidence available for assessment of the value of DDAVP in surgery was low. Benefits in unselected patients appear to be small, and it is unlikely that additional trials will change this finding. Subgroups of people with platelet dysfunction or taking antiplatelet agents may gain greater benefit from DDAVP, and this may be a topic for future research. Incorporation of point‐of‐care platelet function tests or viscoelastic tests in future trials may allow greater precision in the selection of patients who may derive the greatest benefit from DDAVP; this is another potential topic for research. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD001884-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD001884-sec-0029"></div> <div class="table" id="CD001884-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">DDAVP vs placebo or standard care</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participant or population:</b> participants undergoing surgery<br/> <b>Intervention:</b> desmopressin<br/> <b>Comparison:</b> placebo or standard care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with desmopressin</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="4" valign="top"> <p><b>Red cell volume transfused (total)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Adult cardiac surgery:</b> red cell volume transfused in the desmopressin group was 0.52 units less (0.96 fewer to 0.08 fewer units, 14 RCTs, 957 participants) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1454<br/> (23 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Data not pooled due to clinical heterogeneity and reported as subgroups</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Orthopaedic surgery:</b> red cell volume transfused in the desmopressin group was 0.02 units less (0.67 less to 0.64 more units, 6 RCTs, 303 participants) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Vascular surgery:</b> red cell volume transfused in the desmopressin group was 0.06 units more (0.60 less to 0.73 more units, 2 RCTs, 135 participants) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Hepatic surgery:</b> red cell volume transfused in the desmopressin group was 0.47 units less (1.27 less to 0.33 more units, 1 RCT, 59 participants) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants receiving a red cell transfusion (total)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>450 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>436 per 1000<br/> (400 to 476) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.96<br/> (0.86 to 1.06) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1806<br/> (25 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Blood loss (total)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Cardiac surgery:</b> total blood loss in the desmopressin group was 135.24 mL less (210.8 mL to 59.68 mL less, 22 RCTs, 1358 participants). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>1643<br/> (28 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Data not pooled owing to clinical heterogeneity and reported as subgroups</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Orthopaedic surgery:</b> total blood loss in the desmopressin group was 285.76 mL less (514.99 mL to 56.53 mL less, 5 RCTs, 241 participants) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Vascular surgery:</b> total blood loss in the desmopressin group was 582 mL less (1264.07 mL less to 100.07 mL more, 1 RCT, 44 participants) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1000<br/> (7 to 41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>pOR 1.09</p> <p>(0.51 to 2.34)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1631<br/> (22 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>34 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>44 per 1000<br/> (28 to 67) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>pOR 1.36</p> <p>(0.85 to 2.16)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1984<br/> (29 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(No studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <br/> CI: confidence interval; pOR: Peto odds ratio; RCT: randomised controlled trial; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to risk of bias: inadequate reporting of blinding and incomplete outcome data </p> <p><sup>b</sup>Downgraged one level for inconsistency: I<sup>2</sup> = 66% </p> <p><sup>c</sup>Downgraded one level for inconsistency: I<sup>2</sup> = 73% and sensitivity analysis unable to determine cause of heterogeneity </p> <p><sup>d</sup>Downgraded one level for suspected publication bias </p> <p><sup>e</sup>Downgraded one level due to imprecision, as confidence intervals include both clinically important benefit and clinically important harm </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001884-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">DDAVP vs placebo or standard care: platelet dysfunction subgroup</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participant or population:</b> participants with platelet dysfunction undergoing surgery<br/> <b>Intervention:</b> desmopressin<br/> <b>Comparison:</b> placebo or standard care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with desmopressin</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Red cell volume transfused (total)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Red cell volume transfused was 2.6 units</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Red cell volume transfused in the desmopressin group was 0.65 units less (1.16 less to 0.13 less) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>388<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants receiving a red cell transfusion (total)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>541 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>449 per 1000<br/> (357 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.83<br/> (0.66 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>258<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Blood loss (total)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean total blood loss was 1098 mL</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Total blood loss in the desmopressin group was 253.93 mL less (408.01 mL less to 99.85 mL less) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>422<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>All‐cause mortality</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>14 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>10 per 1000</p> <p>(2 to 59)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>pOR 0.72</p> <p>(0.12 to 4.22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>422<br/> (7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>51 per 1000<br/> (19 to 133) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>pOR 1.58<br/> (0.60 to 4.17) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>422<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(No studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <br/> CI: confidence interval; pOR: Peto odds ratio; RCT: randomised controlled trial; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias </p> <p><sup>b</sup>Downgraded one level for inconsistency due to variation in baseline level of transfusion and blood loss </p> <p><sup>c</sup>Downgraded two levels for imprecision, as confidence intervals include clinically important benefit and clinically important harm with low background event rate </p> <p><sup>d</sup>Downgraded one level for imprecision </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001884-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">DDAVP vs tranexamic acid</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participant or population:</b> participants undergoing surgery<br/> <b>Intervention:</b> desmopressin<br/> <b>Comparison:</b> tranexamic acid </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with tranexamic acid</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with desmopressin</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Red cell volume transfused (total)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean red cell volume transfused was 0.2 units</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Red cell volume transfused in the desmopressin group was 0.6 units more (0.09 more to 1.11 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants receiving a red cell transfusion (total)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>239 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>578 per 1000<br/> (248 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.42<br/> (1.04 to 5.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>135<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Blood loss (total)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean blood loss was 270 mL</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Total blood loss in the desmopressin group was 142.81 mL more (79.78 mL more to 205.84 mL more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>115<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(No studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>18 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>51 per 1000<br/> (6 to 471) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.92<br/> (0.32 to 26.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>115<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(No studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <br/> CI: confidence interval; RCT: randomised controlled trial; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias </p> <p><sup>b</sup>Downgraded one level for indirectness because most types of surgery or procedures were not represented by the included trials </p> <p><sup>c</sup>Downgraded one level for imprecision owing to wide confidence intervals </p> <p><sup>d</sup>Downgraded two levels for imprecision owing to very wide confidence intervals </p> <p><sup>e</sup>Outcome not downgraded for indirectness because already downgraded three levels for other reasons </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001884-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">DDAVP vs aprotinin</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participant or population:</b> participants undergoing surgery<br/> <b>Intervention:</b> desmopressin<br/> <b>Comparison:</b> aprotinin </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with aprotinin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with desmopressin</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Red cell volume transfused (total)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(No studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants receiving a red cell transfusion (total)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>265 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>639 per 1000<br/> (385 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.41<br/> (1.45 to 4.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Blood loss (total)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(No studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No deaths in either arm of the trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>14 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>13 per 1000<br/> (1 to 206) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>pOR 0.98<br/> (0.06 to 15.89) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(No studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <br/> CI: confidence interval; pOR: Peto odds ratio; RCT: randomised controlled trial; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias </p> <p><sup>b</sup>Downgraded one level for indirectness because most types of surgery or procedures were not represented by the included trials </p> <p><sup>c</sup>Downgraded two levels for imprecision (no deaths in either arm) </p> <p><sup>d</sup>Not downgraded for indirectness because already downgraded three levels for other reasons </p> <p><sup>e</sup>Downgraded two levels for imprecision (very wide confidence intervals) </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD001884-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD001884-sec-0030"></div> <p>Red cell transfusion is common in the perioperative period for major surgery. Anaemia is known to be an independent predictor of poor outcomes following surgery (<a href="./references#CD001884-bbs2-0102" title="CarsonJL , NoveckH , BerlinJA , GouldSA . Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion2002;42(7):812‐8. ">Carson 2002</a>), but studies examining restrictive or liberal use of red cells in this setting have not found a clear beneficial effect for red cell transfusion (<a href="./references#CD001884-bbs2-0118" title="HolstLB , PetersenMW , HaaseN , PernerA , WetterslevJ . Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta‐analysis and trial sequential analysis. BMJ2015;350:h1354. ">Holst 2015</a>). Red cell transfusions are a biological product associated with risks such as infectious transmission and transfusion reactions (<a href="./references#CD001884-bbs2-0106" title="DelaneyM , WendelS , BercovitzRS , CidJ , CohnC , DunbarNM , et al. Transfusion reactions: prevention, diagnosis, and treatment. Lancet2016;388:2825‐36. ">Delaney 2016</a>). Consequently, agents that could reduce blood loss and the need for red cell transfusion are needed. Recent work has demonstrated the importance of alternative agents such as tranexamic acid, which reduces red cell transfusion requirements and mortality without increasing the risk of thrombotic events when administered perioperatively (<a href="./references#CD001884-bbs2-0122" title="KerK , EdwardsP , PerelP , ShakurH , RobertsI . Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta‐analysis. BMJ2012;344:e3054. ">Ker 2012</a>). Desmopressin (also known as DDAVP, or 1‐deamino‐8‐D‐arginine vasopressin) has a potential role in this setting. </p> <section id="CD001884-sec-0031"> <h3 class="title" id="CD001884-sec-0031">Description of the condition</h3> <section id="CD001884-sec-0032"> <h4 class="title">Surgery</h4> <p>In 2014, people undergoing surgical procedures received 26.7% of the red cell units (12,318 units) transfused in the UK. The largest volumes of blood were transfused in cardiac surgery (6%; 2756 units), trauma (4.8%; 2193 units), orthopaedic surgery (3.9%; 1811 units), gastrointestinal surgery (3.8%; 1764 units), and vascular surgery (2.4%; 1091 units) (<a href="./references#CD001884-bbs2-0141" title="TinegateH , PendryK , MurphyM , BabraP , Grant‐CaseyJ , HopkinsonC , et al. Where do all the red blood cells (RBCs) go? Results of a survey of RBC use in England and North Wales in 2014. Transfusion2016;56(1):139‐45. ">Tinegate 2016</a>), with the remaining 5.8% transfused in surgery for other conditions. Blood loss is associated with increased mortality among people undergoing surgery and is associated with surgical complexity. The mortality risk of routine elective surgery is approximately 0.1%, rising to 1% to 2% for cardiac surgery and to 5% to 8% for vascular surgery (<a href="./references#CD001884-bbs2-0131" title="National Institute for Health and Care Excellence. Detecting, managing and monitoring haemostasis: viscoelastometric point‐of‐care testing (ROTEM, TEG and Sonoclot systems). NICE diagnostics guidance 13, available from: www.nice.org.uk/dg13 2014 (accessed 23 May 2017). ">NICE 2014</a>). Between 5% and 7% of people undergoing cardiac surgery lose more than two litres of blood, and 3.6% to 4.2% of people require a second operation (reoperation) to arrest the bleeding (<a href="./references#CD001884-bbs2-0131" title="National Institute for Health and Care Excellence. Detecting, managing and monitoring haemostasis: viscoelastometric point‐of‐care testing (ROTEM, TEG and Sonoclot systems). NICE diagnostics guidance 13, available from: www.nice.org.uk/dg13 2014 (accessed 23 May 2017). ">NICE 2014</a>). The need for reoperation is associated with a 4.5‐fold increase in risk of mortality (<a href="./references#CD001884-bbs2-0130" title="MehtaRH , ShengS , O'BrienSM , GroverFL , GammieJS , FergusonTB , et al. Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes. Circulation. Cardiovascular Quality and Outcomes2009;2(6):583‐90. ">Mehta 2009</a>), and blood loss of more than two litres is associated with an eight‐fold increase in risk of death (<a href="./references#CD001884-bbs2-0131" title="National Institute for Health and Care Excellence. Detecting, managing and monitoring haemostasis: viscoelastometric point‐of‐care testing (ROTEM, TEG and Sonoclot systems). NICE diagnostics guidance 13, available from: www.nice.org.uk/dg13 2014 (accessed 23 May 2017). ">NICE 2014</a>). Several key points apply in surgical operations for which an intervention such as DDAVP can be administered to prevent bleeding. </p> <p> <ul id="CD001884-list-0001"> <li> <p>Anaesthetic induction: this involves the administration of a general anaesthetic or regional anaesthesia such as a spinal or epidural block and occurs before the operation. </p> </li> <li> <p>First incision in the skin: the start of the operation.</p> </li> <li> <p>Important time points during different types of operations.</p> <ul id="CD001884-list-0002"> <li> <p>Cardiac surgery: once the chest has been opened and the mediastinum accessed, cardiopulmonary bypass (CPB) is initiated. This diverts blood from the heart and lungs, allowing them to be operated on. Patients are given heparin (an anticoagulant drug), which reduces the risk of blood clot formation while patients are on the bypass machine but renders them vulnerable to bleeding. When the procedure is finished, heparin is reversed with protamine, and normal circulation is restored. </p> </li> <li> <p>Vascular surgery: for some procedures, large vessels such as the aorta are cross‐clamped to allow visualisation of the operative field. When the clamps are removed and normal circulation restored, patients are at risk of blood loss from the newly perfused vessel and tributaries. </p> </li> <li> <p>Orthopaedic surgery and plastic surgery: the blood supply to the limbs can be reduced temporarily by a tourniquet applied proximal to the area being operated on. Once the tourniquet is removed, normal blood flow returns, and this may lead to bleeding at the operative site. </p> </li> </ul> </li> <li> <p>Closure of the skin.</p> </li> <li> <p>Postoperative recovery in an intensive care unit or a postoperative recovery ward depending on the type of surgery and any complications that may have arisen. </p> </li> </ul> </p> </section> <section id="CD001884-sec-0033"> <h4 class="title">Interventional procedures</h4> <p>Risk of bleeding is much lower for interventional procedures such as liver or kidney biopsy than for surgical operations. For example, risk of bleeding following a transjugular liver biopsy is approximately 0.07% and risk of death is 0.09% (<a href="./references#CD001884-bbs2-0119" title="KalambokisG , ManousouP , VibhakornS , MarelliL , CholongitasE , SenzoloM , et al. Transjugular liver biopsy ‐ indications, adequacy, quality of specimens, and complications ‐ a systematic review. Journal of Hepatology2007;47(2):284‐94. ">Kalambokis 2007</a>). For these procedures, bleeding is not expected, and the aim of treatment with a drug such as DDAVP is to prevent bleeding, rather than to reduce the volume of blood loss. These procedures may be performed with imaging (such as ultrasound) used to guide the procedure or with the use of anatomical landmarks. Bleeding may be difficult to detect, or it may occur at a site where it cannot be easily arrested, and where mechanical compression cannot be applied. The short duration of these procedures means that drugs such as DDAVP are administered before the procedure is started. </p> </section> <section id="CD001884-sec-0034"> <h4 class="title">Characteristics of people undergoing surgery that may make them vulnerable to bleeding</h4> <p>Particular challenges in preventing blood loss are associated with people with platelet dysfunction (e.g. those taking antiplatelet drugs such as aspirin, which inhibits the function of platelets and so makes these individuals more vulnerable to bleeding). Often antiplatelet agents cannot be stopped before an operation is performed because the procedure is urgent, or the risk of stopping the drug is considered too high (e.g. for those with a recent drug‐eluting coronary artery stent). Other patients who are vulnerable to bleeding include those with low platelet counts or abnormal blood clotting, and those taking anticoagulant drugs such as warfarin. </p> </section> </section> <section id="CD001884-sec-0035"> <h3 class="title" id="CD001884-sec-0035">Description of the intervention</h3> <p>Desmopressin is a synthetic version of the naturally occurring hormone vasopressin. It is used most commonly for treatment of people with inherited bleeding disorders such as haemophilia A or von Willebrand disease, for whom it is administered at a dose of 0.3 μg/kg subcutaneously or intravenously. Desmopressin has been in use for more than 40 years and is a relatively inexpensive drug to administer. Increases in von Willebrand factor (vWF) and in factor VIII have the potential to increase the risk of arterial or venous thrombotic events; this is an important safety consideration (<a href="./references#CD001884-bbs2-0110" title="FranchiniM . The use of desmopressin as a hemostatic agent: a concise review. American Journal of Hematology2007;82(8):731‐5. ">Franchini 2007</a>). DDAVP also results in release of nitric oxide from endothelial cells, which can cause vasodilation with symptoms of facial flushing, tachycardia, and hypotension (<a href="./references#CD001884-bbs2-0120" title="KaufmannJE , VischerUM . Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). Journal of Thrombosis and Haemostasis2003;1(4):682‐9. ">Kaufmann 2003</a>). In rare cases, DDAVP administration may be associated with hyponatraemia and seizures, particularly when it is administered to young children (<a href="./references#CD001884-bbs2-0137" title="SmithTJ , GillJC , AmbrusoDR , HathawayWE . Hyponatraemia and seizures in young children given DDAVP. American Journal of Hematology1989;31(3):199‐202. ">Smith 1989</a>). </p> <section id="CD001884-sec-0036"> <h4 class="title">DDAVP in clinical guidelines</h4> <p>DDAVP is commonly used for treatment of people with mild to moderate haemophilia A and von Willebrand disease and is recommended for treatment of some individuals with inherited platelet disorders (<a href="./references#CD001884-bbs2-0109" title="EstcourtLJ , BirchallJ , AllardS , BasseySJ , HerseyP , KerrJP , et al. Guidelines for the use of platelet transfusions. A British Society for Haematology Guideline. British Journal of Haematology2017;176:365‐94. [DOI: 101111/bjh.14423] ">Estcourt 2017</a>; <a href="./references#CD001884-bbs2-0121" title="KeelingD , TaitC , MakrisM . Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. A United Kingdom Haemophilia Center Doctors' Organisation (UKHCDO) guideline approved by the British Committee for Standards in Haematology. Haemophilia2008;14(4):671‐84. ">Keeling 2008</a>; <a href="./references#CD001884-bbs2-0125" title="LaffanMA , LesterW , O'DonnellJS , WillA , TaitRC , GoodeveA , et al. The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. British Journal of Haematology2014;167(4):453‐65. ">Laffan 2014</a>). </p> <p>Outside the setting of inherited bleeding disorders, DDAVP is recommended by the following guidelines. </p> <p> <ul id="CD001884-list-0003"> <li> <p>European guideline on management of major bleeding and coagulopathy following trauma: "We suggest that desmopressin (0.3 μg/kg) be administered in patients treated with platelet‐inhibiting drugs or with von Willebrand disease. We do not suggest that desmopressin be used routinely in the bleeding trauma patient" (<a href="./references#CD001884-bbs2-0134" title="RossaintR , BouillonB , CernyV , CoatsTJ , DuranteauJ , Fernández‐MondéjarE , et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Critical Care2016;20(1):100. ">Rossaint 2016</a>). </p> </li> <li> <p>American Society of Anesthesiologists (ASA): "Both the consultants and ASA members agree that, in patients with excessive bleeding and platelet dysfunction, consider the use of desmopressin" (<a href="./references#CD001884-bbs2-0101" title="American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology2015;122(2):241‐75. ">American Society of Anesthesiologists 2015</a>). </p> </li> <li> <p>European Society of Anaethesiology: "Following discontinuation of CPB, patients with severe aortic stenosis or drug‐ or CPB‐induced platelet dysfunction may benefit from desmopressin" (<a href="./references#CD001884-bbs2-0123" title="Kozek‐LangeneckerSA , AfshariA , AlbaladejoP , SantullanoCA , DeRobertisE , FilipescuDC , et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. European Journal of Anaesthesia2013;30(6):270‐382. ">Kozek‐Langenecker 2013</a>). </p> </li> <li> <p>Society of Thoracic Surgeons and Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines: "Use of 1‐deamino‐8‐D‐arginine vasopressin (DDAVP) may be reasonable to attenuate excessive bleeding and transfusion in certain patients with demonstrable and specific platelet dysfunction known to respond to this agent (e.g. uraemic or CPB‐induced platelet dysfunction, type I von Willebrand’s disease)" (<a href="./references#CD001884-bbs2-0138" title="Society of Thoracic Surgeons Blood Conservation Guideline Task Force, FerrarisVA , BrownJR , DespotisGJ , HammonJW , ReeceTB , SahaSP , et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Annals of Thoracic Surgery2011;91(3):944‐82. ">Society of Thoracic Surgeons 2011</a>). </p> </li> </ul> </p> </section> </section> <section id="CD001884-sec-0037"> <h3 class="title" id="CD001884-sec-0037">How the intervention might work</h3> <p>Desmopressin stimulates the release of vWF from endothelial cells (<a href="./references#CD001884-bbs2-0120" title="KaufmannJE , VischerUM . Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). Journal of Thrombosis and Haemostasis2003;1(4):682‐9. ">Kaufmann 2003</a>). vWF is essential for forming normal blood clots through platelet adhesion and aggregation following endothelial injury (<a href="./references#CD001884-bbs2-0129" title="MannucciPM . Treatment of von Willebrand's disease. New England Journal of Medicine2004;351(7):683‐94. ">Mannucci 2004)</a>. Increasing vWF levels for people undergoing surgery or invasive procedures may reduce the volume of blood that they lose (or may prevent them from losing blood), and consequently may reduce the need for red cell transfusion. vWF levels often rise naturally in response to stressful stimuli such as surgery, and the benefits of increasing vWF levels with DDAVP may vary according to baseline vWF levels. DDAVP takes approximately 30 minutes to reach peak effectiveness, and this effect lasts up to six to eight hours (<a href="./references#CD001884-bbs2-0110" title="FranchiniM . The use of desmopressin as a hemostatic agent: a concise review. American Journal of Hematology2007;82(8):731‐5. ">Franchini 2007</a>). Consequently, the timing of its administration in clinical trials assessing its efficacy is of key significance. Release of vWF also results in an increase in procoagulant factor VIII levels, as vWF prolongs the half‐life of factor VIII (<a href="./references#CD001884-bbs2-0140" title="SvenssonP , BergqvistPB , JuulKV , BerntorpE . Desmopressin in the treatment of haematological disorders and in the prevention of surgical bleeding. Blood Reviews2014;28(3):95‐102. ">Svensson 2014</a>), which may promote haemostasis or thrombosis. Tissue plasminogen activator, a key promotor of fibrinolysis, is released from Weibel‐Palade bodies at the same time as vWF (<a href="./references#CD001884-bbs2-0120" title="KaufmannJE , VischerUM . Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). Journal of Thrombosis and Haemostasis2003;1(4):682‐9. ">Kaufmann 2003</a>), and co‐administration of an antifibrinolytic agent may increase the efficacy of DDAVP. </p> </section> <section id="CD001884-sec-0038"> <h3 class="title" id="CD001884-sec-0038">Why it is important to do this review</h3> <p>The need to identify effective agents for reduction of blood loss and improvement of surgical outcomes is ongoing. This review is an update of a previous review (<a href="./references#CD001884-bbs2-0145" title="CarlessPA , HenryDA , MoxeyAJ , O'ConnellD , McClellandB , HendersonKM , et al. Desmopressin use for minimising allogeneic blood transfusion. Cochrane Database of Systematic Reviews2004, Issue 1. [DOI: 10.1002/14651858.CD001884.pub2] ">Carless 2004</a>), and builds on the results of previous systematic reviews (<a href="./references#CD001884-bbs2-0103" title="CattaneoM , HarrisAS , StrombergU , MannucciPM . The effect of desmopressin on reducing blood loss in cardiac surgery ‐ a meta‐analysis of double‐blind, placebo‐controlled trials. Thrombosis and Haemostasis1995;74(4):1064‐70. ">Cattaneo 1995</a>; <a href="./references#CD001884-bbs2-0104" title="CrescenziG , LandoniG , Biondi‐ZoccaiG , PappalardoF , NuzziM , BignamiE , et al. Desmopressin reduces transfusion needs after surgery: a meta‐analysis of randomized clinical trials. Anesthesiology2008;109(6):1063‐76. ">Crescenzi 2008</a>; <a href="./references#CD001884-bbs2-0111" title="FremesSE , WongBI , LeeE , MaiR , ChristakisGT , McLeanRF , et al. Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding. Annals of Thoracic Surgery1994;58(6):1580‐8. ">Fremes 1994</a>; <a href="./references#CD001884-bbs2-0148" title="HenryDA , MoxeyAJ , CarlessPA , O'ConnellD , McClellandB , HendersonKM , et al. Desmopressin for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews1998, Issue 12. [DOI: 10.1002/14651858.CD001884] ">Henry 1998</a>; <a href="./references#CD001884-bbs2-0126" title="LaupacisA , FergussonD . Drugs to minimise perioperative blood loss in cardiac surgery: meta‐analyses using perioperative blood transfusion as the outcome. Anaesthesia and Analgesia1997;85(6):1258‐67. ">Laupacis 1997</a>; <a href="./references#CD001884-bbs2-0128" title="LeviM , CromheeckeME , deJongeE , PrinsMH , deMolBJM , BrietE , et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta‐analysis of clinically relevant endpoints. Lancet1999;354(9194):1940‐7. ">Levi 1999</a>). Desmopressin is a cheap drug that may provide particular benefit in countries where risk of infection or other adverse events from blood transfusion is high (<a href="./references#CD001884-bbs2-0107" title="DesboroughMJ , SmethurstPA , EstcourtLJ , StanworthSJ . Alternatives to allogeneic platelet transfusion. British Journal of Haematology2016;175(3):381‐92. ">Desborough 2016a</a>). Currently, blood is not screened for transfusion‐transmitted infection in 39 countries, and only 47% of transfusions from low‐income countries are tested in laboratories with quality assurance. The risk of infection following transfusion in low‐income countries is higher than in high‐income countries: Recent figures show risk of 0.85% for HIV infection in low‐income countries compared with 0.002% in high‐income countries; similarly, 3.59% versus 0.02% for hepatitis B, and 1.07% versus 0.02% for hepatitis C (<a href="./references#CD001884-bbs2-0144" title="World Health Organization. Blood safety and availability. Fact sheet No 279. Available from: www.who.int/mediacentre/factsheets/fs279/en (accessed 17 May 2016). ">World Health Organization 2015</a>). Other agents such as tranexamic acid are used increasingly to reduce surgical blood loss (<a href="./references#CD001884-bbs2-0132" title="PadhiS , Kemmis‐BettyS , RajeshS , HillJ , MurphyMF , Guideline Development Group. Blood transfusion: summary of NICE guidance. BMJ2015;351:h5832. ">Padhi 2015</a>). Therefore, we will also examine trials that compared these agents directly with DDAVP to assess their relative efficacy. </p> <p>See <a href="#CD001884-sec-0274">Published notes</a> for prespecified changes to this review that were made prior to this update. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD001884-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD001884-sec-0039"></div> <p>To examine the evidence for the efficacy of DDAVP in reducing perioperative blood loss and the need for red cell transfusion in people who do not have inherited bleeding disorders. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD001884-sec-0040" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD001884-sec-0040"></div> <section id="CD001884-sec-0041"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD001884-sec-0042"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) with no restriction on language or publication status. </p> </section> <section id="CD001884-sec-0043"> <h4 class="title">Types of participants</h4> <p>We included adults or children undergoing any type of surgery or interventional procedure. We excluded trials that included participants with inherited bleeding disorders such as haemophilia A or von Willebrand disease. However we identified no randomised controlled trials that met our inclusion criteria in people with inherited bleeding disorders. </p> </section> <section id="CD001884-sec-0044"> <h4 class="title">Types of interventions</h4> <p>We included trials that investigated subcutaneous or intravenous DDAVP. We did not include studies on intranasal DDAVP because this route of administration has much lower bioavailability and produces a reduced effect (<a href="./references#CD001884-bbs2-0124" title="KöhlerM , HarrisA . Pharmacokinetics and haematological effects of desmopressin. European Journal of Clinical Pharmacology1988;35(3):281‐5. ">Köhler 1988</a>). </p> <p>We considered:</p> <p> <ul id="CD001884-list-0004"> <li> <p>trials that compared subcutaneous or intravenous DDAVP versus placebo or no active comparator; and </p> </li> <li> <p>trials that compared subcutaneous or intravenous DDAVP versus an active comparator (such as tranexamic acid or aprotinin). </p> </li> </ul> </p> </section> <section id="CD001884-sec-0045"> <h4 class="title">Types of outcome measures</h4> <section id="CD001884-sec-0046"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD001884-list-0005"> <li> <p>Numbers of participants transfused with blood (during the procedure and within 30 days of the procedure) </p> </li> <li> <p>Volume of blood transfused (expressed as total units of blood, or millilitres per kilogram for children) (during the procedure and within 30 days of the procedure) </p> </li> <li> <p>Blood loss in millilitres per adult participant, or blood loss in millilitres per kilogram for children (during the procedure and within 30 days of the procedure) </p> </li> </ul> </p> <section id="CD001884-sec-0047"> <h6 class="title">Justification for timing of assessment</h6> <p>We anticipated that the timing of DDAVP administration would vary between trials, with some administering it preoperatively and others administering it during or after the operation. DDAVP has a relatively short duration of action and may provide greatest benefit during times when blood loss is greatest (e.g. intraoperatively). Consequently, we considered this to be a key time point. We anticipated that most trials would not specify the timing of their assessments for each of the primary outcomes, so we allowed a broad period for reporting. We reported the timing of this outcome assessment in the results section and in <a href="#CD001884-tbl-0005">Table 1</a>; assessment was performed most commonly up to 48 hours, and up to 72 hours in all but one case. </p> <div class="table" id="CD001884-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study characteristics</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Trial</b> </p> <p><b>(country)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Number of participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Surgery type</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Cases</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Antiplatelet agents <br/> or platelet dysfunction (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Anticoagulants (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Coagulopathy (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Thrombocytopenia (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Antifibrinolytics (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Transfusion protocol</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Timing of blood loss or transfusion assessment (hours)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0001" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass [membrane oxygenator]. Japanese Journal of Artificial Organs1991;20(2):2516‐20. "><b>Aida 1991a</b> </a> </p> <p><b>(Japan)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0002" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass. Japanese Journal of Artificial Organs1991;20(2):2516‐20. "><b>Aida 1991b</b> </a> </p> <p><b>(Japan)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0003" title="AcarogluE , AlanayA , SuratA . Desmopressin (DDAVP) in scoliosis surgery. Journal of Bone and Joint Surgery ‐ British Volume. 1997; Vol. 79:Abstract O343. AlanayA , AcarogluE , OzdemirO , ErçelenO , BulutçuE , SuratA . Effects of deamino‐8‐D‐arginin vasopressin on blood loss and coagulation factors in scoliosis surgery. A double‐blind randomized clinical trial. Spine1999;24(9):877‐82. "><b>Alanay 1999</b> </a> </p> <p><b>(Turkey)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0004" title="AnderssonTL , SolemJO , TengbornL , VingeE . Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation. Circulation1990;81(3):872‐8. "><b>Andersson 1990</b> </a> </p> <p><b>(Sweden)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. "><b>Ansell 1992</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 2‐4<sup>a</sup> </p> <p>Placebo: 0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. "><b>Bignami 2016</b> </a> </p> <p><b>(Italy)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>135</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 38<sup>b</sup> </p> <p>Placebo: 43<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 1‐5</p> <p>Placebo: 1‐5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. "><b>Brown 1989</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 60<sup>b</sup> </p> <p>Placebo: 50<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. "><b>Casas 1995</b> </a> </p> <p><b>(Spain)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>149</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 14<sup>b</sup> </p> <p>Placebo: 9‐8<sup>b</sup> </p> <p>Aprotinin: 14‐6<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 0</p> <p>Placebo: 0</p> <p>Aprotinin: 100<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0009" title="ChuangHI , HorngYJ , LiY , ChernFC , ShiehDY , ChiouIS , et al. [Clinical assessment of desmopressin to reduce blood loss in patients after cardiopulmonary bypass]. Ma Zui Xue Za Zhi1993;31(1):35‐42. "><b>Chuang 1993</b> </a> </p> <p><b>(China)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. "><b>Clagett 1995</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>91</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vascular</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0011" title="ProstD , Barbier‐BoehmG , HazebroucqJ , BielskyMC , HvassU . Effect of desmopressin on excessive postoperative bleeding and blood product requirements associated with cardiopulmonary bypass. Thrombosis Research. 1992; Vol. 65:Abstract C132. deProstD , Barbier‐BoehmG , HazebroucqJ , IbrahimH , BielskyMC , HvassU , et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thrombosis and Haemostasis1992;68(2):106‐10. "><b>de Prost 1992</b> </a> </p> <p><b>(France)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 4‐3<sup>d</sup> </p> <p>Placebo: 13‐3<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. "><b>Despotis 1999</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 52<sup>b</sup> </p> <p>Placebo: 66<sup>b</sup> </p> <p>100<sup>f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 6</p> <p>Placebo: 0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP 50<sup>a</sup> </p> <p>Placebo 61<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. "><b>Dilthey 1993</b> </a> </p> <p><b>(Germany)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. "><b>Ellis 2001</b> </a> </p> <p><b>(Israel)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 0</p> <p>TXA: 100<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. "><b>Flordal 1991</b> </a> </p> <p><b>(Sweden)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. "><b>Flordal 1992</b> </a> </p> <p><b>(Sweden)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. "><b>Frankville 1991</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. "><b>Gratz 1992</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. "><b>Guay 1992</b> </a> </p> <p><b>(Canada)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0020" title="GuyuronB , VaughanC , SchlecterB . The role of DDAVP (desmopressin) in orthognathic surgery. Annals of Plastic Surgery1996;37(5):516‐9. "><b>Guyuron 1996</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maxillofacial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. "><b>Hackmann 1989</b> </a> </p> <p><b>(Canada)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 21‐6<sup>b</sup> </p> <p>Placebo: 14‐5<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0022" title="HajjarLA , GalasF , FortimM , Melo , R , FerreiraR , AulerJO . Desmopressin acetate reduces blood loss after cardiac surgery: a double‐bind randomized controlled trial. Circulation. 2007; Vol. 116, issue 16:396. "><b>Hajjar 2007</b> </a> </p> <p><b>(Brazil)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. "><b>Hedderich 1990</b> </a> </p> <p><b>(Canada)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 38‐7<sup>b</sup> </p> <p>Placebo: 41.9<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18 blood loss</p> <p>48 transfusion</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0024" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. "><b>Hemșinli 2012a</b> </a> </p> <p><b>(Turkey)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0025" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. "><b>Hemșinli 2012b</b> </a> </p> <p><b>(Turkey)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0026" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. "><b>Hemșinli 2012c</b> </a> </p> <p><b>(Turkey)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 0</p> <p>TXA: 100<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. "><b>Horrow 1991a</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. "><b>Horrow 1991b</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0029" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. "><b>Horrow 1991c</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 0</p> <p>TXA: 100<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0030" title="JiH , JinL . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Cardiology. 2013; Vol. 126:Abstract. JinL , JiHW . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Chinese Medical Journal2015;128(5):644‐7. "><b>Jin 2015</b> </a> </p> <p><b>(China)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. "><b>Karnezis 1994a</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. "><b>Karnezis 1994b</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0033" title="KobrinskyNL , IsraelisED , LettsM , PatelL , SchwertzN , CheangMS , et al. DDAVP shortens the bleeding time and decreases operative blood loss in hemostatically normal subjects undergoing spinal fusion surgery. Blood. 1985; Vol. 5:Abstract 1176. KobrinskyNL , LettsRM , PatelLR , IsraelsED , MonsonRC , SchwetzN , et al. 1‐Desamino‐8‐D‐arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double‐blinded, controlled trial.. Annals of Internal Medicine1987;107:446‐50. "><b>Kobrinsky 1987</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0034" title="KuitunenAH . Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery. Annals Chirurgiae et Gynaecologiae1992;81(1):11‐8. "><b>Kuitunen 1992</b> </a> </p> <p><b>(Finland)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0035" title="LazarchickJ , ConroyJM . The effect of 6% hydroxyethyl starch and desmopressin infusion on von Willebrand factor: ristocetin cofactor activity. Annals of Clinical and Laboratory Science1995;25(4):306‐9. "><b>Lazarchick 1995</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0036" title="LeeHK , KimYJ , JeongJU , ParkJS , ChiHS , KimSB . Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients. Nephron Clinical Practice2010;114(4):c248‐52. "><b>Lee 2010</b> </a> </p> <p><b>(South Korea)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dialysis catheter</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. "><b>Leino 2010</b> </a> </p> <p><b>(Finland)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0038" title="LethagenS , RugarnP , BergqvistD . Blood loss and safety with desmopressin or placebo during aorto‐iliac graft surgery. European Journal of Vascular Surgery1991;5(2):173‐8. "><b>Lethagen 1991</b> </a> </p> <p><b>(Sweden)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vascular</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0039" title="LettsM , PangE , D'AstousJ , JarvisJ , LawtonL , LukeB , et al. The influence of desmopressin on blood loss during spinal fusion surgery in neuromuscular patients. Spine1998;23(4):475‐8. "><b>Letts 1998</b> </a> </p> <p><b>(Canada)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intraoperative only</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. "><b>Manno 2011</b> </a> </p> <p><b>(Italy)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>162</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kidney biopsy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. "><b>Marquez 1992</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0041" title="Use of preoperative desmopressin in preventing bleeding in patients treated with SSRI's. International Standard Randomised Controlled Trial Number: ISRCTN10353850. MarczinskiSC , Van derMeerYG , Van derBeek enM , EgbertsAC . Use of preoperative desmopressin in preventing bleeding in patients treated with SSRIs [Desmopressine preoperatif vermindert bloedverlies bij SSRI‐gebruikers: gerandomiseerd placebogecontroleerd, dubbelblind onderzoek]. Wetenschappelijk Platform2007;1(3):60‐3. "><b>Marczinski 2007</b> </a> </p> <p><b>(Netherlands)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic/Breast/Abdominal</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. "><b>Mongan 1992a</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. "><b>Mongan 1992b</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>h</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. "><b>Oliver 2000</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Paediatric cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 9.7<sup>b</sup> </p> <p>Placebo: 3.4<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 6.5</p> <p>Placebo: 6.9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. "><b>Ozkisacik 2001</b> </a> </p> <p><b>(Turkey)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. "><b>Pleym 2004</b> </a> </p> <p><b>(Norway)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 6.5<sup>c</sup> </p> <p>Placebo: 17.4<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0048" title="ReichDL , HammerschlagBC , RandJH , Weiss‐BloomL , PeruchoH , GallaJ , et al. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):142‐5. "><b>Reich 1991</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 28.6<sup>b</sup> </p> <p>Placebo: 38.5<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0049" title="ReynoldsLM , NicolsonSC , JobesDR , StevenJM , NorwoodWI , McGonigleME , et al. Desmopressin does not decrease bleeding after cardiac operation in young children. Journal of Thoracic and Cardiovascular Surgery1993;106(6):954‐8. "><b>Reynolds 1993</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>95</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Paediatric cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. "><b>Rocha 1988</b> </a> </p> <p><b>(Spain)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. "><b>Rocha 1994</b> </a> </p> <p><b>(Spain)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>109</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP (1): 0</p> <p>DDAVP (2): 0</p> <p>Control: 0</p> <p>Aprotinin: 100<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0052" title="SalmenperaM , KuitunenA , HynynenM , HeinonenJ . Hemodynamic responses to desmopressin acetate after CABG: a double‐blind trial. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):146‐9. "><b>Salmenpera 1991</b> </a> </p> <p><b>(Finland)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. "><b>Salzman 1986</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. "><b>Schott 1995</b> </a> </p> <p><b>(Sweden)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0055" title="SeearM , WadsworthL , ShepsS , MontgomeryC , AshmoreP . The effect of desmopressin acetate (DDAVP) on post‐operative blood loss after open heart surgery in children. Blood. 1987; Vol. 5:Abstract 380a. SeearMD , WadsworthLD , RogersPC , ShepsS , AshmorePG . The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. Journal of Thoracic and Cardiovascular Surgery1989;98(2):217‐9. "><b>Seear 1989</b> </a> </p> <p><b>(Canada)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Paediatric cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. "><b>Shao 2015</b> </a> </p> <p><b>(China)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sinus</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intraoperative only</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. "><b>Sheridan 1994</b> </a> </p> <p><b>(Canada)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0058" title="SpytTJ , WeerasenaNA , BainWH , LoweGD , RumleyA . The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double‐blind trial. Perfusion1990;5(Suppl):57‐61. WeerasenaNA , SpytTJ , RumleyA , BainWH , LoweGD . Randomised, double‐blind, placebo‐controlled trial of desmopressin in routine coronary artery bypass surgery. British Journal of Haematology. 1990; Vol. 76:Abstract 38. "><b>Spyt 1990</b> </a> </p> <p><b>(UK)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 14.3<sup>b</sup> </p> <p>Placebo: 10.2<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>˜24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. "><b>Steinlechner 2011</b> </a> </p> <p><b>(Austria)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0060" title="TemeckBK , BachenheimerLC , KatzNM , CoughlinSS , WallaceRB . Desmopressin acetate in cardiac surgery: a double‐blind, randomized study. Southern Medical Journal1994;87(6):611‐5. "><b>Temeck 1994</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 20<sup>a</sup> </p> <p>Placebo: 30.2<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0061" title="TherouxMC , CorddryDH , TietzAE , MillerF , PeoplesJD , KettrickRG . A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double‐blinded study. Anesthesiology1997;87(2):260‐7. "><b>Theroux 1997</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0062" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores. Plastic and Reconstructive Surgery1992;89(2):279‐82. "><b>Wingate 1992a</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Plastic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0063" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores (low risk procedures only). Plastic and Reconstructive Surgery1992;89(2):279‐82. "><b>Wingate 1992b</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Plastic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0064" title="WongAY , IrwinMG , HuiTW , FungSK , FanST , MaES . Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Canadian Journal of Anaesthesia2003;50(1):14‐20. "><b>Wong 2003</b> </a> </p> <p><b>(Hong Kong)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hepatic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intraoperative only</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0065" title="ZoharE , FredmanB , EllisMH , IfrachN , SternA , JedeikinR . A comparative study of the postoperative allogeneic blood‐sparing effects of tranexamic acid and of desmopressin after total knee replacement. Transfusion2001;41(10):1285‐9. "><b>Zohar 2001</b> </a> </p> <p><b>(Israel)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 0</p> <p>TXA: 100<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Blank cells indicate that information was not reported in the original papers<br/> <sup>a</sup>Epsilon‐aminocaproic acid<br/> <sup>b</sup>Antiplatelet agents<br/> <sup>c</sup>Tranexamic acid<br/> <sup>d</sup>Aprotinin<br/> <sup>e</sup>Defined as bleeding time greater than 10 seconds<br/> <sup>f</sup>Defined as hemoSTATUS &lt; 60%<br/> <sup>g</sup>Defined as prolonged platelet function analyser‐100 closure time<br/> <sup>h</sup>Defined as thromboelastography maximum clot amplitude &lt; 50 mm </p> </div> </div> </section> </section> <section id="CD001884-sec-0048"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD001884-list-0006"> <li> <p>Reoperation due to bleeding</p> </li> <li> <p>Numbers of participants with any bleeding during the procedure and with any blood loss within 30 days of the procedure (low‐risk procedures only, such as drain insertions or biopsies). These data are reported separately from the other bleeding analyses because blood loss is not expected from these procedures, and consequently the outcome is dichotomous </p> </li> <li> <p>All‐cause mortality within 30 days of the procedure</p> </li> <li> <p>Risk of thrombotic events (arterial or venous):</p> <ul id="CD001884-list-0007"> <li> <p>myocardial infarction up to 30 days post infusion</p> </li> <li> <p>stroke up to 30 days post infusion</p> </li> <li> <p>venous thromboembolism up to 30 days post infusion</p> </li> </ul> </li> <li> <p>Serious adverse events (clinically important hypotension) within 30 days of the procedure</p> </li> <li> <p>Quality of life</p> </li> </ul> </p> </section> </section> </section> <section id="CD001884-sec-0049"> <h3 class="title">Search methods for identification of studies</h3> <p>The Systematic Review Initiative Information Specialist (CD) formulated new search strategies in collaboration with the Cochrane Injuries Review Group. We created a new search strategy (<a href="./appendices#CD001884-sec-0258">Appendix 1</a>), rather than updating the search strategy used in the previous review (<a href="./references#CD001884-bbs2-0145" title="CarlessPA , HenryDA , MoxeyAJ , O'ConnellD , McClellandB , HendersonKM , et al. Desmopressin use for minimising allogeneic blood transfusion. Cochrane Database of Systematic Reviews2004, Issue 1. [DOI: 10.1002/14651858.CD001884.pub2] ">Carless 2004</a>). </p> <section id="CD001884-sec-0050"> <h4 class="title">Electronic searches</h4> <p>We searched for RCTs in the following databases:</p> <p> <ul id="CD001884-list-0008"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) (2017, Issue 3) in the Cochrane Library; </p> </li> <li> <p>MEDLINE (OvidSP, 1946 to 3 April 2017);</p> </li> <li> <p>PubMed (epublications only, to 3 April 2017);</p> </li> <li> <p>Embase (OvidSP, 1974 to 3 April 2017);</p> </li> <li> <p>Cumulative Index to Nursing and Allied Health Literature (CINAHL) (EBSCOhost, 1937 to 3 April 2017); </p> </li> <li> <p>UK Blood Transfusion Services/Systematic Review Initiative (UKBTS/SRI) Transfusion Evidence Library (<a href="http://www.transfusionevidencelibrary.com" target="_blank">www.transfusionevidencelibrary.com</a>) (1950 to 3 April 2017); </p> </li> <li> <p>Web of Science: Conference Proceedings Citation Index‐Science (CPCI‐S) (Thomson Reuters, 1990 to 3 April 2017); </p> </li> <li> <p>Latin American Caribbean Health Sciences Literature (LILACS) (BIREME/PAHO/WHO, 1982 to 3 April 2017); </p> </li> <li> <p>IndMed (ICMR‐NIC, 1985 to 3 April 2017);</p> </li> <li> <p>KoreaMed (KAMJE, 1997 to 3 April 2017);</p> </li> <li> <p>PakMediNet (2001 to 3 April 2017).</p> </li> </ul> </p> <p>We combined searches in MEDLINE, Embase, and CINAHL with adaptations of the Cochrane RCT search filters, as detailed in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD001884-bbs2-0127" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Lefebvre 2011</a>). We also searched ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>), the World Health Organization (WHO) International Clinical Trials Registry (ICTRP ‐ <a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch</a>), and the Hong Kong University Clinical Trials Register (<a href="http://www.hkuctr.com/" target="_blank">www.hkuctr.com</a>), to identify ongoing trials. We included the new search strategy in <a href="./appendices#CD001884-sec-0258">Appendix 1</a>. </p> </section> <section id="CD001884-sec-0051"> <h4 class="title">Searching other resources</h4> <p>We searched the bibliographies of eligible trials, review articles, and reports for further potentially relevant studies. </p> </section> </section> <section id="CD001884-sec-0052"> <h3 class="title" id="CD001884-sec-0052">Data collection and analysis</h3> <p>Two review authors screened all electronically derived citations and abstracts of papers identified by the review search strategy. Two review authors assessed risk of bias in the included studies and extracted data independently. </p> <section id="CD001884-sec-0053"> <h4 class="title">Selection of studies</h4> <p>Two independent review authors (MD, LE) initially screened all electronically derived citations and abstracts of papers identified by the review search strategy for relevance. At this stage, we excluded studies that were clearly irrelevant. Two independent review authors (MD, LE) then formally assessed the full texts of all potentially relevant trials for eligibility against the criteria outlined above. We resolved all disagreements by discussion without the need to consult a third review author (SS). We used an article abstraction form to extract information regarding randomisation criteria, study methods, presence of a transfusion protocol, type of surgery, treatment outcomes, and general comments. We recorded the reasons why potentially relevant studies failed to meet the eligibility criteria. </p> </section> <section id="CD001884-sec-0054"> <h4 class="title">Data extraction and management</h4> <p>We performed a new data extraction for all trials in this update of the review. Any two of the five review authors (MD, KO, CB, SB, LE) extracted data according to Cochrane guidelines (<a href="./references#CD001884-bbs2-0114" title="HigginsJP , DeeksJJ . Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). Review authors resolved disagreements by consensus and were not blinded to names of study authors, institutions, journals, or trial outcomes. Papers not published in English were translated in their entirety, then data extracted in the usual way (<a href="./references#CD001884-bbs2-0001" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass [membrane oxygenator]. Japanese Journal of Artificial Organs1991;20(2):2516‐20. ">Aida 1991a</a>; <a href="./references#CD001884-bbs2-0002" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass. Japanese Journal of Artificial Organs1991;20(2):2516‐20. ">Aida 1991b</a>; <a href="./references#CD001884-bbs2-0041" title="Use of preoperative desmopressin in preventing bleeding in patients treated with SSRI's. International Standard Randomised Controlled Trial Number: ISRCTN10353850. MarczinskiSC , Van derMeerYG , Van derBeek enM , EgbertsAC . Use of preoperative desmopressin in preventing bleeding in patients treated with SSRIs [Desmopressine preoperatif vermindert bloedverlies bij SSRI‐gebruikers: gerandomiseerd placebogecontroleerd, dubbelblind onderzoek]. Wetenschappelijk Platform2007;1(3):60‐3. ">Marczinski 2007</a>). We discussed unclear data or entries directly with the translators. We extracted data from studies in duplicate using an online systematic review management tool (Covidence; <a href="https://www.covidence.org/" target="_blank">www.covidence.org</a>), then entered the data into Review Manager 5 (<a href="./references#CD001884-bbs2-0133" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We collected the following data: </p> <p> <ul id="CD001884-list-0009"> <li> <p>type of study (study design, number of arms, single centre or multicentre);</p> </li> <li> <p>inclusion and exclusion criteria;</p> </li> <li> <p>participants (number of participants randomised, number of participants analysed, age, gender, antiplatelet agents, anticoagulants, coagulopathy, thrombocytopenia, use of tranexamic acid); </p> </li> <li> <p>details of surgery (type of surgery, duration of surgery, duration of cardiopulmonary bypass (if applicable), emergency or elective, use of cell salvage, use of a transfusion protocol); </p> </li> <li> <p>interventions (DDAVP dose, route of administration, diluent, speed of administration, timing of administration); </p> </li> <li> <p>comparators (type of comparator, route of administration, speed of administration, timing of administration); </p> </li> <li> <p>outcomes (number of participants exposed to blood transfusion (expressed as whole blood or packed red cells), blood loss, reoperation for bleeding, number of participants experiencing postoperative complications (thrombosis, myocardial infarction, stroke), mortality, number of participants requiring reoperation due to bleeding, quality of life); </p> </li> <li> <p>risk of bias (see <a href="#CD001884-sec-0055">Assessment of risk of bias in included studies</a>). </p> </li> </ul> </p> <p>When the standard error of the mean was reported, we derived the standard deviation.</p> </section> <section id="CD001884-sec-0055"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We performed an assessment of all RCTs using the Cochrane 'Risk of bias' tool according to Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD001884-bbs2-0115" title="HigginsJP , AltmanDG , SterneJA , editor(s) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). Any two of the five review authors (MD, KO, CB, SB, LE) worked independently to assess each element of potential bias listed below as 'high', 'low', or 'unclear risk of bias'. We considered a trial to be at low risk of bias overall if we judged it to have no high‐risk domains, and if we judged at least half of the domains to be at low risk of bias. In the <a href="./references#CD001884-sec-0299" title="">Characteristics of included studies</a> table we provided a brief description of the judgement statements upon which review authors assessed potential bias. We ensured that we reached consensus on the degree of risk of bias by comparing review authors' statements and, when necessary, by consulting with a third review author. The Cochrane tool for assessing risk of bias includes the following domains: </p> <p> <ul id="CD001884-list-0010"> <li> <p>selection bias: random sequence generation and allocation concealment;</p> </li> <li> <p>performance bias: blinding of participants and personnel;</p> </li> <li> <p>detection bias: blinding of outcome assessment;</p> </li> <li> <p>attrition bias: incomplete outcome data;</p> </li> <li> <p>reporting bias: selective reporting;</p> </li> <li> <p>other bias.</p> </li> </ul> </p> </section> <section id="CD001884-sec-0056"> <h4 class="title">Measures of treatment effect</h4> <p> <ul id="CD001884-list-0011"> <li> <p>For continuous outcomes, we recorded the mean, standard deviation, and total numbers of participants in both treatment and control groups. For dichotomous outcomes, we recorded numbers of events and total numbers of participants in both treatment and control groups. </p> </li> <li> <p>For continuous outcomes, using the same scale, we performed analyses based on the mean difference (MD) with 95% confidence intervals (CIs). </p> </li> <li> <p>For dichotomous outcomes, we reported the pooled risk ratio (RR) with 95% CI. When the number of observed events was small (&lt; 5% of sample per group), and when trials included balanced treatment groups, we reported Peto's odds ratio (pOR) with 95% CI (<a href="./references#CD001884-bbs2-0105" title="DeeksJJ , HigginsJP , AltmanDG , editor(s) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). </p> </li> <li> <p>When data allowed, we undertook quantitative assessments using Review Manager 5 (<a href="./references#CD001884-bbs2-0133" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> </li> <li> <p>When we could not report available data in any of the formats described above, we provided a narrative report and, when appropriate, presented the data in tables. </p> </li> </ul> </p> </section> <section id="CD001884-sec-0057"> <h4 class="title">Unit of analysis issues</h4> <p>We treated trials with three or more arms in accordance with advice given in Chapter 16 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD001884-bbs2-0116" title="HigginsJP , DeeksJJ , AltmanDG , editor(s) . Chapter 16: Special topics in Statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011c</a>). For studies with multiple treatment groups, two review authors excluded subgroups that were considered irrelevant to the analysis. We tabulated all subgroups in the <a href="./references#CD001884-sec-0299" title="">Characteristics of included studies</a> section. When appropriate, we combined groups to create a single pair‐wise comparison. When this was not possible, we selected the most appropriate pair of interventions and excluded the others (<a href="./references#CD001884-bbs2-0116" title="HigginsJP , DeeksJJ , AltmanDG , editor(s) . Chapter 16: Special topics in Statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011c</a>). We identified no cross‐over trials, but for future updates, if we identify them, we plan to establish whether assessment of outcome measures occurred before the cross‐over, and we will include outcomes assessed after the cross‐over if they are not biased by treatment provided before the cross‐over. We will examine each trial individually to determine this eventuality. We did not find any relevant cluster‐randomised trials, but for future updates of this review, we plan to analyse cluster‐randomised trials at the individual participant level, accounting for the cluster design, and to seek statistical advice. </p> </section> <section id="CD001884-sec-0058"> <h4 class="title">Dealing with missing data</h4> <p>When data were identified as missing or unclear in published literature, we contacted study authors directly. This practice was limited to contacting authors of studies published in the past ten years. We recorded the number of participants lost to follow‐up for each study and analysed data on an intention‐to‐treat (ITT) basis (<a href="./references#CD001884-bbs2-0116" title="HigginsJP , DeeksJJ , AltmanDG , editor(s) . Chapter 16: Special topics in Statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011c</a>). </p> </section> <section id="CD001884-sec-0059"> <h4 class="title">Assessment of heterogeneity</h4> <p>When we considered studies to be sufficiently homogenous in study design, we conducted meta‐analysis and assessed statistical heterogeneity of treatment effects between trials by using a Chi<sup>2</sup> test with a significance level at P &lt; 0.1 (<a href="./references#CD001884-bbs2-0105" title="DeeksJJ , HigginsJP , AltmanDG , editor(s) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). We used the I<sup>2</sup> statistic to quantify possible heterogeneity (I<sup>2</sup> &gt; 50% moderate heterogeneity, I<sup>2</sup> &gt; 80% considerable heterogeneity). When necessary, we explored potential causes of heterogeneity by conducting sensitivity and subgroup analyses. </p> </section> <section id="CD001884-sec-0060"> <h4 class="title">Assessment of reporting biases</h4> <p>We explored potential publication bias (small‐trial bias) by generating a funnel plot and by using a modified Harbord test for dichotomous outcomes (<a href="./references#CD001884-bbs2-0112" title="HarbordRM , EggerM , SterneJA . A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints. Statistics in Medicine2006;25(20):3443‐57. ">Harbord 2006</a>), and an Egger's test for continuous outcomes (<a href="./references#CD001884-bbs2-0108" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315(7109):629‐34. ">Egger 1997</a>). We considered a P value &lt; 0.1 as statistically significant for this test (<a href="./references#CD001884-bbs2-0139" title="SterneJA , EggerM , MoherD , editor(s) . Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Sterne 2011</a>). </p> </section> <section id="CD001884-sec-0061"> <h4 class="title">Data synthesis</h4> <p>We performed analyses according to recommendations provided in Chapter 9 of the <i>Cochrane Handbook for Systematic Reviews of Interventions,</i> using aggregated data for analysis (<a href="./references#CD001884-bbs2-0105" title="DeeksJJ , HigginsJP , AltmanDG , editor(s) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). For statistical analysis, we entered data into Review Manager 5 software (<a href="./references#CD001884-bbs2-0133" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). One review author (MD) entered the data, and a second (KO) checked the data for accuracy. When meta‐analysis was feasible, we used the random‐effects model for pooling data. We used the Mantel‐Haenszel method for dichotomous outcomes, and the inverse variance method (or standardised mean difference as necessary) for continuous outcomes. In cases for which events were rare and appropriate conditions were satisfied, we used Peto's odds method. We converted transfused blood volume expressed in millilitres (mL) to units by assuming 300 mL to be equivalent to one unit of blood (<a href="./references#CD001884-bbs2-0143" title="WaltersG . NHSBT Portfolio of Blood Components and Guidance for their Clinical Use. SPECIFICATION SPN223/6.2. http://hospital.blood.co.uk/media/28748/spn223.pdf 2016 (accessed 23 May 2017). ">Walters 2016</a>), as was done in the previous review (<a href="./references#CD001884-bbs2-0145" title="CarlessPA , HenryDA , MoxeyAJ , O'ConnellD , McClellandB , HendersonKM , et al. Desmopressin use for minimising allogeneic blood transfusion. Cochrane Database of Systematic Reviews2004, Issue 1. [DOI: 10.1002/14651858.CD001884.pub2] ">Carless 2004</a>). </p> <section id="CD001884-sec-0062"> <h5 class="title">Trial sequential analysis (TSA)</h5> <p>We provided a sample size estimate showing how many participants needed to be included in a meta‐analysis for it to produce reliable results. We used trial sequential methods to explore all treatment effects attained before the required sample size was reached, by using TSA v0.9 software (<a href="./references#CD001884-bbs2-0142" title="Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, Copenhagen, Denmark. TSA v0.9. Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, Copenhagen, Denmark, 2012. ">TSA 2011</a>). We sequenced trials by first publication date of the full articles. This provided the required information size (the total number of participants) necessary to detect a statistically significant underlying effect. We applied trial sequential analysis to the following outcomes: </p> <p> <ul id="CD001884-list-0012"> <li> <p>total volume of blood transfused (analysed in subgroups only);</p> </li> <li> <p>number of participants transfused with blood;</p> </li> <li> <p>total blood loss (analysed in subgroups only).</p> </li> </ul> </p> <p>We estimated total volume of blood transfused and total blood lost by calculating the mean across the control arms of the trials. We calculated transfusion requirements in this population using the proportion of participants in the control group who were transfused. We calculated the information size necessary for a relative risk reduction of 15%, equivalent to the minimum clinically relevant effect size described for prophylactic use of tranexamic acid before surgery (<a href="./references#CD001884-bbs2-0113" title="HenryDA , CarlessPA , MoxeyAJ , O'ConnellD , StokesBJ , FergussonDA , et al. Anti‐fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews2011, Issue 3. [DOI: 10.1002/14651858.CD001886.pub4] ">Henry 2011</a>; <a href="./references#CD001884-bbs2-0122" title="KerK , EdwardsP , PerelP , ShakurH , RobertsI . Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta‐analysis. BMJ2012;344:e3054. ">Ker 2012</a>). When calculated cumulative Z‐curves crossed trial sequential monitoring boundaries, we determined that statistical significance had been reached and the overall type I error rate had been maintained. We produced futility boundaries such that if the cumulative Z‐curve crossed the futility threshold, evidence showed that the two treatments did not differ more than the anticipated effect size. We used the O'Brien Fleming alpha‐spending function with an overall type I error rate of 5% and with 80% statistical power to derive two‐sided sequential monitoring and futility boundaries. We adjusted estimates according to calculated diversity (D<sup>2</sup>). We calculated variance empirically and used a model variance‐based heterogeneity correction. We performed TSA only for outcomes reported by two or more trials. </p> </section> </section> <section id="CD001884-sec-0063"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>When clinical and methodological characteristics of individual studies were sufficiently homogeneous, we combined the data to perform a meta‐analysis. We assessed statistical heterogeneity of treatment effects between studies using a Chi<sup>2</sup> test with a statistical significance level at P &lt; 0.1. We used the I<sup>2</sup> statistic to quantify the degree of potential heterogeneity and classified heterogeneity as moderate if I<sup>2</sup> was greater than 50%, and as considerable if I<sup>2</sup> exceeded 80%. We assessed potential causes of heterogeneity by conducting sensitivity and subgroup analyses (<a href="./references#CD001884-bbs2-0105" title="DeeksJJ , HigginsJP , AltmanDG , editor(s) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). We performed subgroup analyses for each of the following categories to assess effects on heterogeneity: </p> <p> <ul id="CD001884-list-0013"> <li> <p>type of surgery or procedure;</p> </li> <li> <p>age of participant (paediatric cardiac surgery defined as a separate subgroup);</p> </li> <li> <p>preoperative administration of DDAVP;</p> </li> <li> <p>inclusion of 75% or more participants with platelet dysfunction (measured by bleeding time or platelet function analyser 100) or taking antiplatelet agents, or both; </p> </li> <li> <p>inclusion of 75% or more participants taking an antifibrinolytic agent.</p> </li> </ul> </p> <p>We intended to investigate subgroups of participants with liver disease or kidney disease with uraemia, but the trials included in this review did not report these subgroups. </p> </section> <section id="CD001884-sec-0064"> <h4 class="title">Sensitivity analysis</h4> <p>We assessed the robustness of our findings by performing the following sensitivity analyses when data were sufficient. We included only those trials: </p> <p> <ul id="CD001884-list-0014"> <li> <p>with a ‘low risk of bias’ (defined as trials with no high risk of bias domains and at least half of the remaining domains considered to be at low risk of bias); </p> </li> <li> <p>that used autologous cell salvage (red cell transfusion and bleeding outcomes only);</p> </li> <li> <p>with a transfusion protocol;</p> </li> <li> <p>published as full‐text papers;</p> </li> <li> <p>with less than 20% dropout; and</p> </li> <li> <p>that had been prospectively registered in a trial database, if the study was published during 2010 or more recently. </p> </li> </ul> </p> <section id="CD001884-sec-0065"> <h5 class="title">Summary of findings</h5> <p>We used the GRADE approach to create a 'Summary of findings' table, as suggested in Chapters 11 and 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD001884-bbs2-0135" title="SchünemannHJ , OxmanAD , HigginsJP , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Schünemann 2011a</a>; <a href="./references#CD001884-bbs2-0136" title="SchünemannHJ , OxmanAD , VistGE , HigginsJP , DeeksJJ , GlasziouP , et al. Cochrane Applicability and Recommendations Methods Group. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Schünemann 2011b</a>). We used the GRADE approach to rate the quality of evidence as 'high', 'moderate', 'low', or 'very low', according to the following five GRADE considerations: </p> <p> <ul id="CD001884-list-0015"> <li> <p>risk of bias: serious or very serious;</p> </li> <li> <p>inconsistency: serious or very serious;</p> </li> <li> <p>indirectness: serious or very serious;</p> </li> <li> <p>imprecision: serious or very serious; and</p> </li> <li> <p>publication bias: likely or very likely.</p> </li> </ul> </p> <p>Outcomes included were:</p> <p> <ul id="CD001884-list-0016"> <li> <p>total volume of blood transfused;</p> </li> <li> <p>total number of participants transfused with blood;</p> </li> <li> <p>total blood loss;</p> </li> <li> <p>overall mortality up to 30 days post infusion;</p> </li> <li> <p>risk of thrombotic events (arterial or venous); and</p> </li> <li> <p>quality of life.</p> </li> </ul> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD001884-sec-0066" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD001884-sec-0066"></div> <section id="CD001884-sec-0067"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD001884-sec-0299" title="">Characteristics of included studies</a>; <a href="./references#CD001884-sec-0300" title="">Characteristics of excluded studies</a>; and <a href="./references#CD001884-sec-0302" title="">Characteristics of ongoing studies</a>. </p> <section id="CD001884-sec-0068"> <h4 class="title">Results of the search</h4> <p>Database searches for the 2017 update identified 2578 records, and searching the references of other records revealed one additional record. We reduced these to 1877 after removing duplicates. Two review authors (MD, LE) screened these records according to the criteria defined above and excluded 1760 records that were not RCTs or were clearly outside the scope of this review (see PRISMA diagram; <a href="#CD001884-fig-0001">Figure 1</a>). We obtained the full text of the remaining 117 records and excluded 33 of them. We divided multi‐arm trials into separate trials, which yielded 70 studies with 84 records: 65 completed trials (<a href="./references#CD001884-bbs2-0001" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass [membrane oxygenator]. Japanese Journal of Artificial Organs1991;20(2):2516‐20. ">Aida 1991a</a>; <a href="./references#CD001884-bbs2-0002" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass. Japanese Journal of Artificial Organs1991;20(2):2516‐20. ">Aida 1991b</a>; <a href="./references#CD001884-bbs2-0003" title="AcarogluE , AlanayA , SuratA . Desmopressin (DDAVP) in scoliosis surgery. Journal of Bone and Joint Surgery ‐ British Volume. 1997; Vol. 79:Abstract O343. AlanayA , AcarogluE , OzdemirO , ErçelenO , BulutçuE , SuratA . Effects of deamino‐8‐D‐arginin vasopressin on blood loss and coagulation factors in scoliosis surgery. A double‐blind randomized clinical trial. Spine1999;24(9):877‐82. ">Alanay 1999</a>; <a href="./references#CD001884-bbs2-0004" title="AnderssonTL , SolemJO , TengbornL , VingeE . Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation. Circulation1990;81(3):872‐8. ">Andersson 1990</a>; <a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0009" title="ChuangHI , HorngYJ , LiY , ChernFC , ShiehDY , ChiouIS , et al. [Clinical assessment of desmopressin to reduce blood loss in patients after cardiopulmonary bypass]. Ma Zui Xue Za Zhi1993;31(1):35‐42. ">Chuang 1993</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0011" title="ProstD , Barbier‐BoehmG , HazebroucqJ , BielskyMC , HvassU . Effect of desmopressin on excessive postoperative bleeding and blood product requirements associated with cardiopulmonary bypass. Thrombosis Research. 1992; Vol. 65:Abstract C132. deProstD , Barbier‐BoehmG , HazebroucqJ , IbrahimH , BielskyMC , HvassU , et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thrombosis and Haemostasis1992;68(2):106‐10. ">de Prost 1992</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. ">Dilthey 1993</a>; <a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. ">Ellis 2001</a>; <a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. ">Flordal 1991</a>; <a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. ">Flordal 1992</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>; <a href="./references#CD001884-bbs2-0020" title="GuyuronB , VaughanC , SchlecterB . The role of DDAVP (desmopressin) in orthognathic surgery. Annals of Plastic Surgery1996;37(5):516‐9. ">Guyuron 1996</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0022" title="HajjarLA , GalasF , FortimM , Melo , R , FerreiraR , AulerJO . Desmopressin acetate reduces blood loss after cardiac surgery: a double‐bind randomized controlled trial. Circulation. 2007; Vol. 116, issue 16:396. ">Hajjar 2007</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0024" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012a</a>; <a href="./references#CD001884-bbs2-0025" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012b</a>; <a href="./references#CD001884-bbs2-0026" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012c</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0029" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991c</a>; <a href="./references#CD001884-bbs2-0030" title="JiH , JinL . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Cardiology. 2013; Vol. 126:Abstract. JinL , JiHW . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Chinese Medical Journal2015;128(5):644‐7. ">Jin 2015</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0033" title="KobrinskyNL , IsraelisED , LettsM , PatelL , SchwertzN , CheangMS , et al. DDAVP shortens the bleeding time and decreases operative blood loss in hemostatically normal subjects undergoing spinal fusion surgery. Blood. 1985; Vol. 5:Abstract 1176. KobrinskyNL , LettsRM , PatelLR , IsraelsED , MonsonRC , SchwetzN , et al. 1‐Desamino‐8‐D‐arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double‐blinded, controlled trial.. Annals of Internal Medicine1987;107:446‐50. ">Kobrinsky 1987</a>; <a href="./references#CD001884-bbs2-0034" title="KuitunenAH . Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery. Annals Chirurgiae et Gynaecologiae1992;81(1):11‐8. ">Kuitunen 1992</a>; <a href="./references#CD001884-bbs2-0035" title="LazarchickJ , ConroyJM . The effect of 6% hydroxyethyl starch and desmopressin infusion on von Willebrand factor: ristocetin cofactor activity. Annals of Clinical and Laboratory Science1995;25(4):306‐9. ">Lazarchick 1995</a>; <a href="./references#CD001884-bbs2-0036" title="LeeHK , KimYJ , JeongJU , ParkJS , ChiHS , KimSB . Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients. Nephron Clinical Practice2010;114(4):c248‐52. ">Lee 2010</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0038" title="LethagenS , RugarnP , BergqvistD . Blood loss and safety with desmopressin or placebo during aorto‐iliac graft surgery. European Journal of Vascular Surgery1991;5(2):173‐8. ">Lethagen 1991</a>; <a href="./references#CD001884-bbs2-0039" title="LettsM , PangE , D'AstousJ , JarvisJ , LawtonL , LukeB , et al. The influence of desmopressin on blood loss during spinal fusion surgery in neuromuscular patients. Spine1998;23(4):475‐8. ">Letts 1998</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0041" title="Use of preoperative desmopressin in preventing bleeding in patients treated with SSRI's. International Standard Randomised Controlled Trial Number: ISRCTN10353850. MarczinskiSC , Van derMeerYG , Van derBeek enM , EgbertsAC . Use of preoperative desmopressin in preventing bleeding in patients treated with SSRIs [Desmopressine preoperatif vermindert bloedverlies bij SSRI‐gebruikers: gerandomiseerd placebogecontroleerd, dubbelblind onderzoek]. Wetenschappelijk Platform2007;1(3):60‐3. ">Marczinski 2007</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>; <a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. ">Ozkisacik 2001</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0048" title="ReichDL , HammerschlagBC , RandJH , Weiss‐BloomL , PeruchoH , GallaJ , et al. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):142‐5. ">Reich 1991</a>; <a href="./references#CD001884-bbs2-0049" title="ReynoldsLM , NicolsonSC , JobesDR , StevenJM , NorwoodWI , McGonigleME , et al. Desmopressin does not decrease bleeding after cardiac operation in young children. Journal of Thoracic and Cardiovascular Surgery1993;106(6):954‐8. ">Reynolds 1993</a>; <a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. ">Rocha 1988</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0052" title="SalmenperaM , KuitunenA , HynynenM , HeinonenJ . Hemodynamic responses to desmopressin acetate after CABG: a double‐blind trial. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):146‐9. ">Salmenpera 1991</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>; <a href="./references#CD001884-bbs2-0055" title="SeearM , WadsworthL , ShepsS , MontgomeryC , AshmoreP . The effect of desmopressin acetate (DDAVP) on post‐operative blood loss after open heart surgery in children. Blood. 1987; Vol. 5:Abstract 380a. SeearMD , WadsworthLD , RogersPC , ShepsS , AshmorePG . The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. Journal of Thoracic and Cardiovascular Surgery1989;98(2):217‐9. ">Seear 1989</a>; <a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>; <a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. ">Sheridan 1994</a>; <a href="./references#CD001884-bbs2-0058" title="SpytTJ , WeerasenaNA , BainWH , LoweGD , RumleyA . The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double‐blind trial. Perfusion1990;5(Suppl):57‐61. WeerasenaNA , SpytTJ , RumleyA , BainWH , LoweGD . Randomised, double‐blind, placebo‐controlled trial of desmopressin in routine coronary artery bypass surgery. British Journal of Haematology. 1990; Vol. 76:Abstract 38. ">Spyt 1990</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>; <a href="./references#CD001884-bbs2-0060" title="TemeckBK , BachenheimerLC , KatzNM , CoughlinSS , WallaceRB . Desmopressin acetate in cardiac surgery: a double‐blind, randomized study. Southern Medical Journal1994;87(6):611‐5. ">Temeck 1994</a>; <a href="./references#CD001884-bbs2-0061" title="TherouxMC , CorddryDH , TietzAE , MillerF , PeoplesJD , KettrickRG . A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double‐blinded study. Anesthesiology1997;87(2):260‐7. ">Theroux 1997</a>; <a href="./references#CD001884-bbs2-0062" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores. Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992a</a>; <a href="./references#CD001884-bbs2-0063" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores (low risk procedures only). Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992b</a>; <a href="./references#CD001884-bbs2-0064" title="WongAY , IrwinMG , HuiTW , FungSK , FanST , MaES . Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Canadian Journal of Anaesthesia2003;50(1):14‐20. ">Wong 2003</a>; <a href="./references#CD001884-bbs2-0065" title="ZoharE , FredmanB , EllisMH , IfrachN , SternA , JedeikinR . A comparative study of the postoperative allogeneic blood‐sparing effects of tranexamic acid and of desmopressin after total knee replacement. Transfusion2001;41(10):1285‐9. ">Zohar 2001</a>); four ongoing trials (<a href="./references#CD001884-bbs2-0097" title="DRIVE ‐ Desmopressin for procedures or radiological interventions. ISRCTN number: ISRCTN12845429 (accessed 23 May 2017). ">ISRCTN12845429</a>; <a href="./references#CD001884-bbs2-0098" title="Desmopressin as treatment for postoperative bleeding after cardiac surgery. ClinicalTrials.gov number: NCT00885924 (accessed 23 May 2017). ">NCT00885924</a>; <a href="./references#CD001884-bbs2-0099" title="DDAVP in the reduction of post‐operative ecchymosis in rhinoplasty. ClinicalTrials.gov number: NCT01982760 (accessed 23 May 2017). ">NCT01982760</a>; <a href="./references#CD001884-bbs2-0100" title="Study of DDAVP combined with TXA on the blood loss and transfusion need during and after scoliosis correction surgery. ClinicalTrials.gov number: NCT02084342 (accessed 23 May 2017). ">NCT02084342</a>); and one trial awaiting classification (<a href="./references#CD001884-bbs2-0096" title="Comparison of desmopressin with placebo, in hemostasis after heart transplant surgery. Iranian Registry of Clinical Trials number: IRCT2015010512642N8 (accessed 23 May 2017). JahangirifardA , RazaviMR , AhmadiZH , ForozeshfardM . The effect of desmopressin on the amount of bleeding and transfusion requirements in patients undergoing heart transplant surgery. Basic &amp; Clinical Pharmacology &amp; Toxicology2017:epub ahead of print. [DOI: 10.1111/bcpt.12780] ">Jahangirifard 2017</a>). </p> <div class="figure" id="CD001884-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD001884-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD001884-sec-0069"> <h4 class="title">Included studies</h4> <p>See <a href="./references#CD001884-sec-0299" title="">Characteristics of included studies</a> for full details of each study. </p> <section id="CD001884-sec-0070"> <h5 class="title">Design</h5> <p>We included 65 completed trials in the qualitative synthesis.</p> <p> <ul id="CD001884-list-0017"> <li> <p>Sixty trials were published as full‐text articles, four were reported in abstract form only (<a href="./references#CD001884-bbs2-0022" title="HajjarLA , GalasF , FortimM , Melo , R , FerreiraR , AulerJO . Desmopressin acetate reduces blood loss after cardiac surgery: a double‐bind randomized controlled trial. Circulation. 2007; Vol. 116, issue 16:396. ">Hajjar 2007</a>; <a href="./references#CD001884-bbs2-0024" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012a</a>; <a href="./references#CD001884-bbs2-0025" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012b</a>; <a href="./references#CD001884-bbs2-0026" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012c</a>), and one was published as full text but, despite a worldwide search, the original text could not be found, so we extracted data from the abstract (<a href="./references#CD001884-bbs2-0009" title="ChuangHI , HorngYJ , LiY , ChernFC , ShiehDY , ChiouIS , et al. [Clinical assessment of desmopressin to reduce blood loss in patients after cardiopulmonary bypass]. Ma Zui Xue Za Zhi1993;31(1):35‐42. ">Chuang 1993</a>). </p> </li> <li> <p>Trials were published between 1986 and 2016.</p> </li> <li> <p>Two trials were published in Japanese (<a href="./references#CD001884-bbs2-0001" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass [membrane oxygenator]. Japanese Journal of Artificial Organs1991;20(2):2516‐20. ">Aida 1991a</a>; <a href="./references#CD001884-bbs2-0002" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass. Japanese Journal of Artificial Organs1991;20(2):2516‐20. ">Aida 1991b</a>), one in Chinese (<a href="./references#CD001884-bbs2-0009" title="ChuangHI , HorngYJ , LiY , ChernFC , ShiehDY , ChiouIS , et al. [Clinical assessment of desmopressin to reduce blood loss in patients after cardiopulmonary bypass]. Ma Zui Xue Za Zhi1993;31(1):35‐42. ">Chuang 1993</a>), and one in Dutch (<a href="./references#CD001884-bbs2-0041" title="Use of preoperative desmopressin in preventing bleeding in patients treated with SSRI's. International Standard Randomised Controlled Trial Number: ISRCTN10353850. MarczinskiSC , Van derMeerYG , Van derBeek enM , EgbertsAC . Use of preoperative desmopressin in preventing bleeding in patients treated with SSRIs [Desmopressine preoperatif vermindert bloedverlies bij SSRI‐gebruikers: gerandomiseerd placebogecontroleerd, dubbelblind onderzoek]. Wetenschappelijk Platform2007;1(3):60‐3. ">Marczinski 2007</a>). The remaining 61 trials were published in English. </p> </li> <li> <p>One three‐arm trial compared DDAVP versus placebo and aprotinin (<a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>), and another compared DDAVP versus placebo and tranexamic acid (<a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. ">Ellis 2001</a>): DDAVP was compared with each comparator in separate analyses. Two trials compared two different doses of DDAVP versus placebo (<a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>): for these trials, the dose closest to a single intravenous dose of 0.3 μg/kg was used for DDAVP versus placebo analyses. One four‐arm trial compared two doses of DDAVP versus placebo and aprotinin (<a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>): the dose closest to a single intravenous dose of 0.3 μg/kg was used for DDAVP versus placebo and DDAVP versus aprotinin analyses. Four four‐arm trials were split into two, two‐arm trials, each comparing DDAVP versus placebo (<a href="./references#CD001884-bbs2-0001" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass [membrane oxygenator]. Japanese Journal of Artificial Organs1991;20(2):2516‐20. ">Aida 1991a</a>; <a href="./references#CD001884-bbs2-0002" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass. Japanese Journal of Artificial Organs1991;20(2):2516‐20. ">Aida 1991b</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0062" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores. Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992a</a>; <a href="./references#CD001884-bbs2-0063" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores (low risk procedures only). Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992b</a>). Two four‐arm trials compared DDAVP versus placebo, tranexamic acid, and a combination of tranexamic acid and DDAVP. These were split into the following comparisons: </p> <ul id="CD001884-list-0018"> <li> <p>DDAVP versus placebo (<a href="./references#CD001884-bbs2-0024" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012a</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>), and DDAVP plus tranexamic acid versus tranexamic acid (<a href="./references#CD001884-bbs2-0025" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012b</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>); all analysed in the DDAVP versus placebo comparison, as the only difference between arms was the presence, or absence, of DDAVP). </p> </li> <li> <p>DDAVP versus tranexamic acid (<a href="./references#CD001884-bbs2-0026" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012c</a>; <a href="./references#CD001884-bbs2-0029" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991c</a>). </p> </li> </ul> </li> <li> <p>The remaining 46 trials were parallel‐group two‐arm trials.</p> </li> <li> <p>Two trials were multi‐centre trials (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>), and whether four other trials were single‐centred or multi‐centred remains unclear (<a href="./references#CD001884-bbs2-0022" title="HajjarLA , GalasF , FortimM , Melo , R , FerreiraR , AulerJO . Desmopressin acetate reduces blood loss after cardiac surgery: a double‐bind randomized controlled trial. Circulation. 2007; Vol. 116, issue 16:396. ">Hajjar 2007</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0039" title="LettsM , PangE , D'AstousJ , JarvisJ , LawtonL , LukeB , et al. The influence of desmopressin on blood loss during spinal fusion surgery in neuromuscular patients. Spine1998;23(4):475‐8. ">Letts 1998</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>). The remaining 59 trials were single‐centre studies. </p> </li> </ul> </p> </section> <section id="CD001884-sec-0071"> <h5 class="title">Sample sizes</h5> <p>The trials included 3874 participants, with numbers ranging from nine participants in <a href="./references#CD001884-bbs2-0001" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass [membrane oxygenator]. Japanese Journal of Artificial Organs1991;20(2):2516‐20. ">Aida 1991a</a> to 162 in <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>. </p> </section> <section id="CD001884-sec-0072"> <h5 class="title">Setting</h5> <p>In <a href="#CD001884-tbl-0005">Table 1</a> we summarised full details of the countries where the trials were performed: 24 trials were conducted in the USA; six in Canada; five in Sweden; five in Turkey; three in China; three in Finland; three in Spain; two in Israel; two in Japan; two in Italy; and one each in Austria, Brazil, France, Germany, Hong Kong, the Netherlands, Norway, South Korea, and the UK. </p> </section> <section id="CD001884-sec-0073"> <h5 class="title">Participants</h5> <p>We outlined characteristics of trial participants in <a href="#CD001884-tbl-0005">Table 1</a>. </p> <p> <ul id="CD001884-list-0019"> <li> <p>Settings: 39 trials were in cardiac surgery; 12 in orthopaedic surgery; three in paediatric cardiac surgery; two in plastic surgery; two in vascular surgery; and one each in dialysis catheter insertion, hepatic surgery, kidney biopsy, maxillofacial surgery, and sinus surgery. One trial included a combination of participants undergoing orthopaedic, breast, and abdominal surgery, and one trial did not report the types of surgery included. </p> </li> <li> <p>Fifty‐four trials reported elective surgery or procedures; three trials reported emergency surgery; and eight trials provided insufficient information to reveal whether surgery was elective or emergency in nature. </p> </li> <li> <p>We had access to unpublished data from one trial and were able to extract data for a subgroup with platelet dysfunction (<a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>). Seventeen trials did not include participants with platelet dysfunction; four trials included 0.1% to 25% of participants with platelet dysfunction; three trials included 25.1% to 50% with platelet dysfunction; one trial included 50.1% to 75% with platelet dysfunction; and 12 trials included 75.1% to 100% with platelet dysfunction. Twenty‐eight trials provided no information on the number of participants with platelet dysfunction. </p> </li> <li> <p>Thirty trials did not include participants taking an anticoagulant drug; two trials included up to 10% of participants taking anticoagulants; no trials included more than 10% of participants taking an anticoagulant drug. Thirty‐three trials provided no information about the number of participants taking anticoagulant drugs. </p> </li> <li> <p>Twenty‐two trials did not include participants with a coagulopathy, and one trial reported a single participant with a coagulopathy in each arm. Forty‐two trials provided no information about the number of participants with coagulopathies. </p> </li> <li> <p>Sixteen trials did not include participants with thrombocytopenia, and 49 trials provided no information on the number of participants with thrombocytopenia. </p> </li> <li> <p>Three trials included no participants who received an antifibrinolytic agent; three included 0.1% to 25% of participants taking antifibrinolytic agents; one included 25.1% to 50% taking antifibrinolytic agents; one included 50.1% to 75% taking antifibrinolytic agents; and four included more than 75% of participants taking antifibrinolytic agents. Six trials compared DDAVP directly with an antifibrinolytic agent, and in these trials, no participants in the DDAVP arm received an antifibrinolytic agent. Forty‐seven trials provided no information about whether participants received an antifibrinolytic agent. </p> </li> <li> <p>Two trials did not use autologous cell salvage; 13 trials used autologous cell salvage for all participants; and 50 trials did not report whether autologous cell salvage was used. </p> </li> <li> <p>Two trials did not use a transfusion protocol, and transfusion decisions were made at the discretion of the treating physician; 26 used a transfusion protocol to guide transfusion decisions; and 37 trials did not report whether a transfusion protocol was used to guide transfusion decisions. </p> </li> <li> <p>Seven trials included only children (<a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>; <a href="./references#CD001884-bbs2-0033" title="KobrinskyNL , IsraelisED , LettsM , PatelL , SchwertzN , CheangMS , et al. DDAVP shortens the bleeding time and decreases operative blood loss in hemostatically normal subjects undergoing spinal fusion surgery. Blood. 1985; Vol. 5:Abstract 1176. KobrinskyNL , LettsRM , PatelLR , IsraelsED , MonsonRC , SchwetzN , et al. 1‐Desamino‐8‐D‐arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double‐blinded, controlled trial.. Annals of Internal Medicine1987;107:446‐50. ">Kobrinsky 1987</a>; <a href="./references#CD001884-bbs2-0039" title="LettsM , PangE , D'AstousJ , JarvisJ , LawtonL , LukeB , et al. The influence of desmopressin on blood loss during spinal fusion surgery in neuromuscular patients. Spine1998;23(4):475‐8. ">Letts 1998</a>; <a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>; <a href="./references#CD001884-bbs2-0049" title="ReynoldsLM , NicolsonSC , JobesDR , StevenJM , NorwoodWI , McGonigleME , et al. Desmopressin does not decrease bleeding after cardiac operation in young children. Journal of Thoracic and Cardiovascular Surgery1993;106(6):954‐8. ">Reynolds 1993</a>; <a href="./references#CD001884-bbs2-0055" title="SeearM , WadsworthL , ShepsS , MontgomeryC , AshmoreP . The effect of desmopressin acetate (DDAVP) on post‐operative blood loss after open heart surgery in children. Blood. 1987; Vol. 5:Abstract 380a. SeearMD , WadsworthLD , RogersPC , ShepsS , AshmorePG . The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. Journal of Thoracic and Cardiovascular Surgery1989;98(2):217‐9. ">Seear 1989</a>; <a href="./references#CD001884-bbs2-0061" title="TherouxMC , CorddryDH , TietzAE , MillerF , PeoplesJD , KettrickRG . A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double‐blinded study. Anesthesiology1997;87(2):260‐7. ">Theroux 1997</a>); and in six trials it was unclear whether participants were children or adults (<a href="./references#CD001884-bbs2-0020" title="GuyuronB , VaughanC , SchlecterB . The role of DDAVP (desmopressin) in orthognathic surgery. Annals of Plastic Surgery1996;37(5):516‐9. ">Guyuron 1996</a>; <a href="./references#CD001884-bbs2-0022" title="HajjarLA , GalasF , FortimM , Melo , R , FerreiraR , AulerJO . Desmopressin acetate reduces blood loss after cardiac surgery: a double‐bind randomized controlled trial. Circulation. 2007; Vol. 116, issue 16:396. ">Hajjar 2007</a>; <a href="./references#CD001884-bbs2-0035" title="LazarchickJ , ConroyJM . The effect of 6% hydroxyethyl starch and desmopressin infusion on von Willebrand factor: ristocetin cofactor activity. Annals of Clinical and Laboratory Science1995;25(4):306‐9. ">Lazarchick 1995</a>; <a href="./references#CD001884-bbs2-0060" title="TemeckBK , BachenheimerLC , KatzNM , CoughlinSS , WallaceRB . Desmopressin acetate in cardiac surgery: a double‐blind, randomized study. Southern Medical Journal1994;87(6):611‐5. ">Temeck 1994</a>; <a href="./references#CD001884-bbs2-0062" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores. Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992a</a>; <a href="./references#CD001884-bbs2-0063" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores (low risk procedures only). Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992b</a>). The remaining 52 trials included only adults. </p> </li> </ul> </p> </section> <section id="CD001884-sec-0074"> <h5 class="title">Interventions</h5> <p>We reported full details of interventions for each trial in <a href="./references#CD001884-sec-0299" title="">Characteristics of included studies</a> and summarised these details in <a href="#CD001884-tbl-0006">Table 2</a>. </p> <div class="table" id="CD001884-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Intervention characteristics</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> DDAVP dose(s) (μg/kg)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Timing of dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Timing summary</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Comparator(s)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Preoperative DDAVP</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0003" title="AcarogluE , AlanayA , SuratA . Desmopressin (DDAVP) in scoliosis surgery. Journal of Bone and Joint Surgery ‐ British Volume. 1997; Vol. 79:Abstract O343. AlanayA , AcarogluE , OzdemirO , ErçelenO , BulutçuE , SuratA . Effects of deamino‐8‐D‐arginin vasopressin on blood loss and coagulation factors in scoliosis surgery. A double‐blind randomized clinical trial. Spine1999;24(9):877‐82. "><b>Alanay 1999</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Induction of anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. "><b>Flordal 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 (× 2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At start of surgery and again after 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. "><b>Flordal 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 (× 2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At start of surgery and again after 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. "><b>Guay 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 μg/m<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At time of first skin incision</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0020" title="GuyuronB , VaughanC , SchlecterB . The role of DDAVP (desmopressin) in orthognathic surgery. Annals of Plastic Surgery1996;37(5):516‐9. "><b>Guyuron 1996</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 minutes preoperatively</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0033" title="KobrinskyNL , IsraelisED , LettsM , PatelL , SchwertzN , CheangMS , et al. DDAVP shortens the bleeding time and decreases operative blood loss in hemostatically normal subjects undergoing spinal fusion surgery. Blood. 1985; Vol. 5:Abstract 1176. KobrinskyNL , LettsRM , PatelLR , IsraelsED , MonsonRC , SchwetzN , et al. 1‐Desamino‐8‐D‐arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double‐blinded, controlled trial.. Annals of Internal Medicine1987;107:446‐50. "><b>Kobrinsky 1987</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 μg/m<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after induction of anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0035" title="LazarchickJ , ConroyJM . The effect of 6% hydroxyethyl starch and desmopressin infusion on von Willebrand factor: ristocetin cofactor activity. Annals of Clinical and Laboratory Science1995;25(4):306‐9. "><b>Lazarchick 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After anaesthetic induction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0036" title="LeeHK , KimYJ , JeongJU , ParkJS , ChiHS , KimSB . Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients. Nephron Clinical Practice2010;114(4):c248‐52. "><b>Lee 2010</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. "><b>Leino 2010</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>0.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>At start of surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP 0.2 μg/kg</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0038" title="LethagenS , RugarnP , BergqvistD . Blood loss and safety with desmopressin or placebo during aorto‐iliac graft surgery. European Journal of Vascular Surgery1991;5(2):173‐8. "><b>Lethagen 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately before start of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0039" title="LettsM , PangE , D'AstousJ , JarvisJ , LawtonL , LukeB , et al. The influence of desmopressin on blood loss during spinal fusion surgery in neuromuscular patients. Spine1998;23(4):475‐8. "><b>Letts 1998</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 μg/m<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after induction of anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. "><b>Manno 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 hour before biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0041" title="Use of preoperative desmopressin in preventing bleeding in patients treated with SSRI's. International Standard Randomised Controlled Trial Number: ISRCTN10353850. MarczinskiSC , Van derMeerYG , Van derBeek enM , EgbertsAC . Use of preoperative desmopressin in preventing bleeding in patients treated with SSRIs [Desmopressine preoperatif vermindert bloedverlies bij SSRI‐gebruikers: gerandomiseerd placebogecontroleerd, dubbelblind onderzoek]. Wetenschappelijk Platform2007;1(3):60‐3. "><b>Marczinski 2007</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 μg to 45 μg depending on weight</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. "><b>Schott 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 (× 2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Post induction of anaesthesia and again after 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. "><b>Shao 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After induction of anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. "><b>Steinlechner 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After induction of anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0061" title="TherouxMC , CorddryDH , TietzAE , MillerF , PeoplesJD , KettrickRG . A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double‐blinded study. Anesthesiology1997;87(2):260‐7. "><b>Theroux 1997</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0062" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores. Plastic and Reconstructive Surgery1992;89(2):279‐82. "><b>Wingate 1992a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After induction of anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0063" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores (low risk procedures only). Plastic and Reconstructive Surgery1992;89(2):279‐82. "><b>Wingate 1992b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After induction of anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0064" title="WongAY , IrwinMG , HuiTW , FungSK , FanST , MaES . Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Canadian Journal of Anaesthesia2003;50(1):14‐20. "><b>Wong 2003</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After induction of anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>DDAVP administered at end of operation</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0001" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass [membrane oxygenator]. Japanese Journal of Artificial Organs1991;20(2):2516‐20. "><b>Aida 1991a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 minutes after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0002" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass. Japanese Journal of Artificial Organs1991;20(2):2516‐20. "><b>Aida 1991b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 minutes after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0004" title="AnderssonTL , SolemJO , TengbornL , VingeE . Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation. Circulation1990;81(3):872‐8. "><b>Andersson 1990</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 minutes after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. "><b>Ansell 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. "><b>Bignami 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In event of excessive bleeding, after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation/postoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. "><b>Brown 1989</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. "><b>Casas 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aprotinin<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0009" title="ChuangHI , HorngYJ , LiY , ChernFC , ShiehDY , ChiouIS , et al. [Clinical assessment of desmopressin to reduce blood loss in patients after cardiopulmonary bypass]. Ma Zui Xue Za Zhi1993;31(1):35‐42. "><b>Chuang 1993</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 minutes after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. "><b>Clagett 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 minutes after heparinisation and before aortic cross‐clamp application</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. "><b>Despotis 1999</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. "><b>Dilthey 1993</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 minutes after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. "><b>Ellis 2001</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Before removal of tourniquet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tranexamic acid<sup>b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. "><b>Frankville 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 minutes after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. "><b>Gratz 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. "><b>Hackmann 1989</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0022" title="HajjarLA , GalasF , FortimM , Melo , R , FerreiraR , AulerJO . Desmopressin acetate reduces blood loss after cardiac surgery: a double‐bind randomized controlled trial. Circulation. 2007; Vol. 116, issue 16:396. "><b>Hajjar 2007</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. "><b>Hedderich 1990</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. "><b>Horrow 1991a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. "><b>Horrow 1991b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0029" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. "><b>Horrow 1991c</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tranexamic acid<sup>c</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0030" title="JiH , JinL . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Cardiology. 2013; Vol. 126:Abstract. JinL , JiHW . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Chinese Medical Journal2015;128(5):644‐7. "><b>Jin 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Before cardiac rewarming</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. "><b>Karnezis 1994a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 minutes before closure of wound</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. "><b>Karnezis 1994b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 minutes before closure of wound</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. "><b>Marquez 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP 0.3 μg/kg × 2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. "><b>Mongan 1992a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After reversal of heparin and before chest closure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. "><b>Mongan 1992b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After reversal of heparin and before chest closure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. "><b>Oliver 2000</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 minutes after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. "><b>Ozkisacik 2001</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After reversal of heparin (timing unclear)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. "><b>Pleym 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0048" title="ReichDL , HammerschlagBC , RandJH , Weiss‐BloomL , PeruchoH , GallaJ , et al. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):142‐5. "><b>Reich 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 minutes after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0049" title="ReynoldsLM , NicolsonSC , JobesDR , StevenJM , NorwoodWI , McGonigleME , et al. Desmopressin does not decrease bleeding after cardiac operation in young children. Journal of Thoracic and Cardiovascular Surgery1993;106(6):954‐8. "><b>Reynolds 1993</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 minutes after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. "><b>Rocha 1988</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. "><b>Rocha 1994</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aprotinin<sup>d</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP 0.3 μg/kg × 2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0052" title="SalmenperaM , KuitunenA , HynynenM , HeinonenJ . Hemodynamic responses to desmopressin acetate after CABG: a double‐blind trial. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):146‐9. "><b>Salmenpera 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Via pulmonary artery catheter immediately after sternal closure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. "><b>Salzman 1986</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0055" title="SeearM , WadsworthL , ShepsS , MontgomeryC , AshmoreP . The effect of desmopressin acetate (DDAVP) on post‐operative blood loss after open heart surgery in children. Blood. 1987; Vol. 5:Abstract 380a. SeearMD , WadsworthLD , RogersPC , ShepsS , AshmorePG . The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. Journal of Thoracic and Cardiovascular Surgery1989;98(2):217‐9. "><b>Seear 1989</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After reversal of heparin (timing unclear)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. "><b>Sheridan 1994</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 μg/m<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After reversal of heparin (timing unclear)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0058" title="SpytTJ , WeerasenaNA , BainWH , LoweGD , RumleyA . The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double‐blind trial. Perfusion1990;5(Suppl):57‐61. WeerasenaNA , SpytTJ , RumleyA , BainWH , LoweGD . Randomised, double‐blind, placebo‐controlled trial of desmopressin in routine coronary artery bypass surgery. British Journal of Haematology. 1990; Vol. 76:Abstract 38. "><b>Spyt 1990</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After reversal of heparin (timing unclear)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0060" title="TemeckBK , BachenheimerLC , KatzNM , CoughlinSS , WallaceRB . Desmopressin acetate in cardiac surgery: a double‐blind, randomized study. Southern Medical Journal1994;87(6):611‐5. "><b>Temeck 1994</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After reversal of heparin (timing unclear)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0065" title="ZoharE , FredmanB , EllisMH , IfrachN , SternA , JedeikinR . A comparative study of the postoperative allogeneic blood‐sparing effects of tranexamic acid and of desmopressin after total knee replacement. Transfusion2001;41(10):1285‐9. "><b>Zohar 2001</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 minutes before deflation of tourniquet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tranexamic acid<sup>b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>DDAVP administered postoperatively</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0011" title="ProstD , Barbier‐BoehmG , HazebroucqJ , BielskyMC , HvassU . Effect of desmopressin on excessive postoperative bleeding and blood product requirements associated with cardiopulmonary bypass. Thrombosis Research. 1992; Vol. 65:Abstract C132. deProstD , Barbier‐BoehmG , HazebroucqJ , IbrahimH , BielskyMC , HvassU , et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thrombosis and Haemostasis1992;68(2):106‐10. "><b>de Prost 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Between end of operation and 6 hours postoperatively</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0034" title="KuitunenAH . Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery. Annals Chirurgiae et Gynaecologiae1992;81(1):11‐8. "><b>Kuitunen 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after sternal closure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Timing of DDAVP administration unclear</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0024" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. "><b>Hemșinli 2012a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0025" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. "><b>Hemșinli 2012b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0026" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. "><b>Hemșinli 2012c</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tranexamic acid<sup>c</sup> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>Aprotinin 2 million KIU in 200 mL preoperatively, 2 million KIU in 200 mL in fluid prime, 500,000 KIU in 50 mL/h from skin incision to skin closure<br/> <sup>b</sup>Tranexamic acid 15 mg/kg 30 minutes before tourniquet removed over 30 minutes, then 10 mg/kg/h until 12 hours after tourniquet deflated<br/> <sup>c</sup>Tranexamic acid 10 mg/kg loading dose after induction of anaesthesia and before first skin incision over 30 minutes, then 1 mg/kg/h for 10 hours<br/> <sup>d</sup>Aprotinin 2 million KIU within 30 minutes after induction of anaesthesia followed by a continuous infusion of 500,000 KIU/h until the patient left the operating room, plus an additional bolus of 2 million KIU aprotinin in the pump prime by replacement of crystalloid solution </p> <p><b>Abbreviation</b> </p> <p>KIU: kilounits</p> </div> </div> <p> <ul id="CD001884-list-0020"> <li> <p>Fifty‐two trials used a single dose of 0.3 μg/kg DDAVP intravenously; one trial used a single dose of 0.4 μg/kg DDAVP intravenously; four trials administered two doses of 0.3 μg/kg DDAVP intravenously six hours apart; one trial included two different doses of intravenous DDAVP (0.2 μg/kg and 0.4 μg/kg); four trials administered one dose of 10 μg/m<sup>2</sup> body surface area DDAVP intravenously; two trials administered 20 μg DDAVP intravenously to all participants; and one trial administered a single dose of 15 μg to 45 μg DDAVP intravenously (depending on body weight). </p> </li> <li> <p>Timing of administration varied between trials, with 20 trials administering DDAVP preoperatively; 39 trials administered DDAVP shortly before the end of the operation; two administered DDAVP postoperatively; and one administered it shortly before the end of the operation, or postoperatively in the event of excessive bleeding. Three trials did not report when DDAVP was administered. </p> </li> </ul> </p> </section> <section id="CD001884-sec-0075"> <h5 class="title">Comparators</h5> <p>We reported full details of comparators for each trial in <a href="./references#CD001884-sec-0299" title="">Characteristics of included studies</a> and summarised these details in <a href="#CD001884-tbl-0006">Table 2</a>. </p> <p> <ul id="CD001884-list-0021"> <li> <p>Fifty‐four two‐arm trials used a matching placebo as a comparator, most commonly 0.9% saline. </p> </li> <li> <p>One trial compared DDAVP versus tranexamic acid.</p> </li> <li> <p>One three‐arm trial compared two different doses of DDAVP versus placebo.</p> </li> <li> <p>One three‐arm trial compared DDAVP versus tranexamic acid and placebo.</p> </li> <li> <p>One three‐arm trial compared DDAVP versus aprotinin and placebo.</p> </li> <li> <p>One four‐arm trial compared two different doses of DDAVP versus aprotinin or standard care. </p> </li> <li> <p>Two four‐arm trials (each split into three two‐arm trials) compared DDAVP versus tranexamic acid, placebo, and a combination of DDAVP and tranexamic acid. </p> </li> </ul> </p> </section> <section id="CD001884-sec-0076"> <h5 class="title">Outcomes</h5> <p>We included full details of trial outcomes in <a href="./references#CD001884-sec-0299" title="">Characteristics of included studies</a>. No trial reported all outcomes of interest. One trial did not report any outcomes of interest for this review (<a href="./references#CD001884-bbs2-0035" title="LazarchickJ , ConroyJM . The effect of 6% hydroxyethyl starch and desmopressin infusion on von Willebrand factor: ristocetin cofactor activity. Annals of Clinical and Laboratory Science1995;25(4):306‐9. ">Lazarchick 1995</a>). </p> <p> <ul id="CD001884-list-0022"> <li> <p>Eleven trials reported volume of blood transfused intraoperatively.</p> </li> <li> <p>Forty‐one trials reported total volume of blood transfused.</p> </li> <li> <p>Six trials reported the number of participants transfused with blood intraoperatively.</p> </li> <li> <p>Twenty‐eight trials reported the total number of participants transfused with blood.</p> </li> <li> <p>Seventeen trials reported intraoperative blood loss.</p> </li> <li> <p>Fifty‐two trials reported total blood loss.</p> </li> <li> <p>One trial reported the number of participants undergoing interventional procedures with intraoperative bleeding. </p> </li> <li> <p>One trial reported the number of participants undergoing interventional procedures with any bleeding. </p> </li> <li> <p>Twenty‐four trials reported the number of participants undergoing reoperation due to bleeding. </p> </li> <li> <p>Twenty‐two trials reported overall mortality.</p> </li> <li> <p>Thirty‐one trials reported thrombotic disease (arterial or venous).</p> </li> <li> <p>Eighteen trials reported clinically important hypotension.</p> </li> <li> <p>No trials reported quality of life.</p> </li> </ul> </p> </section> <section id="CD001884-sec-0077"> <h5 class="title">Baseline level of bleeding and red cell transfusion</h5> <p>The baseline total volume of red cell transfusion varied between trials, with a range in the placebo arms of 0.7 units in <a href="./references#CD001884-bbs2-0064" title="WongAY , IrwinMG , HuiTW , FungSK , FanST , MaES . Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Canadian Journal of Anaesthesia2003;50(1):14‐20. ">Wong 2003</a>, to 6.6 units in <a href="./references#CD001884-bbs2-0009" title="ChuangHI , HorngYJ , LiY , ChernFC , ShiehDY , ChiouIS , et al. [Clinical assessment of desmopressin to reduce blood loss in patients after cardiopulmonary bypass]. Ma Zui Xue Za Zhi1993;31(1):35‐42. ">Chuang 1993</a>. Likewise, the proportion of participants who received a red cell transfusion ranged from 0% in <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>, to 100% in <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>, and volume of total blood loss varied between 310 mL in <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>, and 3130 mL in <a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>. </p> </section> <section id="CD001884-sec-0078"> <h5 class="title">Timing of outcome assessments for total volume of blood transfused and total blood loss </h5> <p>We reported full details of the timing of outcome assessments in <a href="#CD001884-tbl-0005">Table 1</a>. Fifty trials reported total volume of blood transfused and total blood loss within 48 hours of drug administration; seven trials reported these outcomes over a longer time; three reported these outcomes only intraoperatively; and five did not report sufficient detail to reveal the timing of this assessment. </p> </section> </section> <section id="CD001884-sec-0079"> <h4 class="title">Excluded studies</h4> <p>We excluded 33 records from the review (see <a href="./references#CD001884-sec-0300" title="">Characteristics of excluded studies</a> for details). </p> <p> <ul id="CD001884-list-0023"> <li> <p>Five records were review articles (<a href="./references#CD001884-bbs2-0069" title="GandhiCD , BulsaraKR , FifiJ , Kass‐HoutT , GrantRA , Delgado AlmandozJE , et al. Platelet function inhibitors and platelet function testing in neurointerventional procedures. Journal of Neurointerventional Surgery2014;6(8):567‐77. ">Gandhi 2014</a>; <a href="./references#CD001884-bbs2-0071" title="HansenPE , HansenJH . Desmopressin (DDAVP) in lumbar puncture. British Medical Journal1980; Vol. 280, issue 6223:1146. ">Hansen 1980</a>; <a href="./references#CD001884-bbs2-0080" title="MannucciPM , CarlssonS , HarrisAS . Desmopressin, surgery and thrombosis. Thrombosis and Haemostasis1994; Vol. 71, issue 1:154‐5. ">Mannucci 1994</a>; <a href="./references#CD001884-bbs2-0082" title="MyrvangH . Biopsy: desmopressin reduces risk of bleeding after percutaneous kidney biopsy. Nature Reviews. Nephrology2011;7(6):304. ">Myrvang 2011</a>; <a href="./references#CD001884-bbs2-0095" title="ZotzRB . A stratified metaanalysis of desmopressin (DDAVP) for minimising perioperative allogeneic blood transfusion. Blood. 2009; Vol. 114:Abstract 1306. ">Zotz 2009</a>). </p> </li> <li> <p>Fourteen studies were not RCTs (<a href="./references#CD001884-bbs2-0066" title="Invloed van voeding op farmacokinetiek en ‐dynamiek van desmopressine tablet in vergelijking met desmopressine MELT‐vorm. EudraCT Number: 2009‐017265‐33 (accessed 23 May 2017). ">EudraCT Number: 2009‐017265‐33</a>; <a href="./references#CD001884-bbs2-0067" title="FlordalPA , SahlinS . Use of desmopressin to prevent bleeding complications in patients treated with aspirin. The British Journal of Surgery1993;80(6):723‐4. ">Flordal 1993</a>; <a href="./references#CD001884-bbs2-0068" title="ForeroCF , RamirezJH , RojasG , SierraJC . Effects of desmopressin on bleeding in patients undergoing surgery to correct scoliosis [Efectos de la desmopresina sobre el sangrado en pacientes sometidos a cirugia para corregir escoliosis]. Revista Colombiana de Ortopedia y Traumatología2003;17(4):22‐7. ">Forero 2003</a>; <a href="./references#CD001884-bbs2-0072" title="HooghiemstraE , RademakerE , StookerW , LauwersH , WesterJ , RademakerB . Desmopressin haemostatic therapy during aortic valve replacement for severe aortic valve stenosis: effects on blood‐loss, use of blood products and postoperative recovery. Applied Cardiopulmonary Physiology. 2012:Abstract P‐26. ">Hooghiemstra 2012</a>; <a href="./references#CD001884-bbs2-0075" title="JohnsonRG , MurphyJM . The role of desmopressin in reducing blood loss during lumbar fusions. Surgery, Gynecology &amp; Obstetrics1990;171(3):223‐6. ">Johnson 1990</a>; <a href="./references#CD001884-bbs2-0076" title="KargerR , ReuterK , RohlfsJ , NimskyC , SureU , KretschmerV . The Platelet Function Analyzer (PFA‐100) as a screening tool in neurosurgery. ISRN Hematology2012;2012:839242. KargerR , ReuterK , RohlfsJ , SureU , KretschmerV . The platelet function analyzer (PFA‐100) as a screening tool in neurosurgery. Symposium of the Nederlandse Vereniging voor Thrombose en Hemostase (NVTH). 2010:Abstract P10‐09. ">Karger 2012</a>; <a href="./references#CD001884-bbs2-0077" title="KeylC , KmittaE , KueriS , ZietakT , TrenkD . Effects of aspirin and desmopressin on platelet reactivity in patients undergoing cardiac surgery with extracorporeal circulation. Thrombosis and Haemostasis2011;105(1):113‐21. ">Keyl 2011</a>; <a href="./references#CD001884-bbs2-0078" title="KimJH , BaekCH , MinJY , KimJS , KimSB , KimH . Desmopressin improves platelet function in uremic patients taking antiplatelet agents who require emergent invasive procedures. Annals of Hematology2015;94(9):1457‐61. ">Kim 2015</a>; <a href="./references#CD001884-bbs2-0079" title="LozanoM , EscolarG , BellucciS , MonteagudoJ , PicoM , OrdinasA , et al. L‐Deamino (8‐D‐arginine) vasopressin infusion partially corrects platelet deposition on subendothelium in Bernard‐Soulier syndrome: the role of factor VIII. Platelets1999;10(1):41‐5. ">Lozano 1999</a>; <a href="./references#CD001884-bbs2-0086" title="Perioperative use of desmopressin (DDAVP) in breast cancer. ClinicalTrials.gov number: NCT01606072 (accessed 23 May 2017). ">NCT01606072</a>; <a href="./references#CD001884-bbs2-0087" title="Desmopressin (DDAVP) in patients with colorectal cancer and rectal bleeding. ClinicalTrials.gov number: NCT01623206 (accessed 23 May 2017). ">NCT01623206</a>; <a href="./references#CD001884-bbs2-0090" title="PalaiaDA , RosenbergMH , BonannoPC . The use of DDAVP desmopressin reduces the incidence of microhematomas after facioplasty. Annals of Plastic Surgery2001;46(5):463‐6. ">Palaia 2001</a>; <a href="./references#CD001884-bbs2-0091" title="SpiroF , PolakowE . The effect of desmopressin on post‐lumbar puncture/myelography morbidity. South African Medical Journal1982; Vol. 62, issue 13:428. ">Spiro 1982</a>; <a href="./references#CD001884-bbs2-0093" title="WeinbergRS , GreccoMO , FerroGS , SeigelshiferDJ , PerroniNV , TerrierFJ , et al. A phase II dose‐escalation trial of perioperative desmopressin (1‐desamino‐8‐d‐arginine vasopressin) in breast cancer patients. SpringerPlus2015;4:428. ">Weinberg 2015</a>). </p> </li> <li> <p>Five were trials that included an ineligible participant group (<a href="./references#CD001884-bbs2-0070" title="HaithLRJr , PattonML , GoldmanWT , McCutchanKM . Diminishing blood loss during operation for burns. Surgery, Gynecology &amp; Obstetrics1993;176(2):119‐23. ">Haith 1993</a>; <a href="./references#CD001884-bbs2-0083" title="Desmopressin acetate 0.2 mg tablets, fasting. ClinicalTrials.gov number: NCT00835211 (accessed 23 May 2017). ">NCT00835211</a>; <a href="./references#CD001884-bbs2-0085" title="Effect of aspirin, hemodilution and desmopressin on platelet dysfunction. ClinicalTrials.gov number: NCT01382134 (accessed 23 May 2017). ">NCT01382134</a>; <a href="./references#CD001884-bbs2-0088" title="NilsenDW , HaeremJ , WestheimA , SkjennaldA , GrendahlH , GodalHC . Venous thrombosis following diagnostic transvenous catheterization by percutaneous catheter insertion: an evaluation of desmopressin as a thromboprophylactic agent. Thrombosis and Haemostasis1984;52(2):121‐3. ">Nilsen 1984</a>; <a href="./references#CD001884-bbs2-0094" title="ZielskeD , SeyfertUT , HeimMU , MrowietzC , JungF . Effects of desmopressin on the primary haemostasis impaired by clopidogrel. Annals of Hematology. 2003; Vol. 82:Abstract 338. ">Zielske 2003</a>). </p> </li> <li> <p>Six did not use the intervention of interest (<a href="./references#CD001884-bbs2-0073" title="The effect of desmopressin in reducing bleeding after cardiac surgery in patients receiving antiplatelet drugs in comparison with placebo. Iranian Registry of Clinical Trials number: IRCT2013092114728N1 (accessed 23 May 2017). ">IRCT2013092114728N1</a>; <a href="./references#CD001884-bbs2-0074" title="Effect of desmopressin on bleeding in coronary artery bypass graft surgery patients undergoing cardiopulmonary bypass pump with antiplatelet drugs. Iranian Registry of Clinical Trials number: IRCT201409304345N3 (accessed 23 May 2017). ">IRCT201409304345N3</a>; <a href="./references#CD001884-bbs2-0081" title="MirmansooriA , FarziF , SedighinejadA , ImantalabV , MohammadzadehA , Atrkar RoushanZ , et al. The effect of desmopressin on the amount of bleeding in patients undergoing coronary artery bypass graft surgery with a cardiopulmonary bypass pump after taking anti‐platelet medicine. Anesthesiology and Pain Medicine2016;6(5):e39226. ">Mirmansoori 2016</a>; <a href="./references#CD001884-bbs2-0084" title="Platelets Antiaggregation Control Enhancement (PACE) study. ClinicalTrials.gov number: NCT01218074 (accessed 23 May 2017). ">NCT01218074</a>; <a href="./references#CD001884-bbs2-0089" title="OzalE , KuralayE , BingolH , CingozF , CeylanS , TatarH . Does tranexamic acid reduce desmopressin‐induced hyperfibrinolysis?. The Journal of Thoracic and Cardiovascular Surgery2002;123(3):539‐43. ">Ozal 2002</a>; <a href="./references#CD001884-bbs2-0092" title="Prevention of bleeding in patients with cirrhosis undergoing dental extraction. ClinicalTrials.gov number: NCT00816127 (accessed 23 May 2017). StancaCM , MontazemAH , LawalA , ZhangJX , SchianoTD . Intranasal desmopressin versus blood transfusion in cirrhotic patients with coagulopathy undergoing dental extraction: a randomized controlled trial. Journal of Oral and Maxillofacial Surgery2010;68(1):138‐43. StancaCM , MontazemAH , ZhangJH , LawalA , SchianoTD . Intranasal desmopressin is effective in preventing bleeding after dental extraction in cirrhotic patients having moderate degrees of coagulopathy. Hepatology. 2007; Vol. 46:Abstract 568A. ">Stanca 2010</a>). </p> </li> <li> <p>Three records were secondary citations of excluded trials.</p> </li> </ul> </p> <section id="CD001884-sec-0080"> <h5 class="title">Ongoing studies</h5> <p>We identified four ongoing studies (see <a href="./references#CD001884-sec-0302" title="">Characteristics of ongoing studies</a>) (<a href="./references#CD001884-bbs2-0097" title="DRIVE ‐ Desmopressin for procedures or radiological interventions. ISRCTN number: ISRCTN12845429 (accessed 23 May 2017). ">ISRCTN12845429</a>; <a href="./references#CD001884-bbs2-0098" title="Desmopressin as treatment for postoperative bleeding after cardiac surgery. ClinicalTrials.gov number: NCT00885924 (accessed 23 May 2017). ">NCT00885924</a>; <a href="./references#CD001884-bbs2-0099" title="DDAVP in the reduction of post‐operative ecchymosis in rhinoplasty. ClinicalTrials.gov number: NCT01982760 (accessed 23 May 2017). ">NCT01982760</a>; <a href="./references#CD001884-bbs2-0100" title="Study of DDAVP combined with TXA on the blood loss and transfusion need during and after scoliosis correction surgery. ClinicalTrials.gov number: NCT02084342 (accessed 23 May 2017). ">NCT02084342</a>). Three of these trials have been completed but have not yet been published (<a href="./references#CD001884-bbs2-0098" title="Desmopressin as treatment for postoperative bleeding after cardiac surgery. ClinicalTrials.gov number: NCT00885924 (accessed 23 May 2017). ">NCT00885924</a>; <a href="./references#CD001884-bbs2-0099" title="DDAVP in the reduction of post‐operative ecchymosis in rhinoplasty. ClinicalTrials.gov number: NCT01982760 (accessed 23 May 2017). ">NCT01982760</a>; <a href="./references#CD001884-bbs2-0100" title="Study of DDAVP combined with TXA on the blood loss and transfusion need during and after scoliosis correction surgery. ClinicalTrials.gov number: NCT02084342 (accessed 23 May 2017). ">NCT02084342</a>). We will monitor the progress of these trials, and on publication (assuming eligibility), we will include them in future updates of this review. All four of the ongoing studies compare DDAVP versus placebo. One is assessing DDAVP before interventional procedures for thrombocytopenic patients (<a href="./references#CD001884-bbs2-0097" title="DRIVE ‐ Desmopressin for procedures or radiological interventions. ISRCTN number: ISRCTN12845429 (accessed 23 May 2017). ">ISRCTN12845429</a>), one involves cardiac surgery (<a href="./references#CD001884-bbs2-0098" title="Desmopressin as treatment for postoperative bleeding after cardiac surgery. ClinicalTrials.gov number: NCT00885924 (accessed 23 May 2017). ">NCT00885924</a>), one orthopaedic surgery (<a href="./references#CD001884-bbs2-0100" title="Study of DDAVP combined with TXA on the blood loss and transfusion need during and after scoliosis correction surgery. ClinicalTrials.gov number: NCT02084342 (accessed 23 May 2017). ">NCT02084342</a>), and one rhinoplasty (<a href="./references#CD001884-bbs2-0099" title="DDAVP in the reduction of post‐operative ecchymosis in rhinoplasty. ClinicalTrials.gov number: NCT01982760 (accessed 23 May 2017). ">NCT01982760</a>). These trials are planning to include approximately 147 participants in total. </p> </section> </section> </section> <section id="CD001884-sec-0081"> <h3 class="title">Risk of bias in included studies</h3> <p>See the ’Risk of bias’ tables within <a href="./references#CD001884-sec-0299" title="">Characteristics of included studies</a> for details of our assessment for each study, and <a href="#CD001884-fig-0002">Figure 2</a> for a tabular summary. </p> <div class="figure" id="CD001884-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001884-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD001884-sec-0082"> <h4 class="title">Allocation</h4> <section id="CD001884-sec-0083"> <h5 class="title">Sequence generation</h5> <p> <ul id="CD001884-list-0024"> <li> <p>Twenty‐one trials were at low risk of bias for sequence generation because they used either: </p> <ul id="CD001884-list-0025"> <li> <p>a table of random numbers (<a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0029" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991c</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>; <a href="./references#CD001884-bbs2-0062" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores. Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992a</a>; <a href="./references#CD001884-bbs2-0063" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores (low risk procedures only). Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992b</a>); or </p> </li> <li> <p>computer‐generated random numbers (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. ">Ellis 2001</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>; <a href="./references#CD001884-bbs2-0065" title="ZoharE , FredmanB , EllisMH , IfrachN , SternA , JedeikinR . A comparative study of the postoperative allogeneic blood‐sparing effects of tranexamic acid and of desmopressin after total knee replacement. Transfusion2001;41(10):1285‐9. ">Zohar 2001</a>). </p> </li> </ul> </li> <li> <p>The remaining 44 trials were at unclear risk of bias because they did not report details of the randomisation sequence. </p> </li> </ul> </p> </section> <section id="CD001884-sec-0084"> <h5 class="title">Concealment of treatment allocation</h5> <p> <ul id="CD001884-list-0026"> <li> <p>Eleven trials were at low risk for concealment of treatment allocation because they used sealed envelopes (<a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0029" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991c</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0055" title="SeearM , WadsworthL , ShepsS , MontgomeryC , AshmoreP . The effect of desmopressin acetate (DDAVP) on post‐operative blood loss after open heart surgery in children. Blood. 1987; Vol. 5:Abstract 380a. SeearMD , WadsworthLD , RogersPC , ShepsS , AshmorePG . The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. Journal of Thoracic and Cardiovascular Surgery1989;98(2):217‐9. ">Seear 1989</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>; <a href="./references#CD001884-bbs2-0064" title="WongAY , IrwinMG , HuiTW , FungSK , FanST , MaES . Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Canadian Journal of Anaesthesia2003;50(1):14‐20. ">Wong 2003</a>). </p> </li> <li> <p>The remaining 54 trials were at unclear risk of bias because they did not report details of treatment allocation. </p> </li> </ul> </p> </section> </section> <section id="CD001884-sec-0085"> <h4 class="title">Blinding</h4> <p> <ul id="CD001884-list-0027"> <li> <p>Twenty‐five trials were at low risk of bias with adequate blinding of participants, personnel, and analysts because: </p> <ul id="CD001884-list-0028"> <li> <p>they used identical vials of DDAVP and placebo (<a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0058" title="SpytTJ , WeerasenaNA , BainWH , LoweGD , RumleyA . The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double‐blind trial. Perfusion1990;5(Suppl):57‐61. WeerasenaNA , SpytTJ , RumleyA , BainWH , LoweGD . Randomised, double‐blind, placebo‐controlled trial of desmopressin in routine coronary artery bypass surgery. British Journal of Haematology. 1990; Vol. 76:Abstract 38. ">Spyt 1990</a>; <a href="./references#CD001884-bbs2-0060" title="TemeckBK , BachenheimerLC , KatzNM , CoughlinSS , WallaceRB . Desmopressin acetate in cardiac surgery: a double‐blind, randomized study. Southern Medical Journal1994;87(6):611‐5. ">Temeck 1994</a>; <a href="./references#CD001884-bbs2-0061" title="TherouxMC , CorddryDH , TietzAE , MillerF , PeoplesJD , KettrickRG . A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double‐blinded study. Anesthesiology1997;87(2):260‐7. ">Theroux 1997</a>); </p> </li> <li> <p>a pharmacist who was not otherwise involved in the trial prepared the DDAVP or matching placebo (<a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0029" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991c</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0041" title="Use of preoperative desmopressin in preventing bleeding in patients treated with SSRI's. International Standard Randomised Controlled Trial Number: ISRCTN10353850. MarczinskiSC , Van derMeerYG , Van derBeek enM , EgbertsAC . Use of preoperative desmopressin in preventing bleeding in patients treated with SSRIs [Desmopressine preoperatif vermindert bloedverlies bij SSRI‐gebruikers: gerandomiseerd placebogecontroleerd, dubbelblind onderzoek]. Wetenschappelijk Platform2007;1(3):60‐3. ">Marczinski 2007</a>; <a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>; <a href="./references#CD001884-bbs2-0049" title="ReynoldsLM , NicolsonSC , JobesDR , StevenJM , NorwoodWI , McGonigleME , et al. Desmopressin does not decrease bleeding after cardiac operation in young children. Journal of Thoracic and Cardiovascular Surgery1993;106(6):954‐8. ">Reynolds 1993</a>; <a href="./references#CD001884-bbs2-0055" title="SeearM , WadsworthL , ShepsS , MontgomeryC , AshmoreP . The effect of desmopressin acetate (DDAVP) on post‐operative blood loss after open heart surgery in children. Blood. 1987; Vol. 5:Abstract 380a. SeearMD , WadsworthLD , RogersPC , ShepsS , AshmorePG . The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. Journal of Thoracic and Cardiovascular Surgery1989;98(2):217‐9. ">Seear 1989</a>; <a href="./references#CD001884-bbs2-0062" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores. Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992a</a>; <a href="./references#CD001884-bbs2-0063" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores (low risk procedures only). Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992b</a>); or </p> </li> <li> <p>a member of the study team who was not involved in determining outcomes prepared the DDAVP or matching placebo, while all other members of the study team and outcome assessors were blinded (<a href="./references#CD001884-bbs2-0003" title="AcarogluE , AlanayA , SuratA . Desmopressin (DDAVP) in scoliosis surgery. Journal of Bone and Joint Surgery ‐ British Volume. 1997; Vol. 79:Abstract O343. AlanayA , AcarogluE , OzdemirO , ErçelenO , BulutçuE , SuratA . Effects of deamino‐8‐D‐arginin vasopressin on blood loss and coagulation factors in scoliosis surgery. A double‐blind randomized clinical trial. Spine1999;24(9):877‐82. ">Alanay 1999</a>; <a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>; <a href="./references#CD001884-bbs2-0064" title="WongAY , IrwinMG , HuiTW , FungSK , FanST , MaES . Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Canadian Journal of Anaesthesia2003;50(1):14‐20. ">Wong 2003</a>). </p> </li> </ul> </li> <li> <p>Two trials were at low risk of bias for blinding of participants and personnel but were at unclear risk for blinding analysts (<a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. ">Dilthey 1993</a>). </p> </li> <li> <p>Four trials were at unclear risk for blinding of participants and personnel and at low risk for blinding of analysts (<a href="./references#CD001884-bbs2-0020" title="GuyuronB , VaughanC , SchlecterB . The role of DDAVP (desmopressin) in orthognathic surgery. Annals of Plastic Surgery1996;37(5):516‐9. ">Guyuron 1996</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>). </p> </li> <li> <p>Two trials were at high risk for blinding of participants and personnel but at low risk of bias for blinding of analysts (<a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. ">Ellis 2001</a>; <a href="./references#CD001884-bbs2-0065" title="ZoharE , FredmanB , EllisMH , IfrachN , SternA , JedeikinR . A comparative study of the postoperative allogeneic blood‐sparing effects of tranexamic acid and of desmopressin after total knee replacement. Transfusion2001;41(10):1285‐9. ">Zohar 2001</a>). </p> </li> <li> <p>Five trials were at high risk of bias for blinding of participants, personnel, and study analysts because: </p> <ul id="CD001884-list-0029"> <li> <p>they were open label (<a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0024" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012a</a>; <a href="./references#CD001884-bbs2-0036" title="LeeHK , KimYJ , JeongJU , ParkJS , ChiHS , KimSB . Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients. Nephron Clinical Practice2010;114(4):c248‐52. ">Lee 2010</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>); or </p> </li> <li> <p>the rapid rate of desmopressin infusion induced clinically important hypotension which is likely to have resulted in unblinding (<a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>). </p> </li> </ul> </li> <li> <p>The remaining 27 trials did not report sufficient information to permit us to determine risk of bias from blinding. </p> </li> </ul> </p> </section> <section id="CD001884-sec-0086"> <h4 class="title">Incomplete outcome data</h4> <p> <ul id="CD001884-list-0030"> <li> <p>We considered 35 trials to be at low risk of bias for incomplete outcome data because participants were analysed on an ITT basis (<a href="./references#CD001884-bbs2-0001" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass [membrane oxygenator]. Japanese Journal of Artificial Organs1991;20(2):2516‐20. ">Aida 1991a</a>; <a href="./references#CD001884-bbs2-0002" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass. Japanese Journal of Artificial Organs1991;20(2):2516‐20. ">Aida 1991b</a>; <a href="./references#CD001884-bbs2-0003" title="AcarogluE , AlanayA , SuratA . Desmopressin (DDAVP) in scoliosis surgery. Journal of Bone and Joint Surgery ‐ British Volume. 1997; Vol. 79:Abstract O343. AlanayA , AcarogluE , OzdemirO , ErçelenO , BulutçuE , SuratA . Effects of deamino‐8‐D‐arginin vasopressin on blood loss and coagulation factors in scoliosis surgery. A double‐blind randomized clinical trial. Spine1999;24(9):877‐82. ">Alanay 1999</a>; <a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. ">Ellis 2001</a>; <a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. ">Flordal 1991</a>; <a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. ">Flordal 1992</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>; <a href="./references#CD001884-bbs2-0020" title="GuyuronB , VaughanC , SchlecterB . The role of DDAVP (desmopressin) in orthognathic surgery. Annals of Plastic Surgery1996;37(5):516‐9. ">Guyuron 1996</a>; <a href="./references#CD001884-bbs2-0030" title="JiH , JinL . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Cardiology. 2013; Vol. 126:Abstract. JinL , JiHW . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Chinese Medical Journal2015;128(5):644‐7. ">Jin 2015</a>; <a href="./references#CD001884-bbs2-0033" title="KobrinskyNL , IsraelisED , LettsM , PatelL , SchwertzN , CheangMS , et al. DDAVP shortens the bleeding time and decreases operative blood loss in hemostatically normal subjects undergoing spinal fusion surgery. Blood. 1985; Vol. 5:Abstract 1176. KobrinskyNL , LettsRM , PatelLR , IsraelsED , MonsonRC , SchwetzN , et al. 1‐Desamino‐8‐D‐arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double‐blinded, controlled trial.. Annals of Internal Medicine1987;107:446‐50. ">Kobrinsky 1987</a>; <a href="./references#CD001884-bbs2-0036" title="LeeHK , KimYJ , JeongJU , ParkJS , ChiHS , KimSB . Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients. Nephron Clinical Practice2010;114(4):c248‐52. ">Lee 2010</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0041" title="Use of preoperative desmopressin in preventing bleeding in patients treated with SSRI's. International Standard Randomised Controlled Trial Number: ISRCTN10353850. MarczinskiSC , Van derMeerYG , Van derBeek enM , EgbertsAC . Use of preoperative desmopressin in preventing bleeding in patients treated with SSRIs [Desmopressine preoperatif vermindert bloedverlies bij SSRI‐gebruikers: gerandomiseerd placebogecontroleerd, dubbelblind onderzoek]. Wetenschappelijk Platform2007;1(3):60‐3. ">Marczinski 2007</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>; <a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. ">Ozkisacik 2001</a>; <a href="./references#CD001884-bbs2-0048" title="ReichDL , HammerschlagBC , RandJH , Weiss‐BloomL , PeruchoH , GallaJ , et al. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):142‐5. ">Reich 1991</a>; <a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. ">Rocha 1988</a>; <a href="./references#CD001884-bbs2-0052" title="SalmenperaM , KuitunenA , HynynenM , HeinonenJ . Hemodynamic responses to desmopressin acetate after CABG: a double‐blind trial. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):146‐9. ">Salmenpera 1991</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>; <a href="./references#CD001884-bbs2-0055" title="SeearM , WadsworthL , ShepsS , MontgomeryC , AshmoreP . The effect of desmopressin acetate (DDAVP) on post‐operative blood loss after open heart surgery in children. Blood. 1987; Vol. 5:Abstract 380a. SeearMD , WadsworthLD , RogersPC , ShepsS , AshmorePG . The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. Journal of Thoracic and Cardiovascular Surgery1989;98(2):217‐9. ">Seear 1989</a>; <a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>; <a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. ">Sheridan 1994</a>; <a href="./references#CD001884-bbs2-0061" title="TherouxMC , CorddryDH , TietzAE , MillerF , PeoplesJD , KettrickRG . A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double‐blinded study. Anesthesiology1997;87(2):260‐7. ">Theroux 1997</a>; <a href="./references#CD001884-bbs2-0062" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores. Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992a</a>; <a href="./references#CD001884-bbs2-0063" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores (low risk procedures only). Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992b</a>). </p> </li> <li> <p>We considered 16 trials to be at high risk of bias because of:</p> <ul id="CD001884-list-0031"> <li> <p>exclusion of participants with severe bleeding or complications post randomisation (<a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0011" title="ProstD , Barbier‐BoehmG , HazebroucqJ , BielskyMC , HvassU . Effect of desmopressin on excessive postoperative bleeding and blood product requirements associated with cardiopulmonary bypass. Thrombosis Research. 1992; Vol. 65:Abstract C132. deProstD , Barbier‐BoehmG , HazebroucqJ , IbrahimH , BielskyMC , HvassU , et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thrombosis and Haemostasis1992;68(2):106‐10. ">de Prost 1992</a>; <a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. ">Dilthey 1993</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0034" title="KuitunenAH . Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery. Annals Chirurgiae et Gynaecologiae1992;81(1):11‐8. ">Kuitunen 1992</a>; <a href="./references#CD001884-bbs2-0038" title="LethagenS , RugarnP , BergqvistD . Blood loss and safety with desmopressin or placebo during aorto‐iliac graft surgery. European Journal of Vascular Surgery1991;5(2):173‐8. ">Lethagen 1991</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0049" title="ReynoldsLM , NicolsonSC , JobesDR , StevenJM , NorwoodWI , McGonigleME , et al. Desmopressin does not decrease bleeding after cardiac operation in young children. Journal of Thoracic and Cardiovascular Surgery1993;106(6):954‐8. ">Reynolds 1993</a>; <a href="./references#CD001884-bbs2-0064" title="WongAY , IrwinMG , HuiTW , FungSK , FanST , MaES . Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Canadian Journal of Anaesthesia2003;50(1):14‐20. ">Wong 2003</a>); or </p> </li> <li> <p>high or unbalanced participant dropout (<a href="./references#CD001884-bbs2-0004" title="AnderssonTL , SolemJO , TengbornL , VingeE . Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation. Circulation1990;81(3):872‐8. ">Andersson 1990</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0060" title="TemeckBK , BachenheimerLC , KatzNM , CoughlinSS , WallaceRB . Desmopressin acetate in cardiac surgery: a double‐blind, randomized study. Southern Medical Journal1994;87(6):611‐5. ">Temeck 1994</a>). </p> </li> </ul> </li> <li> <p>We considered the remaining 14 trials to be at unclear risk of bias, as investigators reported insufficient information to allow us to make a judgement about this domain. </p> </li> </ul> </p> </section> <section id="CD001884-sec-0087"> <h4 class="title">Selective reporting</h4> <p> <ul id="CD001884-list-0032"> <li> <p>We considered three trials to be at low risk of bias because they were prospectively registered and reported all prespecified outcomes (<a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0041" title="Use of preoperative desmopressin in preventing bleeding in patients treated with SSRI's. International Standard Randomised Controlled Trial Number: ISRCTN10353850. MarczinskiSC , Van derMeerYG , Van derBeek enM , EgbertsAC . Use of preoperative desmopressin in preventing bleeding in patients treated with SSRIs [Desmopressine preoperatif vermindert bloedverlies bij SSRI‐gebruikers: gerandomiseerd placebogecontroleerd, dubbelblind onderzoek]. Wetenschappelijk Platform2007;1(3):60‐3. ">Marczinski 2007</a>; <a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>). </p> </li> <li> <p>We considered five trials to be at high risk of bias because they did not report a prespecified outcome (<a href="./references#CD001884-bbs2-0024" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012a</a>; <a href="./references#CD001884-bbs2-0025" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012b</a>; <a href="./references#CD001884-bbs2-0026" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012c</a>; <a href="./references#CD001884-bbs2-0038" title="LethagenS , RugarnP , BergqvistD . Blood loss and safety with desmopressin or placebo during aorto‐iliac graft surgery. European Journal of Vascular Surgery1991;5(2):173‐8. ">Lethagen 1991</a>; <a href="./references#CD001884-bbs2-0060" title="TemeckBK , BachenheimerLC , KatzNM , CoughlinSS , WallaceRB . Desmopressin acetate in cardiac surgery: a double‐blind, randomized study. Southern Medical Journal1994;87(6):611‐5. ">Temeck 1994</a>). </p> </li> <li> <p>We considered the remaining 57 trials to be at unclear risk of bias because they published no protocol or prospective trial registration. </p> </li> </ul> </p> </section> <section id="CD001884-sec-0088"> <h4 class="title">Other potential sources of bias</h4> <p> <ul id="CD001884-list-0033"> <li> <p>We considered 18 trials to be at high risk of bias because they:</p> <ul id="CD001884-list-0034"> <li> <p>were funded by a drug manufacturer or other party with a commercial interest in the outcome of the trial (<a href="./references#CD001884-bbs2-0004" title="AnderssonTL , SolemJO , TengbornL , VingeE . Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation. Circulation1990;81(3):872‐8. ">Andersson 1990</a>; <a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0011" title="ProstD , Barbier‐BoehmG , HazebroucqJ , BielskyMC , HvassU . Effect of desmopressin on excessive postoperative bleeding and blood product requirements associated with cardiopulmonary bypass. Thrombosis Research. 1992; Vol. 65:Abstract C132. deProstD , Barbier‐BoehmG , HazebroucqJ , IbrahimH , BielskyMC , HvassU , et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thrombosis and Haemostasis1992;68(2):106‐10. ">de Prost 1992</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. ">Flordal 1991</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0049" title="ReynoldsLM , NicolsonSC , JobesDR , StevenJM , NorwoodWI , McGonigleME , et al. Desmopressin does not decrease bleeding after cardiac operation in young children. Journal of Thoracic and Cardiovascular Surgery1993;106(6):954‐8. ">Reynolds 1993</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>; <a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. ">Sheridan 1994</a>; <a href="./references#CD001884-bbs2-0058" title="SpytTJ , WeerasenaNA , BainWH , LoweGD , RumleyA . The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double‐blind trial. Perfusion1990;5(Suppl):57‐61. WeerasenaNA , SpytTJ , RumleyA , BainWH , LoweGD . Randomised, double‐blind, placebo‐controlled trial of desmopressin in routine coronary artery bypass surgery. British Journal of Haematology. 1990; Vol. 76:Abstract 38. ">Spyt 1990</a>); </p> </li> <li> <p>had an imbalance in baseline characteristics (<a href="./references#CD001884-bbs2-0001" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass [membrane oxygenator]. Japanese Journal of Artificial Organs1991;20(2):2516‐20. ">Aida 1991a</a>; <a href="./references#CD001884-bbs2-0002" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass. Japanese Journal of Artificial Organs1991;20(2):2516‐20. ">Aida 1991b</a>); </p> </li> <li> <p>had an imbalance in co‐interventions (<a href="./references#CD001884-bbs2-0060" title="TemeckBK , BachenheimerLC , KatzNM , CoughlinSS , WallaceRB . Desmopressin acetate in cardiac surgery: a double‐blind, randomized study. Southern Medical Journal1994;87(6):611‐5. ">Temeck 1994</a>); </p> </li> <li> <p>included re‐randomised participants (<a href="./references#CD001884-bbs2-0003" title="AcarogluE , AlanayA , SuratA . Desmopressin (DDAVP) in scoliosis surgery. Journal of Bone and Joint Surgery ‐ British Volume. 1997; Vol. 79:Abstract O343. AlanayA , AcarogluE , OzdemirO , ErçelenO , BulutçuE , SuratA . Effects of deamino‐8‐D‐arginin vasopressin on blood loss and coagulation factors in scoliosis surgery. A double‐blind randomized clinical trial. Spine1999;24(9):877‐82. ">Alanay 1999</a>); </p> </li> <li> <p>were discontinued prematurely without appropriate rationale (<a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0041" title="Use of preoperative desmopressin in preventing bleeding in patients treated with SSRI's. International Standard Randomised Controlled Trial Number: ISRCTN10353850. MarczinskiSC , Van derMeerYG , Van derBeek enM , EgbertsAC . Use of preoperative desmopressin in preventing bleeding in patients treated with SSRIs [Desmopressine preoperatif vermindert bloedverlies bij SSRI‐gebruikers: gerandomiseerd placebogecontroleerd, dubbelblind onderzoek]. Wetenschappelijk Platform2007;1(3):60‐3. ">Marczinski 2007</a>); or </p> </li> <li> <p>were a subgroup of a larger trial, and the larger trial was never published (<a href="./references#CD001884-bbs2-0052" title="SalmenperaM , KuitunenA , HynynenM , HeinonenJ . Hemodynamic responses to desmopressin acetate after CABG: a double‐blind trial. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):146‐9. ">Salmenpera 1991</a>). </p> </li> </ul> </li> <li> <p>We considered 14 trials to be at low risk of other bias (<a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0029" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991c</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0034" title="KuitunenAH . Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery. Annals Chirurgiae et Gynaecologiae1992;81(1):11‐8. ">Kuitunen 1992</a>; <a href="./references#CD001884-bbs2-0036" title="LeeHK , KimYJ , JeongJU , ParkJS , ChiHS , KimSB . Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients. Nephron Clinical Practice2010;114(4):c248‐52. ">Lee 2010</a>; <a href="./references#CD001884-bbs2-0038" title="LethagenS , RugarnP , BergqvistD . Blood loss and safety with desmopressin or placebo during aorto‐iliac graft surgery. European Journal of Vascular Surgery1991;5(2):173‐8. ">Lethagen 1991</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0055" title="SeearM , WadsworthL , ShepsS , MontgomeryC , AshmoreP . The effect of desmopressin acetate (DDAVP) on post‐operative blood loss after open heart surgery in children. Blood. 1987; Vol. 5:Abstract 380a. SeearMD , WadsworthLD , RogersPC , ShepsS , AshmorePG . The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. Journal of Thoracic and Cardiovascular Surgery1989;98(2):217‐9. ">Seear 1989</a>; <a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>). </p> </li> <li> <p>We considered the remaining 33 trials to be at unclear risk of other bias.</p> </li> </ul> </p> <section id="CD001884-sec-0089"> <h5 class="title">Publication bias</h5> <section id="CD001884-sec-0090"> <h6 class="title">Total volume of red cells transfused</h6> <p>We performed Egger’s test: bias coefficient 0.93 (P = 0.38). Trials were spread equally around the regression line and did not favour one treatment. Egger’s test is known to be sensitive to small‐study effects. Consequently, we consider this result to be indicative, but not conclusive, of a lack of publication bias for this outcome (<a href="#CD001884-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD001884-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: desmopressin vs placebo: total red cell volume transfused. CI: confidence interval; MD: mean difference; SE: standard error." data-id="CD001884-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: desmopressin vs placebo: total red cell volume transfused. CI: confidence interval; MD: mean difference; SE: standard error. </p> </div> </div> </div> </section> <section id="CD001884-sec-0091"> <h6 class="title">Total number of participants transfused with red cells</h6> <p>We performed a modified Harbord test: bias coefficient ‐0.26 (P = 0.67). Trials were spread equally around the regression line and did not favour one treatment. Consequently, we consider this result to be indicative, but not conclusive, of a lack of publication bias for this outcome (<a href="#CD001884-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD001884-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: desmopressin vs placebo: number of participants receiving a red cell transfusion. CI: confidence interval; RR: relative risk." data-id="CD001884-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: desmopressin vs placebo: number of participants receiving a red cell transfusion. CI: confidence interval; RR: relative risk. </p> </div> </div> </div> </section> <section id="CD001884-sec-0092"> <h6 class="title">Total blood loss</h6> <p>We performed Egger’s test: bias coefficient 1.49 (P = 0.01). Trials were spread unequally around the regression line with bias favouring DDAVP. Consequently, we consider this result to demonstrate publication bias for this domain. Egger’s test is known to be sensitive to small‐study effects, but for this domain the small P value suggests publication bias (<a href="#CD001884-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD001884-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: desmopressin vs placebo: total blood loss. CI: confidence interval; MD: mean difference; SE: standard error." data-id="CD001884-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: desmopressin vs placebo: total blood loss. CI: confidence interval; MD: mean difference; SE: standard error. </p> </div> </div> </div> </section> </section> </section> </section> <section id="CD001884-sec-0093"> <h3 class="title" id="CD001884-sec-0093">Effects of interventions</h3> <p>See: <a href="./full#CD001884-tbl-0001"><b>Summary of findings for the main comparison</b> DDAVP vs placebo or standard care</a>; <a href="./full#CD001884-tbl-0002"><b>Summary of findings 2</b> DDAVP vs placebo or standard care: platelet dysfunction subgroup</a>; <a href="./full#CD001884-tbl-0003"><b>Summary of findings 3</b> DDAVP vs tranexamic acid</a>; <a href="./full#CD001884-tbl-0004"><b>Summary of findings 4</b> DDAVP vs aprotinin</a> </p> <p> <ul id="CD001884-list-0035"> <li> <p>Sixty‐two trials with 3672 participants compared DDAVP versus placebo or standard care (see <a href="./full#CD001884-tbl-0001">summary of findings Table for the main comparison</a>). </p> </li> <li> <p>Eleven trials with 606 participants compared DDAVP versus placebo in the platelet dysfunction subgroup (see <a href="./full#CD001884-tbl-0002">summary of findings Table 2</a>) </p> </li> <li> <p>Four trials with 163 participants compared DDAVP versus tranexamic acid (see <a href="./full#CD001884-tbl-0003">summary of findings Table 3</a>) </p> </li> <li> <p>Two trials with 154 participants compared DDAVP versus aprotinin (see <a href="./full#CD001884-tbl-0004">summary of findings Table 4</a>) </p> </li> <li> <p>Multi‐arm trials were not combined and the separate arms were compared in pair‐wise analyses (<a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. ">Ellis 2001</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>). For trials including arms with different doses of DDAVP, we selected the regimen closest to a single intravenous dose of 0.3 µg/kg for inclusion in the analysis of DDAVP versus placebo or standard care (<a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>). We included trials that compared tranexamic acid versus tranexamic acid and DDAVP in the DDAVP versus placebo or standard care analysis, as the characteristics of groups were matched, with the exception of administration of DDAVP or placebo (<a href="./references#CD001884-bbs2-0025" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012b</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>). </p> </li> </ul> </p> <section id="CD001884-sec-0094"> <h4 class="title">DDAVP versus placebo or standard care</h4> <section id="CD001884-sec-0095"> <h5 class="title">Primary outcomes</h5> <section id="CD001884-sec-0096"> <h6 class="title">Volume of blood transfused intraoperatively</h6> <p>Ten trials (388 participants) reported the volume of blood transfused intraoperatively (<a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>; <a href="./references#CD001884-bbs2-0033" title="KobrinskyNL , IsraelisED , LettsM , PatelL , SchwertzN , CheangMS , et al. DDAVP shortens the bleeding time and decreases operative blood loss in hemostatically normal subjects undergoing spinal fusion surgery. Blood. 1985; Vol. 5:Abstract 1176. KobrinskyNL , LettsRM , PatelLR , IsraelsED , MonsonRC , SchwetzN , et al. 1‐Desamino‐8‐D‐arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double‐blinded, controlled trial.. Annals of Internal Medicine1987;107:446‐50. ">Kobrinsky 1987</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0039" title="LettsM , PangE , D'AstousJ , JarvisJ , LawtonL , LukeB , et al. The influence of desmopressin on blood loss during spinal fusion surgery in neuromuscular patients. Spine1998;23(4):475‐8. ">Letts 1998</a>; <a href="./references#CD001884-bbs2-0038" title="LethagenS , RugarnP , BergqvistD . Blood loss and safety with desmopressin or placebo during aorto‐iliac graft surgery. European Journal of Vascular Surgery1991;5(2):173‐8. ">Lethagen 1991</a>; <a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>; <a href="./references#CD001884-bbs2-0061" title="TherouxMC , CorddryDH , TietzAE , MillerF , PeoplesJD , KettrickRG . A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double‐blinded study. Anesthesiology1997;87(2):260‐7. ">Theroux 1997</a>; <a href="./references#CD001884-bbs2-0062" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores. Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992a</a>). Results showed considerable variation in volume of transfusion between types of surgery, so this outcome is reported in subgroups only (<a href="./references#CD001884-fig-0006" title="">Analysis 1.1</a>). Analysis revealed no evidence of a difference between subgroups (Chi<sup>2</sup> = 4.39, degrees of freedom (df) = 4 (P = 0.36); I<sup>2</sup> = 8.8%). </p> <section id="CD001884-sec-0097"> <p><b>Adult cardiac surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in the volume of blood transfused (intraoperatively) for participants treated with DDAVP compared with placebo (MD ‐0.1 units, 95% CI ‐1.22 to 1.02 units; 1 trial, 19 participants; <a href="./references#CD001884-fig-0006" title="">Analysis 1.1</a>). </p> </section> <section id="CD001884-sec-0098"> <p><b>Paediatric cardiac surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in the volume of blood transfused (intraoperatively) for participants treated with DDAVP compared with placebo (MD 0.40 units, 95% CI ‐0.87 to 1.67 units; 1 trial, 60 participants; <a href="./references#CD001884-fig-0006" title="">Analysis 1.1</a>). </p> </section> <section id="CD001884-sec-0099"> <p><b>Orthopaedic surgery</b></p> <p>Six trials (242 participants) reported intraoperative blood loss for orthopaedic surgery (<a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>; <a href="./references#CD001884-bbs2-0033" title="KobrinskyNL , IsraelisED , LettsM , PatelL , SchwertzN , CheangMS , et al. DDAVP shortens the bleeding time and decreases operative blood loss in hemostatically normal subjects undergoing spinal fusion surgery. Blood. 1985; Vol. 5:Abstract 1176. KobrinskyNL , LettsRM , PatelLR , IsraelsED , MonsonRC , SchwetzN , et al. 1‐Desamino‐8‐D‐arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double‐blinded, controlled trial.. Annals of Internal Medicine1987;107:446‐50. ">Kobrinsky 1987</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0039" title="LettsM , PangE , D'AstousJ , JarvisJ , LawtonL , LukeB , et al. The influence of desmopressin on blood loss during spinal fusion surgery in neuromuscular patients. Spine1998;23(4):475‐8. ">Letts 1998</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>; <a href="./references#CD001884-bbs2-0061" title="TherouxMC , CorddryDH , TietzAE , MillerF , PeoplesJD , KettrickRG . A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double‐blinded study. Anesthesiology1997;87(2):260‐7. ">Theroux 1997</a>), but three of these trials did not report this outcome in a way that could be incorporated into meta‐analysis and so are reported narratively in <a href="#CD001884-tbl-0007">Table 3</a>. Results show a reduction in the volume of red cells transfused intraoperatively in those treated with DDAVP compared with placebo (MD ‐0.50 units, 95% CI ‐0.89 to ‐0.11; I<sup>2</sup> = 0%; 3 trials, 144 participants; <a href="./references#CD001884-fig-0006" title="">Analysis 1.1</a>). Restricting the analysis to trials at low risk of bias reduced the effect size (MD ‐0.20 units, 95% CI ‐1.74 to 1.34 units; 1 trial, 30 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>). Restricting the analysis to studies with a transfusion protocol did not change the effect estimate (MD ‐0.38 units, 95% CI ‐0.84 to 0.07 units; I<sup>2</sup> = 0%; 2 trials, 109 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>). </p> <div class="table" id="CD001884-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">DDAVP vs placebo: intraoperative volume of red cells transfused</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reason not included in meta‐analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DDAVP arm</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo arm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Orthopaedic surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. "><b>Leino 2010</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (no standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 units</p> <p>(n = 23)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5 units</p> <p>(n = 24)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0039" title="LettsM , PangE , D'AstousJ , JarvisJ , LawtonL , LukeB , et al. The influence of desmopressin on blood loss during spinal fusion surgery in neuromuscular patients. Spine1998;23(4):475‐8. "><b>Letts 1998</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (no standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.6 units</p> <p>(n = 16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.0 units</p> <p>(n = 14)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0061" title="TherouxMC , CorddryDH , TietzAE , MillerF , PeoplesJD , KettrickRG . A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double‐blinded study. Anesthesiology1997;87(2):260‐7. "><b>Theroux 1997</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median and range</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51.5 (24 to 98.6) mL/kg</p> <p>(n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48.3 (24.5 to 96) mL/kg</p> <p>(n = 11)</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD001884-sec-0100"> <p><b>Vascular surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in the volume of blood transfused (intraoperatively) for participants treated with DDAVP compared with placebo (MD ‐1.2 units, 95% CI ‐2.55 to 0.15 units; 1 trial, 44 participants; <a href="./references#CD001884-fig-0006" title="">Analysis 1.1</a>). </p> </section> <section id="CD001884-sec-0101"> <p><b>Plastic surgery</b></p> <p>Results showed a reduction in the volume of red cells transfused intraoperatively for those treated with DDAVP compared with placebo (MD ‐0.75 units, 95% CI ‐1.23 to ‐0.27 units; 2 trials, 44 participants; <a href="./references#CD001884-fig-0006" title="">Analysis 1.1</a>). </p> </section> </section> <section id="CD001884-sec-0102"> <h6 class="title">Total volume of blood transfused</h6> <p>Thirty‐nine trials (2324 participants) reported the total volume of blood transfused (<a href="./references#CD001884-bbs2-0001" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass [membrane oxygenator]. Japanese Journal of Artificial Organs1991;20(2):2516‐20. ">Aida 1991a</a>; <a href="./references#CD001884-bbs2-0002" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass. Japanese Journal of Artificial Organs1991;20(2):2516‐20. ">Aida 1991b</a>; <a href="./references#CD001884-bbs2-0003" title="AcarogluE , AlanayA , SuratA . Desmopressin (DDAVP) in scoliosis surgery. Journal of Bone and Joint Surgery ‐ British Volume. 1997; Vol. 79:Abstract O343. AlanayA , AcarogluE , OzdemirO , ErçelenO , BulutçuE , SuratA . Effects of deamino‐8‐D‐arginin vasopressin on blood loss and coagulation factors in scoliosis surgery. A double‐blind randomized clinical trial. Spine1999;24(9):877‐82. ">Alanay 1999</a>; <a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0009" title="ChuangHI , HorngYJ , LiY , ChernFC , ShiehDY , ChiouIS , et al. [Clinical assessment of desmopressin to reduce blood loss in patients after cardiopulmonary bypass]. Ma Zui Xue Za Zhi1993;31(1):35‐42. ">Chuang 1993</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0011" title="ProstD , Barbier‐BoehmG , HazebroucqJ , BielskyMC , HvassU . Effect of desmopressin on excessive postoperative bleeding and blood product requirements associated with cardiopulmonary bypass. Thrombosis Research. 1992; Vol. 65:Abstract C132. deProstD , Barbier‐BoehmG , HazebroucqJ , IbrahimH , BielskyMC , HvassU , et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thrombosis and Haemostasis1992;68(2):106‐10. ">de Prost 1992</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. ">Dilthey 1993</a>; <a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. ">Ellis 2001</a>; <a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. ">Flordal 1992</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0020" title="GuyuronB , VaughanC , SchlecterB . The role of DDAVP (desmopressin) in orthognathic surgery. Annals of Plastic Surgery1996;37(5):516‐9. ">Guyuron 1996</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0022" title="HajjarLA , GalasF , FortimM , Melo , R , FerreiraR , AulerJO . Desmopressin acetate reduces blood loss after cardiac surgery: a double‐bind randomized controlled trial. Circulation. 2007; Vol. 116, issue 16:396. ">Hajjar 2007</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0033" title="KobrinskyNL , IsraelisED , LettsM , PatelL , SchwertzN , CheangMS , et al. DDAVP shortens the bleeding time and decreases operative blood loss in hemostatically normal subjects undergoing spinal fusion surgery. Blood. 1985; Vol. 5:Abstract 1176. KobrinskyNL , LettsRM , PatelLR , IsraelsED , MonsonRC , SchwetzN , et al. 1‐Desamino‐8‐D‐arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double‐blinded, controlled trial.. Annals of Internal Medicine1987;107:446‐50. ">Kobrinsky 1987</a>; <a href="./references#CD001884-bbs2-0034" title="KuitunenAH . Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery. Annals Chirurgiae et Gynaecologiae1992;81(1):11‐8. ">Kuitunen 1992</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0038" title="LethagenS , RugarnP , BergqvistD . Blood loss and safety with desmopressin or placebo during aorto‐iliac graft surgery. European Journal of Vascular Surgery1991;5(2):173‐8. ">Lethagen 1991</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. ">Ozkisacik 2001</a>; <a href="./references#CD001884-bbs2-0048" title="ReichDL , HammerschlagBC , RandJH , Weiss‐BloomL , PeruchoH , GallaJ , et al. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):142‐5. ">Reich 1991</a>; <a href="./references#CD001884-bbs2-0049" title="ReynoldsLM , NicolsonSC , JobesDR , StevenJM , NorwoodWI , McGonigleME , et al. Desmopressin does not decrease bleeding after cardiac operation in young children. Journal of Thoracic and Cardiovascular Surgery1993;106(6):954‐8. ">Reynolds 1993</a>; <a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. ">Rocha 1988</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>; <a href="./references#CD001884-bbs2-0058" title="SpytTJ , WeerasenaNA , BainWH , LoweGD , RumleyA . The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double‐blind trial. Perfusion1990;5(Suppl):57‐61. WeerasenaNA , SpytTJ , RumleyA , BainWH , LoweGD . Randomised, double‐blind, placebo‐controlled trial of desmopressin in routine coronary artery bypass surgery. British Journal of Haematology. 1990; Vol. 76:Abstract 38. ">Spyt 1990</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>; <a href="./references#CD001884-bbs2-0061" title="TherouxMC , CorddryDH , TietzAE , MillerF , PeoplesJD , KettrickRG . A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double‐blinded study. Anesthesiology1997;87(2):260‐7. ">Theroux 1997</a>; <a href="./references#CD001884-bbs2-0064" title="WongAY , IrwinMG , HuiTW , FungSK , FanST , MaES . Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Canadian Journal of Anaesthesia2003;50(1):14‐20. ">Wong 2003</a>). Results showed considerable variation in the volume of transfusion between types of surgery, so we reported this outcome in subgroups only (<a href="./references#CD001884-fig-0007" title="">Analysis 1.2</a>). Analysis revealed no evidence of a difference between subgroups (Chi<sup>2</sup> = 2.97, df = 3 (P = 0.40); I<sup>2</sup> = 0%). </p> <section id="CD001884-sec-0103"> <p><b>Adult cardiac surgery</b></p> <p>Twenty‐six trials (1674 participants) reported total volume of red cells transfused for adult cardiac surgery; 12 trials did not report this outcome in a way that allowed inclusion in meta‐analysis, and so we reported these results narratively in <a href="#CD001884-tbl-0008">Table 4</a>. The total volume of blood transfused was less for those treated with DDAVP compared with placebo (MD ‐0.52 units, 95% CI ‐0.96 to ‐0.08 units; I<sup>2</sup> = 70%; 14 trials, 957 participants; <a href="./references#CD001884-fig-0007" title="">Analysis 1.2</a>). </p> <div class="table" id="CD001884-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">DDAVP vs placebo: total volume of red cells transfused</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reason not included in meta‐analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DDAVP arm</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo arm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Adult cardiac surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0001" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass [membrane oxygenator]. Japanese Journal of Artificial Organs1991;20(2):2516‐20. "><b>Aida 1991a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/kg (mean ± standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.3 ± 5.6 mL/kg</p> <p>(n = 5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.8 ± 6.3 mL/kg</p> <p>(n = 4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0002" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass. Japanese Journal of Artificial Organs1991;20(2):2516‐20. "><b>Aida 1991b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/kg (mean ± standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.2 ± 6.4 mL/kg</p> <p>(n = 5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.2 ± 6.6 mL/kg</p> <p>(n = 6)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0003" title="AcarogluE , AlanayA , SuratA . Desmopressin (DDAVP) in scoliosis surgery. Journal of Bone and Joint Surgery ‐ British Volume. 1997; Vol. 79:Abstract O343. AlanayA , AcarogluE , OzdemirO , ErçelenO , BulutçuE , SuratA . Effects of deamino‐8‐D‐arginin vasopressin on blood loss and coagulation factors in scoliosis surgery. A double‐blind randomized clinical trial. Spine1999;24(9):877‐82. "><b>Alanay 1999</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (interquartile range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7 (2.3) units</p> <p>(n = 18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.6 (1.3) units</p> <p>(n = 22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. "><b>Bignami 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (interquartile range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (1 to 4) units</p> <p>(n = 68)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (1 to 3) units</p> <p>(n = 67)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. "><b>Frankville 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (no standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4 units</p> <p>(n = 15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 units</p> <p>(n = 15)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. "><b>Hackmann 1989</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (90% confidence interval)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (1 to 8.5) units</p> <p>(n = 74)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (1 to 9.8) units</p> <p>(n = 76)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0034" title="KuitunenAH . Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery. Annals Chirurgiae et Gynaecologiae1992;81(1):11‐8. "><b>Kuitunen 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.3 (0 to 2) units</p> <p>(n = 15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.1 (0 to 3) units</p> <p>(n = 15)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. "><b>Marquez 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 units</p> <p>(n = 21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 units</p> <p>(n = 22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. "><b>Mongan 1992a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.86 units</p> <p>(n = 44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.79 units</p> <p>n = 42)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. "><b>Mongan 1992b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4 units</p> <p>(n = 13)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.2 units</p> <p>(n = 16)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. "><b>Rocha 1994</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> (mean ± standard deviation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>740.4 ± 416.3 mL/m<sup>2</sup> </p> <p><sup>(n = 25)</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>662.8 ± 380.7 mL/m<sup>2</sup> </p> <p><sup>(n = 28)</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0058" title="SpytTJ , WeerasenaNA , BainWH , LoweGD , RumleyA . The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double‐blind trial. Perfusion1990;5(Suppl):57‐61. WeerasenaNA , SpytTJ , RumleyA , BainWH , LoweGD . Randomised, double‐blind, placebo‐controlled trial of desmopressin in routine coronary artery bypass surgery. British Journal of Haematology. 1990; Vol. 76:Abstract 38. "><b>Spyt 1990</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.38 units</p> <p>(n = 49)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.30 units</p> <p>(n = 49)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Orthopaedic surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. "><b>Ellis 2001</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7 units</p> <p>(n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.1 units</p> <p>(n = 10)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0061" title="TherouxMC , CorddryDH , TietzAE , MillerF , PeoplesJD , KettrickRG . A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double‐blinded study. Anesthesiology1997;87(2):260‐7. "><b>Theroux 1997</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median and range</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.8 (30.3 to 123.6) mL/kg</p> <p>(n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.9 (33.8 to 110) mL/kg</p> <p>(n = 11)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Maxillofacial surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0020" title="GuyuronB , VaughanC , SchlecterB . The role of DDAVP (desmopressin) in orthognathic surgery. Annals of Plastic Surgery1996;37(5):516‐9. "><b>Guyuron 1996</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (no standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.6 units</p> <p>(n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.9 units</p> <p>(n = 10)</p> </td> </tr> </tbody> </table> </div> <p>We noted no change to the effect estimate or to heterogeneity when we restricted the analysis to: </p> <p> <ul id="CD001884-list-0036"> <li> <p>trials with a low risk of bias (MD ‐0.54 units, 95% CI ‐1.40 to 0.31 units; I<sup>2</sup> = 16%; 2 trials, 113 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>); </p> </li> <li> <p>trials that used autologous cell salvage (MD ‐0.62 units; 95% CI ‐1.26 to 0.01 units; I<sup>2</sup> = 52%; 5 trials, 243 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. ">Dilthey 1993</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0048" title="ReichDL , HammerschlagBC , RandJH , Weiss‐BloomL , PeruchoH , GallaJ , et al. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):142‐5. ">Reich 1991</a>); or </p> </li> <li> <p>trials with a transfusion protocol (MD ‐0.52 units; 95% CI ‐1.12 to 0.08 units; I<sup>2</sup> = 51%; 4 trials, 240 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0011" title="ProstD , Barbier‐BoehmG , HazebroucqJ , BielskyMC , HvassU . Effect of desmopressin on excessive postoperative bleeding and blood product requirements associated with cardiopulmonary bypass. Thrombosis Research. 1992; Vol. 65:Abstract C132. deProstD , Barbier‐BoehmG , HazebroucqJ , IbrahimH , BielskyMC , HvassU , et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thrombosis and Haemostasis1992;68(2):106‐10. ">de Prost 1992</a>; <a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. ">Dilthey 1993</a>; <a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. ">Ozkisacik 2001</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>). </p> </li> </ul> </p> <p>Restricting the analysis to trials published as full‐text papers resulted in reduced effect estimate and heterogeneity (MD ‐0.30 units; 95 % CI ‐0.63 to 0.04 units; I<sup>2</sup> = 49%; 12 trials, 759 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0011" title="ProstD , Barbier‐BoehmG , HazebroucqJ , BielskyMC , HvassU . Effect of desmopressin on excessive postoperative bleeding and blood product requirements associated with cardiopulmonary bypass. Thrombosis Research. 1992; Vol. 65:Abstract C132. deProstD , Barbier‐BoehmG , HazebroucqJ , IbrahimH , BielskyMC , HvassU , et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thrombosis and Haemostasis1992;68(2):106‐10. ">de Prost 1992</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. ">Dilthey 1993</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. ">Ozkisacik 2001</a>; <a href="./references#CD001884-bbs2-0048" title="ReichDL , HammerschlagBC , RandJH , Weiss‐BloomL , PeruchoH , GallaJ , et al. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):142‐5. ">Reich 1991</a>; <a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. ">Rocha 1988</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>). </p> <p>TSA showed accrual of 68.5% of the information size so far to detect or reject a 15% (0.52 unit) relative risk reduction based on an estimated mean transfusion volume of 3.45 units in study control arms (D<sup>2</sup> = 75%). When we restricted TSA to trials at low risk of bias, results showed that 18.0% of the information size had been accrued so far. </p> </section> <section id="CD001884-sec-0104"> <p><b>Orthopaedic surgery</b></p> <p>Eight trials (344 participants) reported total volume of red cells transfused for orthopaedic surgery, but two trials (41 participants) did not report this outcome in a way that allowed inclusion in meta‐analysis, and so we reported these results narratively in <a href="#CD001884-tbl-0008">Table 4</a>. Results showed no difference in the total volume of blood transfused for those treated with DDAVP compared with placebo (MD ‐0.02 units, 95% CI ‐0.67 to 0.64 units; I<sup>2</sup> = 71%; 6 trials, 303 participants; <a href="./references#CD001884-fig-0007" title="">Analysis 1.2</a>). </p> <p>Restricting the analysis to trials with:</p> <p> <ul id="CD001884-list-0037"> <li> <p>a low risk of bias increased the effect size but not to clinical significance (MD ‐0.90 units, 95% CI ‐1.93 to 0.13 units; 1 trial, 47 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>); </p> </li> <li> <p>a transfusion protocol did not alter the effect estimate or heterogeneity (MD 0.33 units, 95% CI ‐0.63 to 1.28 units; I<sup>2</sup> = 72%; 4 trials, 218 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>). </p> </li> </ul> </p> <p>TSA showed accrual of 30.8% of the information size so far to detect or reject a 15% (0.52 unit) relative risk reduction based on an estimated mean transfusion volume of 3.48 units in study control arms (D<sup>2</sup> = 73%). When we restricted TSA to trials at low risk of bias, results showed that 16.6% of the information size had been accrued so far. </p> </section> <section id="CD001884-sec-0105"> <p><b>Vascular surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in the total volume of blood transfused for participants treated with DDAVP compared with placebo (MD 0.06 units, 95% CI ‐0.60 to 0.73 units; 2 trials, 135 participants; <a href="./references#CD001884-fig-0007" title="">Analysis 1.2</a>). TSA showed accrual of 9.3% of the information size so far to detect or reject a 15% (0.29 unit) relative risk reduction based on an estimated mean transfusion volume of 1.94 units in the study control arms (D<sup>2</sup> = 0%). When we restricted TSA to trials at low risk of bias, results showed that 7.7% of the information size had been accrued so far. </p> </section> <section id="CD001884-sec-0106"> <p><b>Hepatic surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in total volume of blood transfused for participants treated with DDAVP compared with placebo (MD ‐0.47 units, 95% CI ‐1.27 to 0.33 units; 1 trial, 59 participants; <a href="./references#CD001884-fig-0007" title="">Analysis 1.2</a>). </p> </section> <section id="CD001884-sec-0107"> <p><b>Maxillofacial surgery</b></p> <p>One trial (20 participants) reported total volume of red cells transfused in maxillofacial surgery but did not report this outcome in a way that allowed inclusion in meta‐analysis; so we reported these findings narratively in <a href="#CD001884-tbl-0008">Table 4</a>. </p> </section> <section id="CD001884-sec-0108"> <p><b>Paediatric cardiac surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in the total volume of blood transfused for participants treated with DDAVP compared with placebo (MD 1 mL/kg, 95% CI ‐17.10 to 19.10 mL/kg; 1 trial, 95 participants; <a href="./references#CD001884-fig-0008" title="">Analysis 1.3</a>). </p> </section> </section> <section id="CD001884-sec-0109"> <h6 class="title">Number of participants transfused with blood intraoperatively</h6> <p>Six trials (349 participants) reported the number of participants transfused with blood intraoperatively, and all six contributed data towards the final pooled estimate (<a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0041" title="Use of preoperative desmopressin in preventing bleeding in patients treated with SSRI's. International Standard Randomised Controlled Trial Number: ISRCTN10353850. MarczinskiSC , Van derMeerYG , Van derBeek enM , EgbertsAC . Use of preoperative desmopressin in preventing bleeding in patients treated with SSRIs [Desmopressine preoperatif vermindert bloedverlies bij SSRI‐gebruikers: gerandomiseerd placebogecontroleerd, dubbelblind onderzoek]. Wetenschappelijk Platform2007;1(3):60‐3. ">Marczinski 2007</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0062" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores. Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992a</a>; <a href="./references#CD001884-bbs2-0063" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores (low risk procedures only). Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992b</a>). Results showed no difference in the number of participants transfused with blood intraoperatively between those treated with DDAVP and those not treated with DDAVP (RR 0.74 units, 95% CI 0.50 to 1.09 units; I<sup>2</sup> = 0%; 6 trials, 349 participants; <a href="./references#CD001884-fig-0009" title="">Analysis 1.4</a>). Analysis revealed no evidence of a difference between subgroups (Chi<sup>2</sup> = 0.30, df = 1 (P = 0.58); I<sup>2</sup> = 0%). </p> <p>Results showed no change in the effect estimate when analysis was restricted to trials:</p> <p> <ul id="CD001884-list-0038"> <li> <p>at low risk of bias (RR 0.86, 95% CI 0.45 to 1.64; 3 trials, 206 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0062" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores. Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992a</a>; <a href="./references#CD001884-bbs2-0063" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores (low risk procedures only). Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992b</a>); or </p> </li> <li> <p>with a transfusion protocol (RR 0.68, 95% CI 0.43 to 1.10; 2 trials, 115 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>). </p> </li> </ul> </p> <section id="CD001884-sec-0110"> <p><b>Cardiac surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in the number of participants transfused with blood intraoperatively between those treated with DDAVP and those given placebo (RR 0.68, 95% CI 0.43 to 1.10 units; 2 trials, 45 participants; <a href="./references#CD001884-fig-0009" title="">Analysis 1.4</a>). </p> </section> <section id="CD001884-sec-0111"> <p><b>Plastic surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in the number of participants transfused with blood intraoperatively between those treated with DDAVP and those given placebo (RR 0.86, 95% CI 0.45 to 1.64 units; 2 trials, 44 participants; <a href="./references#CD001884-fig-0009" title="">Analysis 1.4</a>). </p> </section> <section id="CD001884-sec-0112"> <p><b>Kidney biopsy</b></p> <p>One trial in this subgroup reported the number of participants transfused with blood intraoperatively. However, researchers reported no events in either arm of the trial (<a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>). </p> </section> <section id="CD001884-sec-0113"> <p><b>Other types of surgery</b></p> <p>One trial in this subgroup reported the number of participants transfused with blood intraoperatively. However, researchers reported no events in either arm of the trial (<a href="./references#CD001884-bbs2-0041" title="Use of preoperative desmopressin in preventing bleeding in patients treated with SSRI's. International Standard Randomised Controlled Trial Number: ISRCTN10353850. MarczinskiSC , Van derMeerYG , Van derBeek enM , EgbertsAC . Use of preoperative desmopressin in preventing bleeding in patients treated with SSRIs [Desmopressine preoperatif vermindert bloedverlies bij SSRI‐gebruikers: gerandomiseerd placebogecontroleerd, dubbelblind onderzoek]. Wetenschappelijk Platform2007;1(3):60‐3. ">Marczinski 2007</a>). </p> </section> </section> <section id="CD001884-sec-0114"> <h6 class="title">Total number of participants transfused with blood</h6> <p>Twenty‐six trials (1866 participants) reported the total number of participants transfused with blood (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. ">Dilthey 1993</a>; <a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. ">Ellis 2001</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0020" title="GuyuronB , VaughanC , SchlecterB . The role of DDAVP (desmopressin) in orthognathic surgery. Annals of Plastic Surgery1996;37(5):516‐9. ">Guyuron 1996</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0030" title="JiH , JinL . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Cardiology. 2013; Vol. 126:Abstract. JinL , JiHW . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Chinese Medical Journal2015;128(5):644‐7. ">Jin 2015</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>; <a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. ">Ozkisacik 2001</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. ">Sheridan 1994</a>; <a href="./references#CD001884-bbs2-0058" title="SpytTJ , WeerasenaNA , BainWH , LoweGD , RumleyA . The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double‐blind trial. Perfusion1990;5(Suppl):57‐61. WeerasenaNA , SpytTJ , RumleyA , BainWH , LoweGD . Randomised, double‐blind, placebo‐controlled trial of desmopressin in routine coronary artery bypass surgery. British Journal of Haematology. 1990; Vol. 76:Abstract 38. ">Spyt 1990</a>; <a href="./references#CD001884-bbs2-0060" title="TemeckBK , BachenheimerLC , KatzNM , CoughlinSS , WallaceRB . Desmopressin acetate in cardiac surgery: a double‐blind, randomized study. Southern Medical Journal1994;87(6):611‐5. ">Temeck 1994</a>; <a href="./references#CD001884-bbs2-0062" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores. Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992a</a>; <a href="./references#CD001884-bbs2-0063" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores (low risk procedures only). Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992b</a>; <a href="./references#CD001884-bbs2-0064" title="WongAY , IrwinMG , HuiTW , FungSK , FanST , MaES . Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Canadian Journal of Anaesthesia2003;50(1):14‐20. ">Wong 2003</a>). We excluded one trial from the final analysis because every participant in both arms of the trial received a red cell transfusion (<a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>). We found no evidence showing a difference in the total number of participants transfused with blood between those treated with DDAVP and those given placebo (RR 0.96, 95% CI 0.86 to 1.06; I<sup>2</sup> = 17%; 25 trials, 1806 participants; <i>moderate‐quality evidence</i>; <a href="./references#CD001884-fig-0010" title="">Analysis 1.5</a>). Analysis revealed no evidence of a difference between subgroups (Chi<sup>2</sup> = 3.02, df = 2 (P = 0.22), I<sup>2</sup> = 33.7%). The effect estimate was similar to results of the main analysis when we restricted the analysis to trials: </p> <p> <ul id="CD001884-list-0039"> <li> <p>at low risk of bias (RR 1.06, 95% CI 0.90 to 1.25; I<sup>2</sup> = 2%; 9 trials, 691 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>; <a href="./references#CD001884-bbs2-0062" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores. Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992a</a>; <a href="./references#CD001884-bbs2-0063" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores (low risk procedures only). Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992b</a>); </p> </li> <li> <p>that used a transfusion protocol (RR 0.91, 95% CI 0.79 to 1.05; 13 trials, 928 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. ">Dilthey 1993</a>; <a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. ">Ellis 2001</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. ">Ozkisacik 2001</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0058" title="SpytTJ , WeerasenaNA , BainWH , LoweGD , RumleyA . The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double‐blind trial. Perfusion1990;5(Suppl):57‐61. WeerasenaNA , SpytTJ , RumleyA , BainWH , LoweGD . Randomised, double‐blind, placebo‐controlled trial of desmopressin in routine coronary artery bypass surgery. British Journal of Haematology. 1990; Vol. 76:Abstract 38. ">Spyt 1990</a>; <a href="./references#CD001884-bbs2-0064" title="WongAY , IrwinMG , HuiTW , FungSK , FanST , MaES . Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Canadian Journal of Anaesthesia2003;50(1):14‐20. ">Wong 2003</a>); </p> </li> <li> <p>that used autologous cell salvage (RR 1.02, 95% CI 0.82 to 1.26; I<sup>2</sup> = 20%; 6 trials, 532 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>); or </p> </li> <li> <p>published before 2010 plus those registered prospectively and published after 2010 (RR 0.96, 95% CI 0.86 to 1.07; I<sup>2</sup> = 19%; 23 trials, 1543 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. ">Dilthey 1993</a>; <a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. ">Ellis 2001</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0020" title="GuyuronB , VaughanC , SchlecterB . The role of DDAVP (desmopressin) in orthognathic surgery. Annals of Plastic Surgery1996;37(5):516‐9. ">Guyuron 1996</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>; <a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. ">Ozkisacik 2001</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. ">Sheridan 1994</a>; <a href="./references#CD001884-bbs2-0058" title="SpytTJ , WeerasenaNA , BainWH , LoweGD , RumleyA . The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double‐blind trial. Perfusion1990;5(Suppl):57‐61. WeerasenaNA , SpytTJ , RumleyA , BainWH , LoweGD . Randomised, double‐blind, placebo‐controlled trial of desmopressin in routine coronary artery bypass surgery. British Journal of Haematology. 1990; Vol. 76:Abstract 38. ">Spyt 1990</a>; <a href="./references#CD001884-bbs2-0060" title="TemeckBK , BachenheimerLC , KatzNM , CoughlinSS , WallaceRB . Desmopressin acetate in cardiac surgery: a double‐blind, randomized study. Southern Medical Journal1994;87(6):611‐5. ">Temeck 1994</a>; <a href="./references#CD001884-bbs2-0062" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores. Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992a</a>; <a href="./references#CD001884-bbs2-0063" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores (low risk procedures only). Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992b</a>; <a href="./references#CD001884-bbs2-0064" title="WongAY , IrwinMG , HuiTW , FungSK , FanST , MaES . Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Canadian Journal of Anaesthesia2003;50(1):14‐20. ">Wong 2003</a>). </p> </li> </ul> </p> <p>TSA showed accrual of 70% of the information size so far to detect or reject a 15% relative risk reduction based on 43.1% of participants in the study control arms receiving a transfusion (D<sup>2</sup> = 18%). This estimate crossed the futility boundary, suggesting that no evidence shows a difference between desmopressin and placebo for this outcome, and that further trial data are unlikely to alter this estimate. When we restricted TSA to trials at low risk of bias, results showed that 19.4% of the information size had been accrued so far. </p> <section id="CD001884-sec-0115"> <p><b>Cardiac surgery</b></p> <p>We found no evidence showing a difference in the total number of participants transfused with blood between those treated with DDAVP and those given placebo (RR 0.93, 95% CI 0.82 to 1.06; I<sup>2</sup> = 25%; 17 trials, 1350 participants; <a href="./references#CD001884-fig-0010" title="">Analysis 1.5</a>). The effect estimate was similar to results of the main analysis when we restricted the analysis to trials: </p> <p> <ul id="CD001884-list-0040"> <li> <p>at low risk of bias (RR 1.03, 95% CI 0.66 to 1.59; I<sup>2</sup> = 47%; 4 trials, 334 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>); </p> </li> <li> <p>that used a transfusion protocol (RR 0.90, 95% CI 0.77 to 1.05; 11 trials, 848 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. ">Dilthey 1993</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. ">Ozkisacik 2001</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0058" title="SpytTJ , WeerasenaNA , BainWH , LoweGD , RumleyA . The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double‐blind trial. Perfusion1990;5(Suppl):57‐61. WeerasenaNA , SpytTJ , RumleyA , BainWH , LoweGD . Randomised, double‐blind, placebo‐controlled trial of desmopressin in routine coronary artery bypass surgery. British Journal of Haematology. 1990; Vol. 76:Abstract 38. ">Spyt 1990</a>); </p> </li> <li> <p>that used autologous cell salvage (RR 0.99, 95% CI 0.70 to 1.41; I<sup>2</sup> = 34%; 5 trials, 441 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>); or </p> </li> <li> <p>published before 2010 plus those registered prospectively and published after 2010 (RR 0.94, 95% CI 0.82 to 1.06; I<sup>2</sup> = 29%; 16 trials, 1248 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. ">Dilthey 1993</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. ">Ozkisacik 2001</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. ">Sheridan 1994</a>; <a href="./references#CD001884-bbs2-0058" title="SpytTJ , WeerasenaNA , BainWH , LoweGD , RumleyA . The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double‐blind trial. Perfusion1990;5(Suppl):57‐61. WeerasenaNA , SpytTJ , RumleyA , BainWH , LoweGD . Randomised, double‐blind, placebo‐controlled trial of desmopressin in routine coronary artery bypass surgery. British Journal of Haematology. 1990; Vol. 76:Abstract 38. ">Spyt 1990</a>; <a href="./references#CD001884-bbs2-0060" title="TemeckBK , BachenheimerLC , KatzNM , CoughlinSS , WallaceRB . Desmopressin acetate in cardiac surgery: a double‐blind, randomized study. Southern Medical Journal1994;87(6):611‐5. ">Temeck 1994</a>). </p> </li> </ul> </p> </section> <section id="CD001884-sec-0116"> <p><b>Orthopaedic surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in the total number of participants transfused with blood when treated with DDAVP versus placebo (RR 0.86, 95% CI 0.45 to 1.64; 1 trial, 13 participants; <a href="./references#CD001884-fig-0010" title="">Analysis 1.5</a>). </p> </section> <section id="CD001884-sec-0117"> <p><b>Vascular surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in the total number of participants transfused with blood when treated with DDAVP versus placebo (RR 1.05, 95% CI 0.83 to 1.34; 1 trial, 68 participants; <a href="./references#CD001884-fig-0010" title="">Analysis 1.5</a>). </p> </section> <section id="CD001884-sec-0118"> <p><b>Paediatric cardiac surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in the number of participants transfused with blood when treated with DDAVP versus placebo (RR 1.17, 95% CI 0.66 to 2.06; 1 trial, 27 participants; <a href="./references#CD001884-fig-0010" title="">Analysis 1.5</a>). </p> </section> <section id="CD001884-sec-0119"> <p><b>Plastic surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in the number of participants transfused with blood when treated with DDAVP versus placebo (RR 0.86, 95% CI 0.45 to 1.64; 2 trials, 44 participants; <a href="./references#CD001884-fig-0010" title="">Analysis 1.5</a>). </p> </section> <section id="CD001884-sec-0120"> <p><b>Hepatic surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in the number of participants transfused with blood when treated with DDAVP versus placebo (RR 0.58, 95% CI 0.15 to 2.21; 1 trial, 59 participants; <a href="./references#CD001884-fig-0010" title="">Analysis 1.5</a>). </p> </section> <section id="CD001884-sec-0121"> <p><b>Kidney biopsy</b></p> <p>One trial in this subgroup reported the total number of participants transfused with blood. However, researchers reported no events in either arm of the trial (<a href="./references#CD001884-fig-0010" title="">Analysis 1.5</a>). </p> </section> <section id="CD001884-sec-0122"> <p><b>Maxillofacial surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in the number of participants transfused with blood when treated with DDAVP versus placebo (RR 2.00, 95% CI 0.88 to 4.54; 1 trial, 20 participants; <a href="./references#CD001884-fig-0010" title="">Analysis 1.5</a>). </p> </section> </section> <section id="CD001884-sec-0123"> <h6 class="title">Intraoperative blood loss</h6> <p>Seventeen trials (933 participants) reported intraoperative blood loss (<a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. ">Flordal 1992</a>; <a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0033" title="KobrinskyNL , IsraelisED , LettsM , PatelL , SchwertzN , CheangMS , et al. DDAVP shortens the bleeding time and decreases operative blood loss in hemostatically normal subjects undergoing spinal fusion surgery. Blood. 1985; Vol. 5:Abstract 1176. KobrinskyNL , LettsRM , PatelLR , IsraelsED , MonsonRC , SchwetzN , et al. 1‐Desamino‐8‐D‐arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double‐blinded, controlled trial.. Annals of Internal Medicine1987;107:446‐50. ">Kobrinsky 1987</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0038" title="LethagenS , RugarnP , BergqvistD . Blood loss and safety with desmopressin or placebo during aorto‐iliac graft surgery. European Journal of Vascular Surgery1991;5(2):173‐8. ">Lethagen 1991</a>; <a href="./references#CD001884-bbs2-0039" title="LettsM , PangE , D'AstousJ , JarvisJ , LawtonL , LukeB , et al. The influence of desmopressin on blood loss during spinal fusion surgery in neuromuscular patients. Spine1998;23(4):475‐8. ">Letts 1998</a>; <a href="./references#CD001884-bbs2-0041" title="Use of preoperative desmopressin in preventing bleeding in patients treated with SSRI's. International Standard Randomised Controlled Trial Number: ISRCTN10353850. MarczinskiSC , Van derMeerYG , Van derBeek enM , EgbertsAC . Use of preoperative desmopressin in preventing bleeding in patients treated with SSRIs [Desmopressine preoperatif vermindert bloedverlies bij SSRI‐gebruikers: gerandomiseerd placebogecontroleerd, dubbelblind onderzoek]. Wetenschappelijk Platform2007;1(3):60‐3. ">Marczinski 2007</a>; <a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>; <a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. ">Rocha 1988</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>; <a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>; <a href="./references#CD001884-bbs2-0062" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores. Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992a</a>; <a href="./references#CD001884-bbs2-0063" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores (low risk procedures only). Plastic and Reconstructive Surgery1992;89(2):279‐82. ">Wingate 1992b</a>; <a href="./references#CD001884-bbs2-0064" title="WongAY , IrwinMG , HuiTW , FungSK , FanST , MaES . Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Canadian Journal of Anaesthesia2003;50(1):14‐20. ">Wong 2003</a>). Clinical heterogeneity due to differences in baseline blood loss meant that it was not possible to calculate a pooled estimate for the whole population, and we performed analyses in subgroups according to type of surgery (<a href="./references#CD001884-fig-0011" title="">Analysis 1.6</a>). We found no evidence of a difference between subgroups (Chi<sup>2</sup> = 4.10, df = 4 (P = 0.39), I<sup>2</sup> = 2.5%). </p> <section id="CD001884-sec-0124"> <p><b>Adult cardiac surgery</b></p> <p>Four trials (337 participants) reported intraoperative blood loss for adult cardiac surgery (<a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. ">Rocha 1988</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>), but two trials (250 participants) did not report this outcome in a way that allowed inclusion in meta‐analysis, and so we reported this information narratively in <a href="#CD001884-tbl-0009">Table 5</a>. We found no evidence of a difference in intraoperative blood loss for participants treated with DDAVP versus placebo (MD ‐138.2 mL, 95% CI ‐623.4 mL to 347.01 mL; I<sup>2</sup> = 85%; 2 trials, 87 participants; <a href="./references#CD001884-fig-0011" title="">Analysis 1.6</a>). </p> <div class="table" id="CD001884-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">DDAVP vs placebo: intraoperative blood loss</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reason not included in meta‐analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DDAVP arm</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo arm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Adult cardiac surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. "><b>Hackmann 1989</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (90% confidence interval)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>200 (0 to 1150) mL</p> <p>(n = 74)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>200 (0 to 1013) mL</p> <p>(n = 76)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. "><b>Rocha 1988</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> body surface area </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>131 ± 106 mL/m<sup>2</sup> </p> <p>(n = 50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>193 ± 137 mL/m<sup>2</sup> </p> <p>(n = 50)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Paediatric cardiac surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. "><b>Oliver 2000</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49.3 ± 43.7 mL/m<sup>2</sup> </p> <p>(n = 31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73.6 ± 71.1 mL/m<sup>2</sup> </p> <p>(n = 29)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Orthopaedic surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. "><b>Leino 2010</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (no standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1200 mL</p> <p>(n = 23)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1463 mL</p> <p>(n = 24)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Hepatic surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0064" title="WongAY , IrwinMG , HuiTW , FungSK , FanST , MaES . Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Canadian Journal of Anaesthesia2003;50(1):14‐20. "><b>Wong 2003</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>832.5 (350 to 2955) mL</p> <p>(n = 30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>800 mL (250 to 7128) mL</p> <p>(n = 29)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Other surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0041" title="Use of preoperative desmopressin in preventing bleeding in patients treated with SSRI's. International Standard Randomised Controlled Trial Number: ISRCTN10353850. MarczinskiSC , Van derMeerYG , Van derBeek enM , EgbertsAC . Use of preoperative desmopressin in preventing bleeding in patients treated with SSRIs [Desmopressine preoperatif vermindert bloedverlies bij SSRI‐gebruikers: gerandomiseerd placebogecontroleerd, dubbelblind onderzoek]. Wetenschappelijk Platform2007;1(3):60‐3. "><b>Marczinski 2007</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean and range</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>251 (2 to 1330) mL</p> <p>(n = 14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>504 (50 to 2100) mL</p> <p>(n = 14)</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD001884-sec-0125"> <p><b>Paediatric cardiac surgery</b></p> <p>One trial reported intraoperative blood loss for paediatric cardiac surgery, but did not report this outcome in a way that allowed inclusion in meta‐analysis, and so we reported this information narratively in <a href="#CD001884-tbl-0009">Table 5</a>. </p> </section> <section id="CD001884-sec-0126"> <p><b>Orthopaedic surgery</b></p> <p>Six trials (271 participants) reported intraoperative blood loss for orthopaedic surgery (<a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. ">Flordal 1992</a>; <a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>; <a href="./references#CD001884-bbs2-0033" title="KobrinskyNL , IsraelisED , LettsM , PatelL , SchwertzN , CheangMS , et al. DDAVP shortens the bleeding time and decreases operative blood loss in hemostatically normal subjects undergoing spinal fusion surgery. Blood. 1985; Vol. 5:Abstract 1176. KobrinskyNL , LettsRM , PatelLR , IsraelsED , MonsonRC , SchwetzN , et al. 1‐Desamino‐8‐D‐arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double‐blinded, controlled trial.. Annals of Internal Medicine1987;107:446‐50. ">Kobrinsky 1987</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0039" title="LettsM , PangE , D'AstousJ , JarvisJ , LawtonL , LukeB , et al. The influence of desmopressin on blood loss during spinal fusion surgery in neuromuscular patients. Spine1998;23(4):475‐8. ">Letts 1998</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>), but one trial (47 participants) did not report this outcome in a way that allowed inclusion in meta‐analysis, and so we reported this information narratively in <a href="#CD001884-tbl-0009">Table 5</a>. We found no evidence of a difference in intraoperative blood loss for participants treated with DDAVP versus placebo (MD ‐118.24 mL, 95% CI ‐278.43 mL to 41.95 mL; I<sup>2</sup> = 6%; 5 trials, 224 participants; <a href="./references#CD001884-fig-0011" title="">Analysis 1.6</a>). The mean difference was similar when we restricted the analysis to trials: </p> <p> <ul id="CD001884-list-0041"> <li> <p>at low risk of bias (MD ‐126 mL, 95% CI ‐766.22 to 514.22 mL; 1 trial, 30 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>); or </p> </li> <li> <p>with a transfusion protocol (MD ‐103.87 mL, 95% CI ‐350.88 to 143.14 mL; I<sup>2</sup> = 0%; 2 trials, 109 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>). </p> </li> </ul> </p> </section> <section id="CD001884-sec-0127"> <p><b>Vascular surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in intraoperative blood loss for participants treated with DDAVP versus placebo (MD ‐525.00 mL, 95% CI ‐1177.34 to 127.34 mL; 1 trial, 44 participants; <a href="./references#CD001884-fig-0011" title="">Analysis 1.6</a>). </p> </section> <section id="CD001884-sec-0128"> <p><b>Sinus surgery</b></p> <p>Intraoperative blood loss was less for those treated with DDAVP than placebo (MD ‐28 mL, 95% CI ‐31.70 to ‐24.30 mL; 1 trial, 90 participants; <a href="./references#CD001884-fig-0011" title="">Analysis 1.6</a>). </p> </section> <section id="CD001884-sec-0129"> <p><b>Plastic surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in total blood loss for participants treated with DDAVP versus placebo (MD ‐146.02 mL, 95% CI ‐487.86 to 195.83 mL; I<sup>2</sup> = 83%; 2 trials, 44 participants; <a href="./references#CD001884-fig-0011" title="">Analysis 1.6</a>). </p> </section> <section id="CD001884-sec-0130"> <p><b>Hepatic surgery</b></p> <p>One trial (59 participants) reported intraoperative blood loss for hepatic surgery but did not report this outcome in a format that allowed inclusion in meta‐analysis, and so we reported this information narratively in <a href="#CD001884-tbl-0009">Table 5</a>. </p> </section> <section id="CD001884-sec-0131"> <p><b>Other types of surgery</b></p> <p>One trial (28 participants) reported intraoperative blood loss for other types of surgery but did not report this outcome in a format that allowed inclusion in meta‐analysis, and so we reported this information narratively in <a href="#CD001884-tbl-0009">Table 5</a>. </p> </section> </section> <section id="CD001884-sec-0132"> <h6 class="title">Total blood loss</h6> <p>Forty‐eight trials (2808 participants) reported total blood loss (<a href="./references#CD001884-bbs2-0001" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass [membrane oxygenator]. Japanese Journal of Artificial Organs1991;20(2):2516‐20. ">Aida 1991a</a>; <a href="./references#CD001884-bbs2-0002" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass. Japanese Journal of Artificial Organs1991;20(2):2516‐20. ">Aida 1991b</a>; <a href="./references#CD001884-bbs2-0003" title="AcarogluE , AlanayA , SuratA . Desmopressin (DDAVP) in scoliosis surgery. Journal of Bone and Joint Surgery ‐ British Volume. 1997; Vol. 79:Abstract O343. AlanayA , AcarogluE , OzdemirO , ErçelenO , BulutçuE , SuratA . Effects of deamino‐8‐D‐arginin vasopressin on blood loss and coagulation factors in scoliosis surgery. A double‐blind randomized clinical trial. Spine1999;24(9):877‐82. ">Alanay 1999</a>; <a href="./references#CD001884-bbs2-0004" title="AnderssonTL , SolemJO , TengbornL , VingeE . Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation. Circulation1990;81(3):872‐8. ">Andersson 1990</a>; <a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0009" title="ChuangHI , HorngYJ , LiY , ChernFC , ShiehDY , ChiouIS , et al. [Clinical assessment of desmopressin to reduce blood loss in patients after cardiopulmonary bypass]. Ma Zui Xue Za Zhi1993;31(1):35‐42. ">Chuang 1993</a>; <a href="./references#CD001884-bbs2-0011" title="ProstD , Barbier‐BoehmG , HazebroucqJ , BielskyMC , HvassU . Effect of desmopressin on excessive postoperative bleeding and blood product requirements associated with cardiopulmonary bypass. Thrombosis Research. 1992; Vol. 65:Abstract C132. deProstD , Barbier‐BoehmG , HazebroucqJ , IbrahimH , BielskyMC , HvassU , et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thrombosis and Haemostasis1992;68(2):106‐10. ">de Prost 1992</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. ">Dilthey 1993</a>; <a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. ">Flordal 1991</a>; <a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. ">Flordal 1992</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>; <a href="./references#CD001884-bbs2-0020" title="GuyuronB , VaughanC , SchlecterB . The role of DDAVP (desmopressin) in orthognathic surgery. Annals of Plastic Surgery1996;37(5):516‐9. ">Guyuron 1996</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0022" title="HajjarLA , GalasF , FortimM , Melo , R , FerreiraR , AulerJO . Desmopressin acetate reduces blood loss after cardiac surgery: a double‐bind randomized controlled trial. Circulation. 2007; Vol. 116, issue 16:396. ">Hajjar 2007</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0024" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012a</a>; <a href="./references#CD001884-bbs2-0025" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012b</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0030" title="JiH , JinL . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Cardiology. 2013; Vol. 126:Abstract. JinL , JiHW . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Chinese Medical Journal2015;128(5):644‐7. ">Jin 2015</a>; <a href="./references#CD001884-bbs2-0033" title="KobrinskyNL , IsraelisED , LettsM , PatelL , SchwertzN , CheangMS , et al. DDAVP shortens the bleeding time and decreases operative blood loss in hemostatically normal subjects undergoing spinal fusion surgery. Blood. 1985; Vol. 5:Abstract 1176. KobrinskyNL , LettsRM , PatelLR , IsraelsED , MonsonRC , SchwetzN , et al. 1‐Desamino‐8‐D‐arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double‐blinded, controlled trial.. Annals of Internal Medicine1987;107:446‐50. ">Kobrinsky 1987</a>; <a href="./references#CD001884-bbs2-0034" title="KuitunenAH . Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery. Annals Chirurgiae et Gynaecologiae1992;81(1):11‐8. ">Kuitunen 1992</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0038" title="LethagenS , RugarnP , BergqvistD . Blood loss and safety with desmopressin or placebo during aorto‐iliac graft surgery. European Journal of Vascular Surgery1991;5(2):173‐8. ">Lethagen 1991</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. ">Ozkisacik 2001</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0048" title="ReichDL , HammerschlagBC , RandJH , Weiss‐BloomL , PeruchoH , GallaJ , et al. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):142‐5. ">Reich 1991</a>; <a href="./references#CD001884-bbs2-0049" title="ReynoldsLM , NicolsonSC , JobesDR , StevenJM , NorwoodWI , McGonigleME , et al. Desmopressin does not decrease bleeding after cardiac operation in young children. Journal of Thoracic and Cardiovascular Surgery1993;106(6):954‐8. ">Reynolds 1993</a>; <a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. ">Rocha 1988</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0052" title="SalmenperaM , KuitunenA , HynynenM , HeinonenJ . Hemodynamic responses to desmopressin acetate after CABG: a double‐blind trial. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):146‐9. ">Salmenpera 1991</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>; <a href="./references#CD001884-bbs2-0055" title="SeearM , WadsworthL , ShepsS , MontgomeryC , AshmoreP . The effect of desmopressin acetate (DDAVP) on post‐operative blood loss after open heart surgery in children. Blood. 1987; Vol. 5:Abstract 380a. SeearMD , WadsworthLD , RogersPC , ShepsS , AshmorePG . The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. Journal of Thoracic and Cardiovascular Surgery1989;98(2):217‐9. ">Seear 1989</a>; <a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. ">Sheridan 1994</a>; <a href="./references#CD001884-bbs2-0058" title="SpytTJ , WeerasenaNA , BainWH , LoweGD , RumleyA . The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double‐blind trial. Perfusion1990;5(Suppl):57‐61. WeerasenaNA , SpytTJ , RumleyA , BainWH , LoweGD . Randomised, double‐blind, placebo‐controlled trial of desmopressin in routine coronary artery bypass surgery. British Journal of Haematology. 1990; Vol. 76:Abstract 38. ">Spyt 1990</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>; <a href="./references#CD001884-bbs2-0060" title="TemeckBK , BachenheimerLC , KatzNM , CoughlinSS , WallaceRB . Desmopressin acetate in cardiac surgery: a double‐blind, randomized study. Southern Medical Journal1994;87(6):611‐5. ">Temeck 1994</a>; <a href="./references#CD001884-bbs2-0061" title="TherouxMC , CorddryDH , TietzAE , MillerF , PeoplesJD , KettrickRG . A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double‐blinded study. Anesthesiology1997;87(2):260‐7. ">Theroux 1997</a>). Clinical heterogeneity due to differences in baseline blood loss meant that it was not possible to obtain a pooled estimate for the whole population, and so we performed analyses in subgroups according to type of surgery (<a href="./references#CD001884-fig-0012" title="">Analysis 1.7</a>; <a href="./references#CD001884-fig-0013" title="">Analysis 1.8</a>). We found no evidence of a difference between subgroups (Chi<sup>2</sup> = 3.02, df = 2 (P = 0.22); I<sup>2</sup> = 33.7%). </p> <section id="CD001884-sec-0133"> <p><b>Adult cardiac surgery</b></p> <p>Thirty‐seven trials (2354 participants) reported total blood loss for adult cardiac surgery (<a href="./references#CD001884-bbs2-0001" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass [membrane oxygenator]. Japanese Journal of Artificial Organs1991;20(2):2516‐20. ">Aida 1991a</a>; <a href="./references#CD001884-bbs2-0002" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass. Japanese Journal of Artificial Organs1991;20(2):2516‐20. ">Aida 1991b</a>; <a href="./references#CD001884-bbs2-0003" title="AcarogluE , AlanayA , SuratA . Desmopressin (DDAVP) in scoliosis surgery. Journal of Bone and Joint Surgery ‐ British Volume. 1997; Vol. 79:Abstract O343. AlanayA , AcarogluE , OzdemirO , ErçelenO , BulutçuE , SuratA . Effects of deamino‐8‐D‐arginin vasopressin on blood loss and coagulation factors in scoliosis surgery. A double‐blind randomized clinical trial. Spine1999;24(9):877‐82. ">Alanay 1999</a>; <a href="./references#CD001884-bbs2-0004" title="AnderssonTL , SolemJO , TengbornL , VingeE . Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation. Circulation1990;81(3):872‐8. ">Andersson 1990</a>; <a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0009" title="ChuangHI , HorngYJ , LiY , ChernFC , ShiehDY , ChiouIS , et al. [Clinical assessment of desmopressin to reduce blood loss in patients after cardiopulmonary bypass]. Ma Zui Xue Za Zhi1993;31(1):35‐42. ">Chuang 1993</a>; <a href="./references#CD001884-bbs2-0011" title="ProstD , Barbier‐BoehmG , HazebroucqJ , BielskyMC , HvassU . Effect of desmopressin on excessive postoperative bleeding and blood product requirements associated with cardiopulmonary bypass. Thrombosis Research. 1992; Vol. 65:Abstract C132. deProstD , Barbier‐BoehmG , HazebroucqJ , IbrahimH , BielskyMC , HvassU , et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thrombosis and Haemostasis1992;68(2):106‐10. ">de Prost 1992</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. ">Dilthey 1993</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0022" title="HajjarLA , GalasF , FortimM , Melo , R , FerreiraR , AulerJO . Desmopressin acetate reduces blood loss after cardiac surgery: a double‐bind randomized controlled trial. Circulation. 2007; Vol. 116, issue 16:396. ">Hajjar 2007</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0024" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012a</a>; <a href="./references#CD001884-bbs2-0025" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012b</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0030" title="JiH , JinL . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Cardiology. 2013; Vol. 126:Abstract. JinL , JiHW . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Chinese Medical Journal2015;128(5):644‐7. ">Jin 2015</a>; <a href="./references#CD001884-bbs2-0034" title="KuitunenAH . Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery. Annals Chirurgiae et Gynaecologiae1992;81(1):11‐8. ">Kuitunen 1992</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. ">Ozkisacik 2001</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0048" title="ReichDL , HammerschlagBC , RandJH , Weiss‐BloomL , PeruchoH , GallaJ , et al. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):142‐5. ">Reich 1991</a>; <a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. ">Rocha 1988</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0052" title="SalmenperaM , KuitunenA , HynynenM , HeinonenJ . Hemodynamic responses to desmopressin acetate after CABG: a double‐blind trial. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):146‐9. ">Salmenpera 1991</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. ">Sheridan 1994</a>; <a href="./references#CD001884-bbs2-0058" title="SpytTJ , WeerasenaNA , BainWH , LoweGD , RumleyA . The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double‐blind trial. Perfusion1990;5(Suppl):57‐61. WeerasenaNA , SpytTJ , RumleyA , BainWH , LoweGD . Randomised, double‐blind, placebo‐controlled trial of desmopressin in routine coronary artery bypass surgery. British Journal of Haematology. 1990; Vol. 76:Abstract 38. ">Spyt 1990</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>; <a href="./references#CD001884-bbs2-0060" title="TemeckBK , BachenheimerLC , KatzNM , CoughlinSS , WallaceRB . Desmopressin acetate in cardiac surgery: a double‐blind, randomized study. Southern Medical Journal1994;87(6):611‐5. ">Temeck 1994</a>), but 15 trials (996 participants) did not report this outcome in a way that allowed inclusion in meta‐analysis, and so we reported this information narratively in <a href="#CD001884-tbl-0010">Table 6</a>. </p> <div class="table" id="CD001884-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">DDAVP vs placebo: total blood loss</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reason not included in meta‐analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DDAVP arm</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo arm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Adult cardiac surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0001" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass [membrane oxygenator]. Japanese Journal of Artificial Organs1991;20(2):2516‐20. "><b>Aida 1991a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/kg (mean ± standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.0 ± 1.4 mL/kg</p> <p>(n = 5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.9 ± 1.5 mL/kg</p> <p>(n = 4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0002" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass. Japanese Journal of Artificial Organs1991;20(2):2516‐20. "><b>Aida 1991b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/kg (mean ± standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.3 ± 10 mL/kg</p> <p>(n = 5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.5 ± 4 mL/kg</p> <p>(n = 6)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0003" title="AcarogluE , AlanayA , SuratA . Desmopressin (DDAVP) in scoliosis surgery. Journal of Bone and Joint Surgery ‐ British Volume. 1997; Vol. 79:Abstract O343. AlanayA , AcarogluE , OzdemirO , ErçelenO , BulutçuE , SuratA . Effects of deamino‐8‐D‐arginin vasopressin on blood loss and coagulation factors in scoliosis surgery. A double‐blind randomized clinical trial. Spine1999;24(9):877‐82. "><b>Alanay 1999</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (interquartile range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>950 (950) mL</p> <p>(n = 18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>975 (811) mL</p> <p>(n = 22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. "><b>Bignami 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (interquartile range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>575 (422.5 to 770) mL</p> <p>(n = 68)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>590 (476.25 to 1013.75) mL</p> <p>(n = 67)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. "><b>Casas 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> body surface area (mean ± standard deviation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>400 ± 192 mL/m<sup>2</sup> </p> <p>(n = 50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>489 ± 361 mL/m<sup>2</sup> </p> <p>(n = 51)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0011" title="ProstD , Barbier‐BoehmG , HazebroucqJ , BielskyMC , HvassU . Effect of desmopressin on excessive postoperative bleeding and blood product requirements associated with cardiopulmonary bypass. Thrombosis Research. 1992; Vol. 65:Abstract C132. deProstD , Barbier‐BoehmG , HazebroucqJ , IbrahimH , BielskyMC , HvassU , et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thrombosis and Haemostasis1992;68(2):106‐10. "><b>de Prost 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> body surface area (mean ± standard deviation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>582 ± 410 mL/m<sup>2</sup> </p> <p>(n = 44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>465 ± 303 mL/m<sup>2</sup> </p> <p>(n = 37)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. "><b>Dilthey 1993</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1000 (600 to 1800) mL</p> <p>(n = 19)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1075 (400 to 1740) mL</p> <p>(n = 20)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. "><b>Hackmann 1989</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (90% confidence interval)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>865 (358 to 2495) mL</p> <p>(n = 74)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>783 (300 to 2219) mL</p> <p>(n = 76)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0022" title="HajjarLA , GalasF , FortimM , Melo , R , FerreiraR , AulerJO . Desmopressin acetate reduces blood loss after cardiac surgery: a double‐bind randomized controlled trial. Circulation. 2007; Vol. 116, issue 16:396. "><b>Hajjar 2007</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> (mean ± standard deviation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>258 ± 106 mL/m<sup>2</sup> </p> <p>(n = 75)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>526 ± 314 mL/m<sup>2</sup> </p> <p>(n = 75)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0024" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. "><b>Hemșinli 2012a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (no standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1430 mL</p> <p>(n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1767 mL</p> <p>(n = 10)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0025" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. "><b>Hemșinli 2012b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (no standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>574 mL</p> <p>(n = 16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>535 mL</p> <p>(n = 18)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. "><b>Marquez 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1157 mL</p> <p>(n = 21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1180 mL</p> <p>(n = 22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. "><b>Rocha 1988</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> body surface area (mean ± standard deviation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>458 ± 206 mL/m<sup>2</sup> </p> <p>(n = 50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>536 ± 304 mL/m<sup>2</sup> </p> <p>(n = 50)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. "><b>Rocha 1994</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> body surface area (mean ± standard deviation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>551.8 ± 324.1 mL/m<sup>2</sup> </p> <p>(n = 28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>438.7 ± 228.1 mL/m<sup>2</sup> </p> <p>(n = 25)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0052" title="SalmenperaM , KuitunenA , HynynenM , HeinonenJ . Hemodynamic responses to desmopressin acetate after CABG: a double‐blind trial. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):146‐9. "><b>Salmenpera 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1020 (530 to 1155) mL</p> <p>(n = 15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1100 (425 to 1720) mL</p> <p>(n = 15)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Orthopaedic surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. "><b>Flordal 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (no standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1320 mL</p> <p>(n = 6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1380 mL</p> <p>(n = 6)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0061" title="TherouxMC , CorddryDH , TietzAE , MillerF , PeoplesJD , KettrickRG . A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double‐blinded study. Anesthesiology1997;87(2):260‐7. "><b>Theroux 1997</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as estimated percentage blood loss: median (range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>147.8% (57% to 428.8%)</p> <p>(n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111.2% (65% to 239.5%)</p> <p>(n = 11)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Maxillofacial surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0020" title="GuyuronB , VaughanC , SchlecterB . The role of DDAVP (desmopressin) in orthognathic surgery. Annals of Plastic Surgery1996;37(5):516‐9. "><b>Guyuron 1996</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>675 (380 to 1330) mL</p> <p>(n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>819 (200 to 1600) mL</p> <p>(n = 10)</p> </td> </tr> </tbody> </table> </div> <p>Total blood loss for participants undergoing cardiac surgery was less for participants treated with DDAVP than placebo (MD ‐135.24 mL, 95% CI ‐210.8 to ‐59.68 mL; I<sup>2</sup> = 78%; 22 trials, 1358 participants; <a href="./references#CD001884-fig-0012" title="">Analysis 1.7</a>). Sensitivity analyses could not account for the level of heterogeneity observed. Heterogenity was not improved by restricting the analysis to trials: </p> <p> <ul id="CD001884-list-0042"> <li> <p>at low risk of bias (MD ‐89.77 mL, 95% CI ‐227.72 to 48.19 mL; I<sup>2</sup> = 85%; 5 trials, 312 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>); or </p> </li> <li> <p>published as full‐text papers (MD ‐98.96 mL, 95% CI ‐163.75 to ‐34.17 mL; I<sup>2</sup> = 68%; 21 trials, 1310 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0004" title="AnderssonTL , SolemJO , TengbornL , VingeE . Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation. Circulation1990;81(3):872‐8. ">Andersson 1990</a>; <a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0030" title="JiH , JinL . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Cardiology. 2013; Vol. 126:Abstract. JinL , JiHW . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Chinese Medical Journal2015;128(5):644‐7. ">Jin 2015</a>; <a href="./references#CD001884-bbs2-0034" title="KuitunenAH . Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery. Annals Chirurgiae et Gynaecologiae1992;81(1):11‐8. ">Kuitunen 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. ">Ozkisacik 2001</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0048" title="ReichDL , HammerschlagBC , RandJH , Weiss‐BloomL , PeruchoH , GallaJ , et al. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):142‐5. ">Reich 1991</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. ">Sheridan 1994</a>; <a href="./references#CD001884-bbs2-0058" title="SpytTJ , WeerasenaNA , BainWH , LoweGD , RumleyA . The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double‐blind trial. Perfusion1990;5(Suppl):57‐61. WeerasenaNA , SpytTJ , RumleyA , BainWH , LoweGD . Randomised, double‐blind, placebo‐controlled trial of desmopressin in routine coronary artery bypass surgery. British Journal of Haematology. 1990; Vol. 76:Abstract 38. ">Spyt 1990</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>; <a href="./references#CD001884-bbs2-0060" title="TemeckBK , BachenheimerLC , KatzNM , CoughlinSS , WallaceRB . Desmopressin acetate in cardiac surgery: a double‐blind, randomized study. Southern Medical Journal1994;87(6):611‐5. ">Temeck 1994</a>). </p> </li> </ul> </p> <p>Restricting the analysis to trials:</p> <p> <ul id="CD001884-list-0043"> <li> <p>with a transfusion protocol did not reduce the effect estimate and heterogeneity (MD ‐17.12 mL, 95% CI ‐84.61 to 50.36 mL; I<sup>2</sup> = 35%; 7 trials, 394 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0048" title="ReichDL , HammerschlagBC , RandJH , Weiss‐BloomL , PeruchoH , GallaJ , et al. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):142‐5. ">Reich 1991</a>); </p> </li> <li> <p>published before 2010 plus those registered prospectively and published after 2010 did not alter the effect estimate and heterogeneity (MD ‐143.99 mL, 95% CI ‐225.09 to ‐62.90 mL; I<sup>2</sup> = 78%; 21 trials, 1256 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0004" title="AnderssonTL , SolemJO , TengbornL , VingeE . Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation. Circulation1990;81(3):872‐8. ">Andersson 1990</a>; <a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0009" title="ChuangHI , HorngYJ , LiY , ChernFC , ShiehDY , ChiouIS , et al. [Clinical assessment of desmopressin to reduce blood loss in patients after cardiopulmonary bypass]. Ma Zui Xue Za Zhi1993;31(1):35‐42. ">Chuang 1993</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0034" title="KuitunenAH . Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery. Annals Chirurgiae et Gynaecologiae1992;81(1):11‐8. ">Kuitunen 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. ">Ozkisacik 2001</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0048" title="ReichDL , HammerschlagBC , RandJH , Weiss‐BloomL , PeruchoH , GallaJ , et al. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):142‐5. ">Reich 1991</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. ">Sheridan 1994</a>; <a href="./references#CD001884-bbs2-0058" title="SpytTJ , WeerasenaNA , BainWH , LoweGD , RumleyA . The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double‐blind trial. Perfusion1990;5(Suppl):57‐61. WeerasenaNA , SpytTJ , RumleyA , BainWH , LoweGD . Randomised, double‐blind, placebo‐controlled trial of desmopressin in routine coronary artery bypass surgery. British Journal of Haematology. 1990; Vol. 76:Abstract 38. ">Spyt 1990</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>; <a href="./references#CD001884-bbs2-0060" title="TemeckBK , BachenheimerLC , KatzNM , CoughlinSS , WallaceRB . Desmopressin acetate in cardiac surgery: a double‐blind, randomized study. Southern Medical Journal1994;87(6):611‐5. ">Temeck 1994</a>). </p> </li> </ul> </p> <p>TSA showed accrual of 157% of the information size so far to detect or reject a 15% (150.5 mL) reduction in blood loss based on an estimated mean blood loss of 1003.3 mL in study control arms (D<sup>2</sup> = 84%). This crossed the 5% O'Brien‐Fleming boundary, suggesting that DDAVP results in a statistically significant reduction in blood loss and that further trial data are unlikely to change this estimate. However, this result included many trials that we assessed as being at high risk of bias, and results show risk of systematic error. When we restricted TSA to trials at low risk of bias, results showed that 23.6% of the information size had been accrued so far. </p> </section> <section id="CD001884-sec-0134"> <p><b>Orthopaedic surgery</b></p> <p>Seven trials (274 participants) reported total blood loss for orthopaedic surgery (<a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. ">Flordal 1991</a>; <a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. ">Flordal 1992</a>; <a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>; <a href="./references#CD001884-bbs2-0033" title="KobrinskyNL , IsraelisED , LettsM , PatelL , SchwertzN , CheangMS , et al. DDAVP shortens the bleeding time and decreases operative blood loss in hemostatically normal subjects undergoing spinal fusion surgery. Blood. 1985; Vol. 5:Abstract 1176. KobrinskyNL , LettsRM , PatelLR , IsraelsED , MonsonRC , SchwetzN , et al. 1‐Desamino‐8‐D‐arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double‐blinded, controlled trial.. Annals of Internal Medicine1987;107:446‐50. ">Kobrinsky 1987</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>; <a href="./references#CD001884-bbs2-0061" title="TherouxMC , CorddryDH , TietzAE , MillerF , PeoplesJD , KettrickRG . A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double‐blinded study. Anesthesiology1997;87(2):260‐7. ">Theroux 1997</a>), but two trials (33 participants) did not report this outcome in a way that allowed inclusion in meta‐analysis, and so we reported this information narratively in <a href="#CD001884-tbl-0010">Table 6</a>. Among participants undergoing orthopaedic surgery, total blood loss was less for those treated with DDAVP than placebo (MD ‐285.76 mL, 95% CI ‐514.99 mL to ‐56.53 mL; I<sup>2</sup> = 0%; 5 trials, 241 participants; <a href="./references#CD001884-fig-0012" title="">Analysis 1.7</a>). Restricting the analysis to trials: </p> <p> <ul id="CD001884-list-0044"> <li> <p>at low risk of bias did not alter the estimate (MD ‐285.63 mL, 95% CI ‐741.88 to 170.63 mL; I<sup>2</sup> = 0%; 2 trials, 77 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>); </p> </li> <li> <p>with a transfusion protocol did not affect the effect estimate (MD ‐277.23 mL, 95% CI ‐543.75 to ‐10.71 mL; I<sup>2</sup> = 0%; 4 trials, 191 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>; <a href="./references#CD001884-bbs2-0033" title="KobrinskyNL , IsraelisED , LettsM , PatelL , SchwertzN , CheangMS , et al. DDAVP shortens the bleeding time and decreases operative blood loss in hemostatically normal subjects undergoing spinal fusion surgery. Blood. 1985; Vol. 5:Abstract 1176. KobrinskyNL , LettsRM , PatelLR , IsraelsED , MonsonRC , SchwetzN , et al. 1‐Desamino‐8‐D‐arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double‐blinded, controlled trial.. Annals of Internal Medicine1987;107:446‐50. ">Kobrinsky 1987</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>); </p> </li> <li> <p>published before 2010 plus those registered prospectively and published after 2010 did not alter the effect estimate (MD ‐262.24, 95% CI ‐510.07 to ‐14.40; I<sup>2</sup> = 0%; 4 trials, 194 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. ">Flordal 1992</a>; <a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>; <a href="./references#CD001884-bbs2-0033" title="KobrinskyNL , IsraelisED , LettsM , PatelL , SchwertzN , CheangMS , et al. DDAVP shortens the bleeding time and decreases operative blood loss in hemostatically normal subjects undergoing spinal fusion surgery. Blood. 1985; Vol. 5:Abstract 1176. KobrinskyNL , LettsRM , PatelLR , IsraelsED , MonsonRC , SchwetzN , et al. 1‐Desamino‐8‐D‐arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double‐blinded, controlled trial.. Annals of Internal Medicine1987;107:446‐50. ">Kobrinsky 1987</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>). </p> </li> </ul> </p> <p>TSA showed that 99.2% of the information size required to detect or reject a 15% (326.8 mL) reduction in blood loss based on an estimated mean blood loss of 2178.7 mL in study control arms (D<sup>2</sup> = 0%) had been accrued so far. This crossed the 5% O'Brien‐Fleming boundary, suggesting that DDAVP results in a statistically significant reduction in blood loss and that further trial data are unlikely to change this estimate. However, this result included many trials that we assessed as being at high risk of bias, and so results show risk of systematic error. When we restricted TSA to trials at low risk of bias, results showed that 14.4% of the information size had been accrued so far. </p> </section> <section id="CD001884-sec-0135"> <p><b>Vascular surgery</b></p> <p>Total blood loss for participants undergoing vascular surgery was less for participants treated with DDAVP than placebo (MD ‐582.00 mL, 95% CI ‐1264.07 to 100.07 mL; 1 study, 44 participants; <a href="./references#CD001884-fig-0012" title="">Analysis 1.7</a>). TSA showed that 8.3% of the information size required to detect or reject a 15% (281.6 mL) reduction in blood loss based on an estimated mean blood loss of 1877 mL in study control arms (D<sup>2</sup> = 0%) had been accrued so far. </p> </section> <section id="CD001884-sec-0136"> <p><b>Paediatric cardiac surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in total blood loss for paediatric participants undergoing cardiac surgery among those treated with DDAVP versus placebo (MD 1.11 mL/kg, 95% CI ‐12.92 mL/kg to 15.15 mL/kg; I<sup>2</sup> = 35%; 2 studies, 155 participants; <a href="./references#CD001884-fig-0013" title="">Analysis 1.8</a>). TSA showed that 6.0% of the information size had been accrued so far to detect or reject a 15% (4.9 mL/m<sup>2</sup>) reduction in blood loss based on an estimated mean blood loss of 33.1 mL/m<sup>2</sup> in study control arms (D<sup>2</sup> = 38%). When we restricted TSA to trials at low risk of bias, results showed that 1.3% of the information size had been accrued so far. </p> </section> </section> </section> <section id="CD001884-sec-0137"> <h5 class="title">Secondary outcomes</h5> <section id="CD001884-sec-0138"> <h6 class="title">Number of participants with intraoperative bleeding (interventional procedures only)</h6> <p>One trial (48 participants) reported the number of participants undergoing interventional procedures with intraoperative bleeding (<a href="./references#CD001884-bbs2-0036" title="LeeHK , KimYJ , JeongJU , ParkJS , ChiHS , KimSB . Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients. Nephron Clinical Practice2010;114(4):c248‐52. ">Lee 2010</a>). Owing to the small number of participants, we are uncertain whether results showed a difference in the number of participants who had an intraoperative bleed in the DDAVP arm versus the placebo arm (RR 0.29, 95% CI 0.07 to 1.24; 1 trial, 48 participants; <a href="./references#CD001884-fig-0014" title="">Analysis 1.9</a>). </p> </section> <section id="CD001884-sec-0139"> <h6 class="title">Number of participants with any bleeding (interventional procedures only)</h6> <p>One trial (162 participants) reported the number of participants undergoing interventional procedures with any bleeding (<a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>). Fewer participants had an intraoperative bleed in the DDAVP arm compared to the placebo arm (RR 0.45, 95% CI 0.24 to 0.85; 1 trial, 162 participants; <a href="./references#CD001884-fig-0015" title="">Analysis 1.10</a>). </p> </section> <section id="CD001884-sec-0140"> <h6 class="title">Reoperation due to bleeding</h6> <p>Twenty‐three trials (1783 participants) reported the number of participants undergoing reoperation due to bleeding, and all 23 contributed data towards the final pooled estimate (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0011" title="ProstD , Barbier‐BoehmG , HazebroucqJ , BielskyMC , HvassU . Effect of desmopressin on excessive postoperative bleeding and blood product requirements associated with cardiopulmonary bypass. Thrombosis Research. 1992; Vol. 65:Abstract C132. deProstD , Barbier‐BoehmG , HazebroucqJ , IbrahimH , BielskyMC , HvassU , et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thrombosis and Haemostasis1992;68(2):106‐10. ">de Prost 1992</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0036" title="LeeHK , KimYJ , JeongJU , ParkJS , ChiHS , KimSB . Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients. Nephron Clinical Practice2010;114(4):c248‐52. ">Lee 2010</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>; <a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. ">Ozkisacik 2001</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. ">Rocha 1988</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>). Results showed no difference in the number of participants who required reoperation due to bleeding between those treated with DDAVP versus placebo (pOR 0.66, 95% CI 0.40 to 1.09l; I<sup>2</sup> = 33%; 23 trials, 1783 participants; <a href="./references#CD001884-fig-0016" title="">Analysis 1.11</a>). We found no evidence of a difference between subgroups (Chi<sup>2</sup> = 1.40, df = 1 (P = 0.24), I<sup>2</sup> = 28.6%). When we restricted analysis to trials: </p> <p> <ul id="CD001884-list-0045"> <li> <p>at low risk of bias, the effect estimate was similar (pOR 0.75, 95% CI 0.35 to 1.59; I<sup>2</sup> = 14%; 9 trials, 699 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>); </p> </li> <li> <p>published before 2010 plus those registered prospectively and published after 2010, the effect estimate was unchanged (pOR 0.66, 95% CI 0.40 to 1.09; I<sup>2</sup> = 33%; 22 trials, 1599 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0011" title="ProstD , Barbier‐BoehmG , HazebroucqJ , BielskyMC , HvassU . Effect of desmopressin on excessive postoperative bleeding and blood product requirements associated with cardiopulmonary bypass. Thrombosis Research. 1992; Vol. 65:Abstract C132. deProstD , Barbier‐BoehmG , HazebroucqJ , IbrahimH , BielskyMC , HvassU , et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thrombosis and Haemostasis1992;68(2):106‐10. ">de Prost 1992</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0036" title="LeeHK , KimYJ , JeongJU , ParkJS , ChiHS , KimSB . Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients. Nephron Clinical Practice2010;114(4):c248‐52. ">Lee 2010</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>; <a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. ">Ozkisacik 2001</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. ">Rocha 1988</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>). </p> </li> </ul> </p> <section id="CD001884-sec-0141"> <p><b>Cardiac surgery</b></p> <p>We found no evidence of a difference in reoperation due to bleeding (pOR 0.64, 95% CI 0.38 to 1.05; I<sup>2</sup> = 33%; 19 trials, 1483 participants; <a href="./references#CD001884-fig-0016" title="">Analysis 1.11</a>). When we restricted analysis to trials: </p> <p> <ul id="CD001884-list-0046"> <li> <p>at low risk of bias, the effect estimate was similar (RR 0.69, 95% CI 0.32 to 1.48; I<sup>2</sup> = 12%; 6 trials, 447 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>); </p> </li> <li> <p>using autologous cell salvage, the direction of effect was reversed, although this finding did not reach statistical significance (RR 1.36, 95% CI 0.50 to 3.68; I<sup>2</sup> = 34%; 5 trials, 424 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>). </p> </li> </ul> </p> </section> <section id="CD001884-sec-0142"> <p><b>Orthopaedic surgery</b></p> <p>One trial in this subgroup reported reoperation due to bleeding. However, no participants in either arm of the trial returned to theatre with bleeding (<a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. ">Guay 1992</a>). </p> </section> <section id="CD001884-sec-0143"> <p><b>Paediatric cardiac surgery</b></p> <p>Owing to the small number of participants, we are uncertain if results showed a difference in the number of participants undergoing reoperation due to bleeding after treatment with DDAVP versus placebo (pOR 6.93, 95% CI 0.14 to 349.88; 1 trial, 60 participants; <a href="./references#CD001884-fig-0016" title="">Analysis 1.11</a>) (<a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>). </p> </section> <section id="CD001884-sec-0144"> <p><b>Dialysis catheter insertion</b></p> <p>One trial in this subgroup reported reoperation due to bleeding. However, no participants in either arm of the trial returned to theatre with bleeding (<a href="./references#CD001884-bbs2-0036" title="LeeHK , KimYJ , JeongJU , ParkJS , ChiHS , KimSB . Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients. Nephron Clinical Practice2010;114(4):c248‐52. ">Lee 2010</a>). </p> </section> <section id="CD001884-sec-0145"> <p><b>Kidney biopsy</b></p> <p>One trial in this subgroup reported reoperation due to bleeding. However, no participants in either arm of the trial returned to theatre with bleeding (<a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>). </p> </section> </section> <section id="CD001884-sec-0146"> <h6 class="title">All‐cause mortality</h6> <p>Twenty‐two trials (1631 participants) reported all‐cause mortality, and all 22 contributed data towards the final pooled estimate (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0030" title="JiH , JinL . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Cardiology. 2013; Vol. 126:Abstract. JinL , JiHW . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Chinese Medical Journal2015;128(5):644‐7. ">Jin 2015</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0034" title="KuitunenAH . Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery. Annals Chirurgiae et Gynaecologiae1992;81(1):11‐8. ">Kuitunen 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. ">Rocha 1988</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>; <a href="./references#CD001884-bbs2-0055" title="SeearM , WadsworthL , ShepsS , MontgomeryC , AshmoreP . The effect of desmopressin acetate (DDAVP) on post‐operative blood loss after open heart surgery in children. Blood. 1987; Vol. 5:Abstract 380a. SeearMD , WadsworthLD , RogersPC , ShepsS , AshmorePG . The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. Journal of Thoracic and Cardiovascular Surgery1989;98(2):217‐9. ">Seear 1989</a>; <a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. ">Sheridan 1994</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>). We found no evidence of a difference in all‐cause mortality between participants treated with DDAVP versus placebo (pOR 1.09, 95% CI 0.51 to 2.34; I<sup>2</sup> = 3%; 22 trials, 1631 participants; <a href="./references#CD001884-fig-0017" title="">Analysis 1.12</a>). We found no evidence of a difference between subgroups (Chi<sup>2</sup> = 4.29, df = 2 (P = 0.12); I<sup>2</sup> = 53.4%). When we restricted the analysis to: </p> <p> <ul id="CD001884-list-0047"> <li> <p>trials at low risk of bias, the effect estimate was similar (pOR 1.16, 95% CI 0.41 to 3.25; I<sup>2</sup> = 31%; 6 trials, 469 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0055" title="SeearM , WadsworthL , ShepsS , MontgomeryC , AshmoreP . The effect of desmopressin acetate (DDAVP) on post‐operative blood loss after open heart surgery in children. Blood. 1987; Vol. 5:Abstract 380a. SeearMD , WadsworthLD , RogersPC , ShepsS , AshmorePG . The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. Journal of Thoracic and Cardiovascular Surgery1989;98(2):217‐9. ">Seear 1989</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>); </p> </li> <li> <p>trials published before 2010 plus those registered prospectively and published after 2010, the effect estimate was not altered (pOR 1.09, 95% CI 0.51 to 2.34; I<sup>2</sup> = 3%; 21 trials, 1529 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0034" title="KuitunenAH . Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery. Annals Chirurgiae et Gynaecologiae1992;81(1):11‐8. ">Kuitunen 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. ">Rocha 1988</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>; <a href="./references#CD001884-bbs2-0055" title="SeearM , WadsworthL , ShepsS , MontgomeryC , AshmoreP . The effect of desmopressin acetate (DDAVP) on post‐operative blood loss after open heart surgery in children. Blood. 1987; Vol. 5:Abstract 380a. SeearMD , WadsworthLD , RogersPC , ShepsS , AshmorePG . The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. Journal of Thoracic and Cardiovascular Surgery1989;98(2):217‐9. ">Seear 1989</a>; <a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. ">Sheridan 1994</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>). </p> </li> </ul> </p> <section id="CD001884-sec-0147"> <p><b>Cardiac surgery</b></p> <p>We found no evidence of a difference in all‐cause mortality for participants treated with DDAVP versus placebo (pOR 1.09, 95% CI 0.48 to 2.51; I<sup>2</sup> = 0%; 16 trials, 1239 participants; <a href="./references#CD001884-fig-0017" title="">Analysis 1.12</a>). When we restricted the analysis to: </p> <p> <ul id="CD001884-list-0048"> <li> <p>trials at low risk of bias, the effect estimate was similar (pOR 1.20, 95% CI 0.36 to 4.02; I<sup>2</sup> = 0%; 3 trials, 248 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>); </p> </li> <li> <p>trials published before 2010 plus those registered prospectively and published after 2010, the effect estimate was not altered (pOR 1.09, 95% CI 0.48 to 2.51; I<sup>2</sup> = 0%; 15 trials, 1137 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. ">Hackmann 1989</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0034" title="KuitunenAH . Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery. Annals Chirurgiae et Gynaecologiae1992;81(1):11‐8. ">Kuitunen 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. ">Rocha 1988</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. ">Sheridan 1994</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>). </p> </li> </ul> </p> </section> <section id="CD001884-sec-0148"> <p><b>Orthopaedic surgery</b></p> <p>Three trials in this subgroup reported all‐cause mortality as an outcome, however, no deaths occurred during these trials (<a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>). </p> </section> <section id="CD001884-sec-0149"> <p><b>Vascular surgery</b></p> <p>Owing to the small number of participants, we are uncertain if results showed a difference in all‐cause mortality between participants treated with DDAVP versus placebo (pOR 8.50, 95% CI 0.52 to 138.60; 1 trial, 91 participants; <a href="./references#CD001884-fig-0017" title="">Analysis 1.12</a>). </p> </section> <section id="CD001884-sec-0150"> <p><b>Paediatric cardiac surgery</b></p> <p>Owing to the small number of participants, we are uncertain if results showed a difference in all‐cause mortality between participants treated with DDAVP versus placebo (pOR 0.13, 95% CI 0.01 to 2.14; 2 trials, 130 participants; <a href="./references#CD001884-fig-0017" title="">Analysis 1.12</a>). </p> </section> </section> <section id="CD001884-sec-0151"> <h6 class="title">All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism) </h6> <p>Twenty‐nine trials (1984 participants) reported thrombotic events, and all 29 contributed data towards the final pooled estimate (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. ">Flordal 1991</a>; <a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. ">Flordal 1992</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0030" title="JiH , JinL . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Cardiology. 2013; Vol. 126:Abstract. JinL , JiHW . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Chinese Medical Journal2015;128(5):644‐7. ">Jin 2015</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0038" title="LethagenS , RugarnP , BergqvistD . Blood loss and safety with desmopressin or placebo during aorto‐iliac graft surgery. European Journal of Vascular Surgery1991;5(2):173‐8. ">Lethagen 1991</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0052" title="SalmenperaM , KuitunenA , HynynenM , HeinonenJ . Hemodynamic responses to desmopressin acetate after CABG: a double‐blind trial. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):146‐9. ">Salmenpera 1991</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>; <a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>; <a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. ">Sheridan 1994</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>). We found no evidence of a difference in thrombotic events between participants treated with DDAVP versus placebo (pOR 1.36, 95% CI 0.85 to 2.16; I<sup>2</sup> = 0%; 29 trials, 1984 participants; <a href="./references#CD001884-fig-0018" title="">Analysis 1.13</a>). We found no evidence of a difference between subgroups (Chi<sup>2</sup> = 1.60, df = 2 (P = 0.45); I<sup>2</sup> = 0%). When we restricted the analysis to: </p> <p> <ul id="CD001884-list-0049"> <li> <p>trials at low risk of bias, the effect estimate was similar (pOR 1.14, 95% CI 0.51 to 2.58; I<sup>2</sup> = 0%; 9 trials, 497 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>); </p> </li> <li> <p>trials published before 2010 plus those registered prospectively and published after 2010, the effect estimate was not altered (pOR 1.36, 95% CI 0.85 to 2.16; I<sup>2</sup> = 0%; 26 trials, 1528 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. ">Flordal 1991</a>; <a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. ">Flordal 1992</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0038" title="LethagenS , RugarnP , BergqvistD . Blood loss and safety with desmopressin or placebo during aorto‐iliac graft surgery. European Journal of Vascular Surgery1991;5(2):173‐8. ">Lethagen 1991</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0052" title="SalmenperaM , KuitunenA , HynynenM , HeinonenJ . Hemodynamic responses to desmopressin acetate after CABG: a double‐blind trial. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):146‐9. ">Salmenpera 1991</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>; <a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. ">Sheridan 1994</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>). </p> </li> </ul> </p> <section id="CD001884-sec-0152"> <p><b>Cardiac surgery</b></p> <p>We found no evidence of a difference in thrombotic events for cardiac surgery between participants treated with DDAVP versus placebo (pOR 1.46, 95% CI 0.88 to 2.42; I<sup>2</sup> = 0%; 19 trials, 1311 participants; <a href="./references#CD001884-fig-0018" title="">Analysis 1.13</a>). When we restricted the analysis to: </p> <p> <ul id="CD001884-list-0050"> <li> <p>trials at low risk of bias, the effect estimate was similar (pOR 1.58, 95% CI 0.52 to 4.77; I<sup>2</sup> = 0%; 5 trials, 407 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>); </p> </li> <li> <p>trials published before 2010 plus those registered prospectively and published after 2010, the effect estimate was not altered (pOR 1.46, 95% CI 0.88 to 2.42; I<sup>2</sup> = 0%; 18 trials, 1209 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0052" title="SalmenperaM , KuitunenA , HynynenM , HeinonenJ . Hemodynamic responses to desmopressin acetate after CABG: a double‐blind trial. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):146‐9. ">Salmenpera 1991</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. ">Sheridan 1994</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>). </p> </li> </ul> </p> </section> <section id="CD001884-sec-0153"> <p><b>Orthopaedic surgery</b></p> <p>Six trials in the orthopaedic surgery subgroup reported thrombotic events as an outcome, however, these trials reported only a single thrombotic event between them (<a href="./references#CD001884-fig-0018" title="">Analysis 1.13</a>). </p> </section> <section id="CD001884-sec-0154"> <p><b>Vascular surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in thrombotic events for vascular surgery between participants treated with DDAVP versus placebo (pOR 0.77, 95% CI 0.23 to 2.60; 2 trials, 141 participants; <a href="./references#CD001884-fig-0018" title="">Analysis 1.13</a>) (<a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0038" title="LethagenS , RugarnP , BergqvistD . Blood loss and safety with desmopressin or placebo during aorto‐iliac graft surgery. European Journal of Vascular Surgery1991;5(2):173‐8. ">Lethagen 1991</a>). </p> </section> <section id="CD001884-sec-0155"> <p><b>Sinus surgery</b></p> <p>One trial in this subgroup reported thrombotic events as an outcome, however, neither arm of this trial reported any thrombotic events (<a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>). </p> </section> <section id="CD001884-sec-0156"> <p><b>Renal biopsy</b></p> <p>One trial in this subgroup reported thrombotic events as an outcome, however, neither arm of this trial reported any thrombotic events (<a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>). </p> </section> </section> <section id="CD001884-sec-0157"> <h6 class="title">Myocardial infarction</h6> <p>Twenty‐six trials (1704 participants) reported myocardial infarction, and all 26 contributed data towards the final pooled estimate (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. ">Flordal 1991</a>; <a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. ">Flordal 1992</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0030" title="JiH , JinL . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Cardiology. 2013; Vol. 126:Abstract. JinL , JiHW . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Chinese Medical Journal2015;128(5):644‐7. ">Jin 2015</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0038" title="LethagenS , RugarnP , BergqvistD . Blood loss and safety with desmopressin or placebo during aorto‐iliac graft surgery. European Journal of Vascular Surgery1991;5(2):173‐8. ">Lethagen 1991</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0052" title="SalmenperaM , KuitunenA , HynynenM , HeinonenJ . Hemodynamic responses to desmopressin acetate after CABG: a double‐blind trial. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):146‐9. ">Salmenpera 1991</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>; <a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>). We found no evidence of a difference in myocardial infarction between participants treated with DDAVP versus placebo (pOR 1.32, 95% CI 0.70 to 2.46; I<sup>2</sup> = 0%; 26 trials, 1704 participants; <a href="./references#CD001884-fig-0019" title="">Analysis 1.14</a>). We found no evidence of a difference between subgroups (Chi<sup>2</sup> = 1.24, df = 1 (P = 0.27); I<sup>2</sup> = 19.3%). When we restricted the analysis to: </p> <p> <ul id="CD001884-list-0051"> <li> <p>trials at low risk of bias, the effect estimate was similar (pOR 0.65, 95% CI 0.16 to 2.67; I<sup>2</sup> = 0%; 8 trials, 662 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>); </p> </li> <li> <p>trials published before 2010 plus those registered prospectively and published after 2010, the effect estimate was not altered (pOR 1.32, 95% CI 0.70 to 2.46; I<sup>2</sup> = 0%; 24 trials, 1512 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. ">Flordal 1991</a>; <a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. ">Flordal 1992</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0038" title="LethagenS , RugarnP , BergqvistD . Blood loss and safety with desmopressin or placebo during aorto‐iliac graft surgery. European Journal of Vascular Surgery1991;5(2):173‐8. ">Lethagen 1991</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0052" title="SalmenperaM , KuitunenA , HynynenM , HeinonenJ . Hemodynamic responses to desmopressin acetate after CABG: a double‐blind trial. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):146‐9. ">Salmenpera 1991</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>; <a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>). </p> </li> </ul> </p> <section id="CD001884-sec-0158"> <p><b>Cardiac surgery</b></p> <p>We found no evidence of a difference in myocardial infarction between participants treated with DDAVP versus placebo (pOR 1.52, 95% CI 0.77 to 3.00; I<sup>2</sup> = 0%; 16 trials, 1031 participants; <a href="./references#CD001884-fig-0019" title="">Analysis 1.14</a>). When we restricted the analysis to: </p> <p> <ul id="CD001884-list-0052"> <li> <p>trials at low risk of bias, the effect estimate was similar (pOR 1.00, 95% CI 0.06 to 16.32; I<sup>2</sup> = 0%; 4 trials, 272 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>); </p> </li> <li> <p>trials published before 2010 plus those registered prospectively and published after 2010, the effect estimate was not altered (pOR 1.52, 95% CI 0.77 to 3.00; I<sup>2</sup> = 0%; 15 trials, 929 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. ">Hedderich 1990</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0052" title="SalmenperaM , KuitunenA , HynynenM , HeinonenJ . Hemodynamic responses to desmopressin acetate after CABG: a double‐blind trial. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):146‐9. ">Salmenpera 1991</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>). </p> </li> </ul> </p> </section> <section id="CD001884-sec-0159"> <p><b>Orthopaedic surgery</b></p> <p>Six trials in this subgroup reported myocardial infarction as an outcome, however, no myocardial infarctions occurred during these trials (<a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. ">Flordal 1991</a>; <a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. ">Flordal 1992</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>). </p> </section> <section id="CD001884-sec-0160"> <p><b>Vascular surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in myocardial infarction between participants treated with DDAVP versus placebo (pOR 0.55, 95% CI 0.11 to 2.88; 2 trials, 141 participants; <a href="./references#CD001884-fig-0019" title="">Analysis 1.14</a>). </p> </section> <section id="CD001884-sec-0161"> <p><b>Sinus surgery</b></p> <p>One trial in this subgroup reported myocardial infarction as an outcome, however, no myocardial infarctions occurred in either arm of this trial (<a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>). </p> </section> <section id="CD001884-sec-0162"> <p><b>Renal biopsy</b></p> <p>One trial in this subgroup reported myocardial infarction as an outcome, however, no myocardial infarctions occurred in either arm of this trial (<a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>). </p> </section> </section> <section id="CD001884-sec-0163"> <h6 class="title">Stroke</h6> <p>Nineteen trials (1277 participants) reported stroke, and all 19 contributed data towards the final pooled estimate (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. ">Flordal 1991</a>; <a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. ">Flordal 1992</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0030" title="JiH , JinL . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Cardiology. 2013; Vol. 126:Abstract. JinL , JiHW . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Chinese Medical Journal2015;128(5):644‐7. ">Jin 2015</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>; <a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. ">Sheridan 1994</a>). We found no evidence of a difference in stroke for participants treated with DDAVP versus placebo (pOR 2.95, 95% CI 0.94 to 9.24; I<sup>2</sup> = 0%; 19 trials, 1277 participants; <a href="./references#CD001884-fig-0020" title="">Analysis 1.15</a>). When we restricted the analysis to: </p> <p> <ul id="CD001884-list-0053"> <li> <p>trials at low risk of bias, the effect estimate was similar (pOR 4.09, 95% CI 0.81 to 20.59; I<sup>2</sup> = 0%; 7 trials, 619 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>); </p> </li> <li> <p>trials published before 2010 plus those registered prospectively and published after 2010, the effect estimate was not altered (RR 2.07, 95% CI 0.69 to 6.25; I<sup>2</sup> = 0%; 16 trials, 923 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. ">Flordal 1991</a>; <a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. ">Flordal 1992</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. ">Sheridan 1994</a>). </p> </li> </ul> </p> <section id="CD001884-sec-0164"> <p><b>Cardiac surgery</b></p> <p>We found no evidence of a difference in stroke between participants treated with DDAVP versus placebo (pOR 2.95, 95% CI 0.94 to 9.24; I<sup>2</sup> = 0%; 11 trials, 733 participants; <a href="./references#CD001884-fig-0020" title="">Analysis 1.15</a>). When we restricted the analysis to: </p> <p> <ul id="CD001884-list-0054"> <li> <p>trials at low risk of bias, the effect estimate was similar (pOR 4.09, 95% CI 0.81 to 20.59; I<sup>2</sup> = 0%; 3 trials, 229 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>); </p> </li> <li> <p>trials published before 2010 plus those registered prospectively and published after 2010, the effect estimate was not altered (pOR 2.95, 95% CI 0.94 to 9.24; I<sup>2</sup> = 0%; 10 trials, 631 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. ">Sheridan 1994</a>). </p> </li> </ul> </p> </section> <section id="CD001884-sec-0165"> <p><b>Orthopaedic surgery</b></p> <p>Five trials in this subgroup reported stroke as an outcome, however, no strokes occurred during these trials (<a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. ">Flordal 1991</a>; <a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. ">Flordal 1992</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>). </p> </section> <section id="CD001884-sec-0166"> <p><b>Vascular surgery</b></p> <p>One trial in this subgroup reported stroke as an outcome, however, no strokes occurred in either arm of this trial (<a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>). </p> </section> <section id="CD001884-sec-0167"> <p><b>Sinus surgery</b></p> <p>One trial in this subgroup reported stroke as an outcome, however, no strokes occurred in either arm of this trial (<a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>). </p> </section> <section id="CD001884-sec-0168"> <p><b>Renal biopsy</b></p> <p>One trial in this subgroup reported stroke as an outcome, however, no strokes occurred in either arm of this trial (<a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>). </p> </section> </section> <section id="CD001884-sec-0169"> <h6 class="title">Venous thromboembolism</h6> <p>Twenty trials (1377 participants) reported venous thromboembolism, and all 20 contributed data towards the final pooled estimate (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. ">Flordal 1991</a>; <a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. ">Flordal 1992</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0030" title="JiH , JinL . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Cardiology. 2013; Vol. 126:Abstract. JinL , JiHW . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Chinese Medical Journal2015;128(5):644‐7. ">Jin 2015</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>; <a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>). We found no evidence of a difference in venous thromboembolism between participants treated with DDAVP versus placebo (pOR 0.77, 95% CI 0.17 to 3.38; I<sup>2</sup> = 0%; 20 trials, 1377 participants; <a href="./references#CD001884-fig-0021" title="">Analysis 1.16</a>). We found no evidence of a difference between subgroups (Chi<sup>2</sup> = 1.47, df = 1 (P = 0.23); I<sup>2</sup> = 31.8%). When we restricted the analysis to: </p> <p> <ul id="CD001884-list-0055"> <li> <p>trials at low risk of bias, the effect estimate was similar (pOR 0.14, 95% CI 0.01 to 2.23: I<sup>2</sup> = 0%; 7 trials, 592 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>); </p> </li> <li> <p>trials published before 2010 plus those registered prospectively and published after 2010, the effect estimate was not altered (pOR 0.77, 95% CI 0.17 to 3.38; I<sup>2</sup> = 0%; 17 trials, 1023 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>; <a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. ">Flordal 1991</a>; <a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. ">Flordal 1992</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>). </p> </li> </ul> </p> <section id="CD001884-sec-0170"> <p><b>Cardiac surgery</b></p> <p>We found no evidence of a difference in venous thromboembolism for participants treated with DDAVP versus placebo (pOR 0.53, 95% CI 0.11 to 2.62; I<sup>2</sup> = 0%; 11 trials, 754 participants; <a href="./references#CD001884-fig-0021" title="">Analysis 1.16</a>). When we restricted the analysis to: </p> <p> <ul id="CD001884-list-0056"> <li> <p>trials at low risk of bias, the effect estimate was similar (pOR 0.14, 95% CI 0.01 to 2.23; I<sup>2</sup> = 0%; 3 trials, 202 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>); </p> </li> <li> <p>trials published before 2010 plus those registered prospectively and published after 2010, the effect estimate was not altered (pOR 0.53, 95% CI 0.11 to 2.62; I<sup>2</sup> = 0%; 10 trials, 652 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. ">Ansell 1992</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. ">Gratz 1992</a>; <a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991a</a>; <a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991b</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. ">Steinlechner 2011</a>). </p> </li> </ul> </p> </section> <section id="CD001884-sec-0171"> <p><b>Orthopaedic surgery</b></p> <p>Six trials in this subgroup reported venous thromboembolism as an outcome, however, no venous thromboembolic events occurred during these trials (<a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. ">Flordal 1991</a>; <a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. ">Flordal 1992</a>; <a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994a</a>; <a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. ">Karnezis 1994b</a>; <a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. ">Leino 2010</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>). </p> </section> <section id="CD001884-sec-0172"> <p><b>Vascular surgery</b></p> <p>One trial in this subgroup reported venous thromboembolism as an outcome, however, no venous thromboembolic events occurred in either arm of this trial (<a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. ">Clagett 1995</a>). </p> </section> <section id="CD001884-sec-0173"> <p><b>Sinus surgery</b></p> <p>One trial in this subgroup reported venous thromboembolism as an outcome, however, no venous thromboembolic events occurred in either arm of this trial (<a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>). </p> </section> <section id="CD001884-sec-0174"> <p><b>Renal biopsy</b></p> <p>One trial in this subgroup reported venous thromboembolism as an outcome, however, no venous thromboembolic events occurred in either arm of this trial (<a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>). </p> </section> </section> <section id="CD001884-sec-0175"> <h6 class="title">Clinically important hypotension</h6> <p>Eighteen trials (1183 participants) reported clinically important hypotension, and all 18 contributed data towards the final pooled estimate (<a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. ">Dilthey 1993</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0039" title="LettsM , PangE , D'AstousJ , JarvisJ , LawtonL , LukeB , et al. The influence of desmopressin on blood loss during spinal fusion surgery in neuromuscular patients. Spine1998;23(4):475‐8. ">Letts 1998</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0048" title="ReichDL , HammerschlagBC , RandJH , Weiss‐BloomL , PeruchoH , GallaJ , et al. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):142‐5. ">Reich 1991</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0052" title="SalmenperaM , KuitunenA , HynynenM , HeinonenJ . Hemodynamic responses to desmopressin acetate after CABG: a double‐blind trial. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):146‐9. ">Salmenpera 1991</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>; <a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>). Clinically important hypotension was more frequent for participants treated with DDAVP than for those given placebo (RR 2.32, 95% CI 1.37 to 3.91; I<sup>2</sup> = 0%; 18 trials, 1183 participants; <a href="./references#CD001884-fig-0022" title="">Analysis 1.17</a>). We found no evidence of a difference between subgroups (Chi<sup>2</sup> = 0.83, df = 2 (P = 0.66); I<sup>2</sup> = 0%). When we restricted the analysis to: </p> <p> <ul id="CD001884-list-0057"> <li> <p>trials at low risk of bias, the effect estimate was similar (RR 2.34, 95% CI 0.71 to 7.69; I<sup>2</sup> = 0%; 7 trials, 587 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>); </p> </li> <li> <p>trials published before 2010 plus those registered prospectively and published after 2010, the effect estimate was altered (RR 2.32, 95% CI 1.37 to 3.91; I<sup>2</sup> = 0%; 16 trials, 931 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. ">Brown 1989</a>; <a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. ">Despotis 1999</a>; <a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. ">Dilthey 1993</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0039" title="LettsM , PangE , D'AstousJ , JarvisJ , LawtonL , LukeB , et al. The influence of desmopressin on blood loss during spinal fusion surgery in neuromuscular patients. Spine1998;23(4):475‐8. ">Letts 1998</a>; <a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>; <a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. ">Marquez 1992</a>; <a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. ">Mongan 1992a</a>; <a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. ">Mongan 1992b</a>; <a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. ">Oliver 2000</a>; <a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. ">Pleym 2004</a>; <a href="./references#CD001884-bbs2-0048" title="ReichDL , HammerschlagBC , RandJH , Weiss‐BloomL , PeruchoH , GallaJ , et al. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):142‐5. ">Reich 1991</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-bbs2-0052" title="SalmenperaM , KuitunenA , HynynenM , HeinonenJ . Hemodynamic responses to desmopressin acetate after CABG: a double‐blind trial. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):146‐9. ">Salmenpera 1991</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>; <a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. ">Schott 1995</a>). </p> </li> </ul> </p> <section id="CD001884-sec-0176"> <p><b>Cardiac surgery</b></p> <p>Clinically important hypotension was more frequent for participants treated with DDAVP than for those given placebo (RR 2.88, 95% CI 1.32 to 6.30; I<sup>2</sup> = 0%; 13 trials, 762 participants; <a href="./references#CD001884-fig-0022" title="">Analysis 1.17</a>). </p> <p>When we restricted the analysis to trials at low risk of bias, the effect estimate was similar (RR 2.98, 95% CI 0.64 to 13.90; I<sup>2</sup> = 0%; 3 trials, 245 participants; analysis not shown) (<a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. ">Bignami 2016</a>; <a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. ">Frankville 1991</a>; <a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. ">Salzman 1986</a>). </p> </section> <section id="CD001884-sec-0177"> <p><b>Orthopaedic surgery</b></p> <p>Clinically important hypotension was more frequent for participants treated with DDAVP than for those given placebo (RR 2.05, 95% CI 0.99 to 4.24; I<sup>2</sup> = 0%; 2 trials, 109 participants; <a href="./references#CD001884-fig-0022" title="">Analysis 1.17</a>). </p> </section> <section id="CD001884-sec-0178"> <p><b>Paediatric cardiac surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference between participants treated with DDAVP versus placebo (RR 0.94, 95% CI 0.06 to 14.27; 1 trial, 60 participants; <a href="./references#CD001884-fig-0022" title="">Analysis 1.17</a>). </p> </section> <section id="CD001884-sec-0179"> <p><b>Sinus surgery</b></p> <p>One trial in this subgroup reported clinically important hypotension as an outcome (<a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. ">Shao 2015</a>), however, no clinically important episodes of hypotension occurred in either arm of this trial. </p> </section> <section id="CD001884-sec-0180"> <p><b>Kidney biopsy</b></p> <p>One trial in this subgroup reported clinically important hypotension as an outcome (<a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. ">Manno 2011</a>), however, no clinically important episodes of hypotension occurred in either arm of this trial. </p> </section> </section> <section id="CD001884-sec-0181"> <h6 class="title">Quality of life</h6> <p>No trials reported quality of life as an outcome.</p> </section> </section> </section> <section id="CD001884-sec-0182"> <h4 class="title">DDAVP versus placebo: platelet dysfunction subgroup</h4> <p>In 11 of the trials (606 participants) that compared DDAVP versus placebo, at least 75% of participants had platelet dysfunction. </p> <section id="CD001884-sec-0183"> <h5 class="title">Primary outcomes</h5> <section id="CD001884-sec-0184"> <h6 class="title">Volume of blood transfused intraoperatively</h6> <p>None of the trials that reported this outcome included participants with platelet dysfunction. </p> </section> <section id="CD001884-sec-0185"> <h6 class="title">Total volume of blood transfused</h6> <p>The total volume of red cells transfused was less for those treated with DDAVP than for controls (MD ‐0.65 units, 95% CI ‐1.16 to ‐0.13 units; I<sup>2</sup> = 36%; 6 trials, 388 participants; <a href="./references#CD001884-fig-0023" title="">Analysis 2.1</a>). </p> </section> <section id="CD001884-sec-0186"> <h6 class="title">Number of participants transfused with blood intraoperatively</h6> <p>Owing to the small number of participants, we are uncertain whether results showed a difference in the number of participants transfused with blood intraoperatively between participants treated with DDAVP and those given placebo (RR 0.55, 95% CI 0.22 to 1.38 units; 1 trial, 29 participants; <a href="./references#CD001884-fig-0024" title="">Analysis 2.2</a>). </p> </section> <section id="CD001884-sec-0187"> <h6 class="title">Total number of participants transfused with blood</h6> <p>We found no difference in the number of participants transfused with blood when treated with DDAVP versus placebo (RR 0.83, 95% CI 0.66 to 1.04; I<sup>2</sup> = 14%; 5 trials, 258 participants; <a href="./references#CD001884-fig-0025" title="">Analysis 2.3</a>). </p> </section> <section id="CD001884-sec-0188"> <h6 class="title">Intraoperative blood loss</h6> <p>No trials reported intraoperative blood loss for this subgroup.</p> </section> <section id="CD001884-sec-0189"> <h6 class="title">Total blood loss</h6> <p>Ten trials (547 participants) in the platelet dysfunction subgroup reported total blood loss. Four trials reported this outcome in a way that did not allow inclusion in meta‐analysis, and so we reported this information narratively in <a href="#CD001884-tbl-0010">Table 6</a> (<a href="./references#CD001884-bbs2-0011" title="ProstD , Barbier‐BoehmG , HazebroucqJ , BielskyMC , HvassU . Effect of desmopressin on excessive postoperative bleeding and blood product requirements associated with cardiopulmonary bypass. Thrombosis Research. 1992; Vol. 65:Abstract C132. deProstD , Barbier‐BoehmG , HazebroucqJ , IbrahimH , BielskyMC , HvassU , et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thrombosis and Haemostasis1992;68(2):106‐10. ">de Prost 1992</a>; <a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. ">Dilthey 1993</a>; <a href="./references#CD001884-bbs2-0024" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012a</a>; <a href="./references#CD001884-bbs2-0025" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012b</a>). We are very uncertain whether total blood loss is less for participants treated with DDAVP versus placebo owing to high levels of heterogeneity (MD ‐253.93 mL, 95% CI ‐408.01 to ‐99.85 mL; I<sup>2</sup> = 75%; 6 trials, 422 participants; <a href="./references#CD001884-fig-0026" title="">Analysis 2.4</a>). </p> </section> </section> <section id="CD001884-sec-0190"> <h5 class="title">Secondary outcomes</h5> <section id="CD001884-sec-0191"> <h6 class="title">Reoperation due to bleeding</h6> <p>The number of participants returning to theatre with bleeding was lower for participants treated with DDAVP than for those given placebo (pOR 0.39, 95% CI 0.18 to 0.84; I<sup>2</sup> = 0%; 6 trials, 413 participants; <a href="./references#CD001884-fig-0027" title="">Analysis 2.5</a>). </p> </section> <section id="CD001884-sec-0192"> <h6 class="title">All‐cause mortality</h6> <p>Owing to the small number of events, we are uncertain whether results showed a difference in all‐cause mortality between participants treated with DDAVP versus placebo (pOR 0.72, 95% CI 0.12 to 4.22; I<sup>2</sup> = 24%; 6 trials, 422 participants; <a href="./references#CD001884-fig-0028" title="">Analysis 2.6</a>). </p> </section> <section id="CD001884-sec-0193"> <h6 class="title">All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism) </h6> <p>Owing to the small number of events, we are uncertain whether results showed a difference in thrombotic events between participants treated with DDAVP versus placebo (pOR 1.58, 95% CI 0.60 to 4.17; I<sup>2</sup> = 0%; 7 trials, 422 participants; <a href="./references#CD001884-fig-0029" title="">Analysis 2.7</a>). </p> </section> <section id="CD001884-sec-0194"> <h6 class="title">Myocardial infarction</h6> <p>Owing to the small number of events, we are uncertain whether results showed a difference in myocardial infarction between participants treated with DDAVP versus placebo (pOR 2.72, 95% CI 0.60 to 12.37; I<sup>2</sup> = 0%; 4 trials, 277 participants; <a href="./references#CD001884-fig-0030" title="">Analysis 2.8</a>). </p> </section> <section id="CD001884-sec-0195"> <h6 class="title">Stroke</h6> <p>Owing to the small number of events, we are uncertain whether results showed a difference in stroke between participants treated with DDAVP versus placebo (pOR 1.21, 95% CI 0.07 to 20.17; I<sup>2</sup> = 0%; 3 trials, 157 participants; <a href="./references#CD001884-fig-0031" title="">Analysis 2.9</a>). </p> </section> <section id="CD001884-sec-0196"> <h6 class="title">Venous thromboembolism</h6> <p>Owing to the small number of events, we are uncertain whether results showed a difference in venous thromboembolism between participants treated with DDAVP versus placebo (pOR 0.56, 95% CI 0.06 to 5.50; I<sup>2</sup> = 60%; 3 trials, 157 participants; <a href="./references#CD001884-fig-0032" title="">Analysis 2.10</a>). </p> </section> <section id="CD001884-sec-0197"> <h6 class="title">Clinically important hypotension</h6> <p>Clinically important hypotension was more frequent among participants treated with DDAVP than in those given placebo (RR 6.58, 95% CI 1.18 to 36.76; I<sup>2</sup> = 0%; 5 trials, 315 participants; <a href="./references#CD001884-fig-0033" title="">Analysis 2.11</a>). </p> </section> </section> </section> <section id="CD001884-sec-0198"> <h4 class="title">DDAVP versus tranexamic acid</h4> <p>Three trials compared DDAVP versus tranexamic acid (<a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. ">Ellis 2001</a>; <a href="./references#CD001884-bbs2-0029" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991c</a>; <a href="./references#CD001884-bbs2-0065" title="ZoharE , FredmanB , EllisMH , IfrachN , SternA , JedeikinR . A comparative study of the postoperative allogeneic blood‐sparing effects of tranexamic acid and of desmopressin after total knee replacement. Transfusion2001;41(10):1285‐9. ">Zohar 2001</a>). </p> <section id="CD001884-sec-0199"> <h5 class="title">Primary outcomes</h5> <section id="CD001884-sec-0200"> <h6 class="title">Volume of blood transfused intraoperatively</h6> <p>No trial reported volume of blood transfused intraoperatively as an outcome.</p> </section> <section id="CD001884-sec-0201"> <h6 class="title">Total volume of blood transfused</h6> <p>Two orthopaedic surgery trials (60 participants) reported total volume of blood transfused (<a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. ">Ellis 2001</a>; <a href="./references#CD001884-bbs2-0065" title="ZoharE , FredmanB , EllisMH , IfrachN , SternA , JedeikinR . A comparative study of the postoperative allogeneic blood‐sparing effects of tranexamic acid and of desmopressin after total knee replacement. Transfusion2001;41(10):1285‐9. ">Zohar 2001</a>). One trial (20 participants) reported this outcome in a way that did not allow inclusion in meta‐analysis; we reported this information in <a href="#CD001884-tbl-0011">Table 7</a>. Investigators transfused more red cells for participants treated with DDAVP than for those given tranexamic acid (MD 0.60 units, 95% CI 0.09 to 1.11 units; 1 trial, 40 participants; <a href="./references#CD001884-fig-0034" title="">Analysis 3.1</a>). </p> <div class="table" id="CD001884-tbl-0011"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">DDAVP vs tranexamic acid: total volume of red cells transfused</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reason not included in meta‐analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DDAVP arm</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Tranexamic acid arm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Orthopaedic surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. "><b>Ellis 2001</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7 units</p> <p>(n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.1 units</p> <p>(n = 10)</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD001884-sec-0202"> <h6 class="title">Number of participants transfused with blood intraoperatively</h6> <p>No trial reported the number of participants transfused with blood intraoperatively.</p> </section> <section id="CD001884-sec-0203"> <h6 class="title">Total number of participants transfused with blood</h6> <p>Three trials (135 participants) reported the total number of participants transfused with blood (<a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. ">Ellis 2001</a>; <a href="./references#CD001884-bbs2-0029" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991c</a>; <a href="./references#CD001884-bbs2-0065" title="ZoharE , FredmanB , EllisMH , IfrachN , SternA , JedeikinR . A comparative study of the postoperative allogeneic blood‐sparing effects of tranexamic acid and of desmopressin after total knee replacement. Transfusion2001;41(10):1285‐9. ">Zohar 2001</a>). More participants were transfused with blood when given DDAVP than tranexamic acid (RR 2.42, 95% CI 1.04 to 5.64; I<sup>2</sup> = 0%; 3 trials, 135 participants; <a href="./references#CD001884-fig-0035" title="">Analysis 3.2</a>). </p> <section id="CD001884-sec-0204"> <p><b>Cardiac surgery</b></p> <p>One trial (75 participants) reported the total number of participants transfused with blood (<a href="./references#CD001884-bbs2-0029" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991c</a>). Owing to the small number of participants, we are uncertain whether results showed a difference in the number transfused with blood when treated with DDAVP versus tranexamic acid (RR 1.46, 95% CI 0.82 to 2.59; 1 trial, 75 participants). </p> </section> <section id="CD001884-sec-0205"> <p><b>Orthopaedic surgery</b></p> <p>Two trials (105 participants) reported the total number of participants transfused with blood (<a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. ">Ellis 2001</a>; <a href="./references#CD001884-bbs2-0065" title="ZoharE , FredmanB , EllisMH , IfrachN , SternA , JedeikinR . A comparative study of the postoperative allogeneic blood‐sparing effects of tranexamic acid and of desmopressin after total knee replacement. Transfusion2001;41(10):1285‐9. ">Zohar 2001</a>). More participants were transfused with blood when given DDAVP than tranexamic acid (RR 4.15, 95% CI 1.58 to 10.90; I<sup>2</sup> = 0%; 2 trials, 60 participants). </p> </section> </section> <section id="CD001884-sec-0206"> <h6 class="title">Intraoperative blood loss</h6> <p>No trial reported intraoperative blood loss.</p> </section> <section id="CD001884-sec-0207"> <h6 class="title">Total blood loss</h6> <p>Three trials (133 participants) reported total blood loss (<a href="./references#CD001884-bbs2-0026" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. ">Hemșinli 2012c</a>; <a href="./references#CD001884-bbs2-0029" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991c</a>; <a href="./references#CD001884-bbs2-0065" title="ZoharE , FredmanB , EllisMH , IfrachN , SternA , JedeikinR . A comparative study of the postoperative allogeneic blood‐sparing effects of tranexamic acid and of desmopressin after total knee replacement. Transfusion2001;41(10):1285‐9. ">Zohar 2001</a>). One trial (28 participants) reported this outcome in a way that did not allow inclusion in meta‐analysis, and so we reported this information in <a href="#CD001884-tbl-0012">Table 8</a>. We pooled the results of the remaining trials for meta‐analysis because baseline blood loss was similar between trials. Results showed a greater volume of blood loss among participants treated with DDAVP than tranexamic acid (MD 142.81 mL, 95% CI 79.78 to 205.84 mL; I<sup>2</sup> = 0%; 2 trials, 115 participants; <a href="./references#CD001884-fig-0036" title="">Analysis 3.3</a>). </p> <div class="table" id="CD001884-tbl-0012"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">DDAVP vs tranexamic acid: total blood loss</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reason not included in meta‐analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DDAVP arm</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Tranexamic acid arm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Adult cardiac surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0026" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. "><b>Hemșinli 2012c</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (no standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1430 mL</p> <p>(n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>535 mL</p> <p>(n = 18)</p> </td> </tr> </tbody> </table> </div> <section id="CD001884-sec-0208"> <p><b>Cardiac surgery</b></p> <p>One trial (75 participants) reported total blood loss (<a href="./references#CD001884-bbs2-0029" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991c</a>). Results showed a greater volume of blood loss among participants treated with DDAVP than tranexamic acid (MD 115.00 mL, 95% CI 35.38 to 194.62 mL; 1 trial, 75 participants). </p> </section> <section id="CD001884-sec-0209"> <p><b>Orthopaedic surgery</b></p> <p>One trial (75 participants) reported total blood loss (<a href="./references#CD001884-bbs2-0065" title="ZoharE , FredmanB , EllisMH , IfrachN , SternA , JedeikinR . A comparative study of the postoperative allogeneic blood‐sparing effects of tranexamic acid and of desmopressin after total knee replacement. Transfusion2001;41(10):1285‐9. ">Zohar 2001</a>). Results showed a greater volume of blood loss among participants treated with DDAVP than tranexamic acid (MD 180.00 mL, 95% CI 86.82 to 273.18 mL; 1 trial, 40 participants). </p> </section> </section> </section> <section id="CD001884-sec-0210"> <h5 class="title">Secondary outcomes</h5> <section id="CD001884-sec-0211"> <h6 class="title">Reoperation due to bleeding</h6> <p>One cardiac surgery trial reported reoperation due to bleeding, but only a single event occurred (<a href="./references#CD001884-fig-0037" title="">Analysis 3.4</a>). </p> </section> <section id="CD001884-sec-0212"> <h6 class="title">Number of participants with any bleeding (interventional procedures only, e.g. kidney biopsy) </h6> <p>No trial reported the number of participants with any bleeding.</p> </section> <section id="CD001884-sec-0213"> <h6 class="title">All‐cause mortality</h6> <p>No trial reported all‐cause mortality.</p> </section> <section id="CD001884-sec-0214"> <h6 class="title">All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism) </h6> <p>Two trials (115 participants) reported thrombotic events, and both contributed to the final pooled estimate (<a href="./references#CD001884-bbs2-0029" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991c</a>; <a href="./references#CD001884-bbs2-0065" title="ZoharE , FredmanB , EllisMH , IfrachN , SternA , JedeikinR . A comparative study of the postoperative allogeneic blood‐sparing effects of tranexamic acid and of desmopressin after total knee replacement. Transfusion2001;41(10):1285‐9. ">Zohar 2001</a>). Owing to the small number of events, we are uncertain whether results showed a difference in the number of participants treated with DDAVP with thrombotic events versus those treated with tranexamic acid (RR 2.92, 95% CI 0.32 to 26.83; I<sup>2</sup> = 0%; 2 trials, 115 participants; <a href="./references#CD001884-fig-0038" title="">Analysis 3.5</a>). </p> <section id="CD001884-sec-0215"> <p><b>Cardiac surgery</b></p> <p>Owing to the small number of participants, we are uncertain whether results showed a difference between the number of participants who had thrombotic events treated with DDAVP versus tranexamic acid (RR 2.92, 95% CI 0.32 to 26.83; 1 trial, 75 participants) (<a href="./references#CD001884-bbs2-0029" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991c</a>). </p> </section> <section id="CD001884-sec-0216"> <p><b>Orthopaedic surgery</b></p> <p>One trial reported thrombotic events, but no events occurred in either arm of the trial (<a href="./references#CD001884-bbs2-0065" title="ZoharE , FredmanB , EllisMH , IfrachN , SternA , JedeikinR . A comparative study of the postoperative allogeneic blood‐sparing effects of tranexamic acid and of desmopressin after total knee replacement. Transfusion2001;41(10):1285‐9. ">Zohar 2001</a>). </p> </section> </section> <section id="CD001884-sec-0217"> <h6 class="title">Myocardial infarction</h6> <p>Two trials (115 participants) reported myocardial infarction, but no events occurred in either trial (<a href="./references#CD001884-fig-0039" title="">Analysis 3.6</a>). </p> </section> <section id="CD001884-sec-0218"> <h6 class="title">Stroke</h6> <p>Two trials (115 participants) reported stroke, and both contributed to the final pooled estimate (<a href="./references#CD001884-bbs2-0029" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. ">Horrow 1991c</a>; <a href="./references#CD001884-bbs2-0065" title="ZoharE , FredmanB , EllisMH , IfrachN , SternA , JedeikinR . A comparative study of the postoperative allogeneic blood‐sparing effects of tranexamic acid and of desmopressin after total knee replacement. Transfusion2001;41(10):1285‐9. ">Zohar 2001</a>). Owing to the small number of events, we are uncertain whether results showed a difference between the number of participants who had a stroke treated with DDAVP versus tranexamic acid (RR 2.92, 95% CI 0.32 to 26.83; I<sup>2</sup> = 0%; 2 trials, 115 participants; <a href="./references#CD001884-fig-0040" title="">Analysis 3.7</a>). </p> <section id="CD001884-sec-0219"> <p><b>Cardiac surgery</b></p> <p>Owing to the small number of events, we are uncertain whether results showed a difference in the number of participants who had a stroke treated with DDAVP versus tranexamic acid (RR 2.92, 95% CI 0.32 to 26.83; 1 trial, 75 participants; <a href="./references#CD001884-fig-0040" title="">Analysis 3.7</a>). </p> </section> <section id="CD001884-sec-0220"> <p><b>Orthopaedic surgery</b></p> <p>One trial reported stroke, but no events occurred in either arm of the trial (<a href="./references#CD001884-fig-0040" title="">Analysis 3.7</a>). </p> </section> </section> <section id="CD001884-sec-0221"> <h6 class="title">Venous thromboembolism</h6> <p>Two trials (115 participants) reported venous thromboembolism, but no events occurred in either trial (<a href="./references#CD001884-fig-0041" title="">Analysis 3.8</a>). </p> </section> <section id="CD001884-sec-0222"> <h6 class="title">Clinically important hypotension</h6> <p>No trial reported clinically important hypotension as an outcome.</p> </section> <section id="CD001884-sec-0223"> <h6 class="title">Quality of life</h6> <p>No trial reported quality of life as an outcome.</p> </section> </section> </section> <section id="CD001884-sec-0224"> <h4 class="title">DDAVP versus aprotinin</h4> <p>Two trials compared DDAVP versus aprotinin (<a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>). </p> <section id="CD001884-sec-0225"> <h5 class="title">Primary outcomes</h5> <section id="CD001884-sec-0226"> <h6 class="title">Volume of blood transfused intraoperatively</h6> <p>No trial reported volume of blood transfused intraoperatively as an outcome.</p> </section> <section id="CD001884-sec-0227"> <h6 class="title">Total volume of blood transfused</h6> <p>One cardiac surgery trial (53 participants) reported total volume of blood transfused. Results of this trial are reported in <a href="#CD001884-tbl-0013">Table 9</a>. </p> <div class="table" id="CD001884-tbl-0013"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">DDAVP vs aprotinin: total volume of red cells transfused</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reason not included in meta‐analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DDAVP arm</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Aprotinin arm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Adult cardiac surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. "><b>Rocha 1994</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> body surface area (mean ± standard deviation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>740.4 ± 416.3 mL/m<sup>2</sup> </p> <p>(n = 25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>366.1 ± 331.9 mL/m<sup>2</sup> </p> <p>(n = 28)</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD001884-sec-0228"> <h6 class="title">Number of participants transfused with blood intraoperatively</h6> <p>No trial reported the number of participants transfused with blood intraoperatively.</p> </section> <section id="CD001884-sec-0229"> <h6 class="title">Total number of participants transfused with blood</h6> <p>One trial (99 participants) reported the total number of participants transfused with blood (<a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>). More participants treated with DDAVP were transfused with blood than those treated with aprotinin (RR 2.41, 95% CI 1.45 to 4.02; 1 trial, 99 participants; <a href="./references#CD001884-fig-0042" title="">Analysis 4.1</a>). </p> </section> <section id="CD001884-sec-0230"> <h6 class="title">Intraoperative blood loss</h6> <p>No trial reported intraoperative blood loss.</p> </section> <section id="CD001884-sec-0231"> <h6 class="title">Total blood loss</h6> <p>Two cardiac surgery trials (152 participants) reported total volume of blood transfused but in a format that was not suitable for meta‐analysis (<a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>). Results of these trials are reported in <a href="#CD001884-tbl-0014">Table 10</a>. </p> <div class="table" id="CD001884-tbl-0014"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">DDAVP vs aprotinin: total blood loss</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reason not included in meta‐analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DDAVP arm</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Aprotinin arm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Adult cardiac surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. "><b>Casas 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> body surface area (mean ± standard deviation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>400 ± 192 mL/m<sup>2</sup> </p> <p>(n = 50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>195 ± 146 mL/m<sup>2</sup> </p> <p>(n = 48)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. "><b>Rocha 1994</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> body surface area (mean ± standard deviation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>551.8 ± 324.1 mL/m<sup>2</sup> </p> <p>(n = 25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>358.5 ± 156.3 mL/m<sup>2</sup> </p> <p>(n = 28)</p> </td> </tr> </tbody> </table> </div> </section> </section> <section id="CD001884-sec-0232"> <h5 class="title">Secondary outcomes</h5> <section id="CD001884-sec-0233"> <h6 class="title">Reoperation due to bleeding</h6> <p>Two cardiac surgery trials reported reoperation due to bleeding (<a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>). Owing to the small number of events, we are uncertain whether results showed a difference in the numbers of participants who required reoperation owing to bleeding (pOR 1.93, 95% CI 0.20 to 19.04; I<sup>2</sup> = 0%; 2 trials, 152 participants; <a href="./references#CD001884-fig-0043" title="">Analysis 4.2</a>). </p> </section> <section id="CD001884-sec-0234"> <h6 class="title">Number of participants with any bleeding (interventional procedures only)</h6> <p>No trial reported the number of participants with any bleeding.</p> </section> <section id="CD001884-sec-0235"> <h6 class="title">All‐cause mortality</h6> <p>One trial reported all‐cause mortality, but no deaths occurred in either arm of the trial (<a href="./references#CD001884-fig-0044" title="">Analysis 4.3</a>). </p> </section> <section id="CD001884-sec-0236"> <h6 class="title">All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism) </h6> <p>Two cardiac surgery trials (152 participants) reported thrombotic events, and both contributed to the final pooled estimate (<a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>). Owing to the small number of events, we are uncertain whether results showed a difference in thrombotic events between those treated with DDAVP and those given aprotinin (pOR 0.98, 95% CI 0.06 to 15.89; I<sup>2</sup> = 0%; 2 trials, 152 participants; <a href="./references#CD001884-fig-0045" title="">Analysis 4.4</a>). </p> </section> <section id="CD001884-sec-0237"> <h6 class="title">Myocardial infarction</h6> <p>Two cardiac surgery trials (152 participants) reported myocardial infarction, but no events occurred in either trial (<a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-fig-0046" title="">Analysis 4.5</a>). </p> </section> <section id="CD001884-sec-0238"> <h6 class="title">Stroke</h6> <p>Two cardiac surgery trials (152 participants) reported stroke, but only a single event occurred (<a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-fig-0047" title="">Analysis 4.6</a>). </p> </section> <section id="CD001884-sec-0239"> <h6 class="title">Venous thromboembolism</h6> <p>Two trials (152 participants) reported venous thromboembolism, but no events occurred in either trial (<a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. ">Casas 1995</a>; <a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-fig-0048" title="">Analysis 4.7</a>). </p> </section> <section id="CD001884-sec-0240"> <h6 class="title">Clinically important hypotension</h6> <p>One trial (53 participants) reported clinically important hypotension, but no events occurred in either arm of the trial (<a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. ">Rocha 1994</a>; <a href="./references#CD001884-fig-0049" title="">Analysis 4.8</a>). </p> </section> <section id="CD001884-sec-0241"> <h6 class="title">Quality of life</h6> <p>No trial reported quality of life as an outcome.</p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD001884-sec-0242" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD001884-sec-0242"></div> <section id="CD001884-sec-0243"> <h3 class="title" id="CD001884-sec-0243">Summary of main results</h3> <section id="CD001884-sec-0244"> <h4 class="title">DDAVP versus placebo or standard care</h4> <p>Sixty‐two trials compared DDAVP (1‐deamino‐8‐D‐arginine‐vasopressin; desmopressin) versus placebo or standard care. Compared with placebo, DDAVP may lead to little or no difference in the total volume of red cells transfused for orthopaedic surgery, vascular surgery, or hepatic surgery (<a href="./references#CD001884-fig-0007" title="">Analysis 1.2</a>). DDAVP may slightly reduce the total volume of red cells transfused in adult cardiac surgery (<a href="./references#CD001884-fig-0007" title="">Analysis 1.2</a>). However, this difference is small and is unlikely to be of clinical benefit. DDAVP probably leads to little or no difference in the total number of people receiving a red cell transfusion (<a href="./references#CD001884-fig-0010" title="">Analysis 1.5</a>). It is uncertain whether DDAVP improves or worsens total blood loss because the quality of evidence is very low (<a href="./references#CD001884-fig-0012" title="">Analysis 1.7</a>). DDAVP may lead to little or no difference in the risk of mortality (<a href="./references#CD001884-fig-0017" title="">Analysis 1.12</a>) or thrombotic events (<a href="./references#CD001884-fig-0018" title="">Analysis 1.13</a>). </p> </section> <section id="CD001884-sec-0245"> <h4 class="title">DDAVP versus placebo or standard care: platelet dysfunction subgroup</h4> <p>Ten trials compared DDAVP versus placebo or standard care in people with platelet dysfunction. Compared with placebo, DDAVP may lead to a reduction in the total volume of red cells transfused (<a href="./references#CD001884-fig-0023" title="">Analysis 2.1</a>) and in total blood loss (<a href="./references#CD001884-fig-0026" title="">Analysis 2.4</a>). DDAVP probably leads to little or no difference in the total number of people receiving a red cell transfusion (<a href="./references#CD001884-fig-0025" title="">Analysis 2.3</a>). It is uncertain whether DDAVP improves or worsens all‐cause mortality (<a href="./references#CD001884-fig-0028" title="">Analysis 2.6</a>) or risk of thrombotic events (<a href="./references#CD001884-fig-0029" title="">Analysis 2.7</a>) compared with placebo because the quality of evidence is very low. </p> </section> <section id="CD001884-sec-0246"> <h4 class="title">DDAVP versus tranexamic acid</h4> <p>Four trials compared DDAVP versus tranexamic acid. DDAVP may increase the total volume of red cells transfused (<a href="./references#CD001884-fig-0034" title="">Analysis 3.1</a>) and total blood loss (<a href="./references#CD001884-fig-0012" title="">Analysis 1.7</a>) compared with tranexamic acid. It is uncertain whether DDAVP improves or worsens the total number of people receiving a red cell transfusion (<a href="./references#CD001884-fig-0035" title="">Analysis 3.2</a>) or risk of thrombotic events (<a href="./references#CD001884-fig-0038" title="">Analysis 3.5</a>) compared with tranexamic acid because the quality of evidence is very low. </p> </section> <section id="CD001884-sec-0247"> <h4 class="title">DDAVP versus aprotinin</h4> <p>Two trials compared DDAVP versus aprotinin. DDAVP may increase the total number of people who receive a red cell transfusion compared with aprotinin (<a href="./references#CD001884-fig-0042" title="">Analysis 4.1</a>). It is uncertain whether DDAVP improves or worsens risk of all‐cause mortality (<a href="./references#CD001884-fig-0044" title="">Analysis 4.3</a>) or thrombotic events (<a href="./references#CD001884-fig-0045" title="">Analysis 4.4</a>) compared with aprotinin because the quality of evidence is very low. </p> </section> </section> <section id="CD001884-sec-0248"> <h3 class="title" id="CD001884-sec-0248">Overall completeness and applicability of evidence</h3> <p>This review provides the most up‐to‐date evidence for administration of DDAVP to minimise blood transfusion. The review identified 65 trials with 3874 participants and four ongoing trials with 147 participants. Most of these trials (46/65; 71%) were performed over 20 years ago, and changes in surgical and transfusion practice since that time may alter the relevance of these findings. The most common trial settings were adult cardiac surgery (39/65 trials; 60%) and orthopaedic surgery (12/65 trials; 18%); relatively few trials have examined the use of DDAVP in other types of surgery. Only 20 of the 65 (31%) trials administered DDAVP preoperatively, three trials (5%) administered DDAVP in combination with an antifibrinolytic agent, 12 trials (18%) included more than 75% of participants with platelet dysfunction, and no trials included people with thrombocytopenia or coagulopathy. These key groups are relatively under‐represented in the review dataset. Across all outcomes, available data on overall mortality and adverse events due to thrombotic events are insufficient to show clearly whether an increase, or a decrease, in events is associated with DDAVP administration. No trials reported quality of life. </p> </section> <section id="CD001884-sec-0249"> <h3 class="title" id="CD001884-sec-0249">Quality of the evidence</h3> <p>We have summarised the GRADE quality of evidence in <a href="./full#CD001884-tbl-0001">summary of findings Table for the main comparison</a>, <a href="./full#CD001884-tbl-0002">summary of findings Table 2</a>, <a href="./full#CD001884-tbl-0003">summary of findings Table 3</a>, and <a href="./full#CD001884-tbl-0004">summary of findings Table 4</a>. The overall quality of the evidence ranged from very low to moderate. We downgraded all outcomes one point for risk of bias. Most trials did not report sufficient detail to allow assessment of bias. We considered only one trial to be at low risk of bias in all domains. Domains with high risk of bias included blinding of outcome assessors, incomplete outcome data, and selective reporting. Heterogeneity was a problem for continuous outcomes, total volume of blood loss, and total number of red cells transfused owing to large differences in baseline blood loss between procedures. Mortality and thrombotic events were rare and, consequently, introduced risk of imprecision. Lastly, the trials in this review did not represent many types of surgery, and this introduced inconsistency. This was particularly the case for comparisons of DDAVP versus tranexamic acid or aprotinin. </p> </section> <section id="CD001884-sec-0250"> <h3 class="title" id="CD001884-sec-0250">Potential biases in the review process</h3> <p>We noted no obvious biases within the review process. We conducted a wide search ‐ that was not restricted by language or by full‐text publication ‐ to optimise the chances of identifying all relevant trials. Two review authors who were blinded to the other's results performed screening and data extraction in duplicate to minimise bias. A limitation of this review is that for many outcomes, the original authors published results in a format that did not allow inclusion in meta‐analysis (e.g. reported medians and ranges instead of means and standard deviations). This meant that many published trials did not contribute data to the outcomes, particularly for total volume of blood transfused and total blood loss. </p> </section> <section id="CD001884-sec-0251"> <h3 class="title" id="CD001884-sec-0251">Agreements and disagreements with other studies or reviews</h3> <p>This review is an update of a Cochrane Review published in 2004 (<a href="./references#CD001884-bbs2-0145" title="CarlessPA , HenryDA , MoxeyAJ , O'ConnellD , McClellandB , HendersonKM , et al. Desmopressin use for minimising allogeneic blood transfusion. Cochrane Database of Systematic Reviews2004, Issue 1. [DOI: 10.1002/14651858.CD001884.pub2] ">Carless 2004</a>). The original review identified 29 eligible trials. In 2008, another published meta‐analysis included 38 eligible trials (<a href="./references#CD001884-bbs2-0104" title="CrescenziG , LandoniG , Biondi‐ZoccaiG , PappalardoF , NuzziM , BignamiE , et al. Desmopressin reduces transfusion needs after surgery: a meta‐analysis of randomized clinical trials. Anesthesiology2008;109(6):1063‐76. ">Crescenzi 2008</a>). Compared with the most recent systematic review of DDAVP for prevention of perioperative transfusion (<a href="./references#CD001884-bbs2-0104" title="CrescenziG , LandoniG , Biondi‐ZoccaiG , PappalardoF , NuzziM , BignamiE , et al. Desmopressin reduces transfusion needs after surgery: a meta‐analysis of randomized clinical trials. Anesthesiology2008;109(6):1063‐76. ">Crescenzi 2008</a>), this review identified 26 more trials with an additional 1386 participants. For the present update, we included interventional procedures and children, neither of which were eligible for inclusion in the original Cochrane Review. The overall findings of this update are similar to those of the original review, which also found small decreases in the total volume of red cells transfused and in total blood loss, but no difference in the number of participants receiving a red cell transfusion nor in overall mortality or thrombotic events. The original review examined heterogeneity through sensitivity analysis by subgroups (cardiac surgery and other): participants taking antiplatelet agents, use of cell salvage, use of a transfusion protocol, and duration of cardiopulmonary bypass. Data on the subgroup of participants with platelet dysfunction or taking antiplatelet agents have been co‐published separately (<a href="./references#CD001884-bbs2-0147" title="DesboroughMJ , OaklandKA , LandoniG , CrivellariM , DoreeC , EstcourtLJ , et al. Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta‐analysis of randomized controlled trials. Journal of Thrombosis and Haemostasis2017;15:263‐72. ">Desborough 2017</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD001884-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD001884-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001884-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: desmopressin vs placebo: total red cell volume transfused. CI: confidence interval; MD: mean difference; SE: standard error." data-id="CD001884-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Funnel plot of comparison: desmopressin vs placebo: total red cell volume transfused. CI: confidence interval; MD: mean difference; SE: standard error. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: desmopressin vs placebo: number of participants receiving a red cell transfusion. CI: confidence interval; RR: relative risk." data-id="CD001884-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: desmopressin vs placebo: number of participants receiving a red cell transfusion. CI: confidence interval; RR: relative risk. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: desmopressin vs placebo: total blood loss. CI: confidence interval; MD: mean difference; SE: standard error." data-id="CD001884-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: desmopressin vs placebo: total blood loss. CI: confidence interval; MD: mean difference; SE: standard error. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Desmopressin vs placebo, Outcome 1 Red cell volume transfused (intraoperatively)." data-id="CD001884-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Desmopressin vs placebo, Outcome 1 Red cell volume transfused (intraoperatively).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Desmopressin vs placebo, Outcome 2 Red cell volume transfused (total)." data-id="CD001884-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Desmopressin vs placebo, Outcome 2 Red cell volume transfused (total).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Desmopressin vs placebo, Outcome 3 Red cell volume transfused (children only, total)." data-id="CD001884-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Desmopressin vs placebo, Outcome 3 Red cell volume transfused (children only, total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Desmopressin vs placebo, Outcome 4 Number of participants receiving a red cell transfusion (intraoperatively)." data-id="CD001884-fig-0009" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Desmopressin vs placebo, Outcome 4 Number of participants receiving a red cell transfusion (intraoperatively). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Desmopressin vs placebo, Outcome 5 Number of participants receiving a red cell transfusion (total)." data-id="CD001884-fig-0010" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Desmopressin vs placebo, Outcome 5 Number of participants receiving a red cell transfusion (total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Desmopressin vs placebo, Outcome 6 Blood loss (intraoperative)." data-id="CD001884-fig-0011" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Desmopressin vs placebo, Outcome 6 Blood loss (intraoperative).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Desmopressin vs placebo, Outcome 7 Blood loss (total)." data-id="CD001884-fig-0012" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Desmopressin vs placebo, Outcome 7 Blood loss (total).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Desmopressin vs placebo, Outcome 8 Blood loss (children only, total)." data-id="CD001884-fig-0013" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Desmopressin vs placebo, Outcome 8 Blood loss (children only, total).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Desmopressin vs placebo, Outcome 9 Number of participants with any bleeding (intraoperatively)." data-id="CD001884-fig-0014" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Desmopressin vs placebo, Outcome 9 Number of participants with any bleeding (intraoperatively). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Desmopressin vs placebo, Outcome 10 Number of participants with any bleeding (total)." data-id="CD001884-fig-0015" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Desmopressin vs placebo, Outcome 10 Number of participants with any bleeding (total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Desmopressin vs placebo, Outcome 11 Reoperation due to bleeding." data-id="CD001884-fig-0016" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Desmopressin vs placebo, Outcome 11 Reoperation due to bleeding.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Desmopressin vs placebo, Outcome 12 All‐cause mortality." data-id="CD001884-fig-0017" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Desmopressin vs placebo, Outcome 12 All‐cause mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Desmopressin vs placebo, Outcome 13 All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism)." data-id="CD001884-fig-0018" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Desmopressin vs placebo, Outcome 13 All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Desmopressin vs placebo, Outcome 14 Myocardial infarction." data-id="CD001884-fig-0019" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Desmopressin vs placebo, Outcome 14 Myocardial infarction.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Desmopressin vs placebo, Outcome 15 Stroke." data-id="CD001884-fig-0020" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Desmopressin vs placebo, Outcome 15 Stroke.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Desmopressin vs placebo, Outcome 16 Venous thromboembolism." data-id="CD001884-fig-0021" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Desmopressin vs placebo, Outcome 16 Venous thromboembolism.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Desmopressin vs placebo, Outcome 17 Clinically important hypotension." data-id="CD001884-fig-0022" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Desmopressin vs placebo, Outcome 17 Clinically important hypotension.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 1 Red cell volume transfused (total)." data-id="CD001884-fig-0023" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 1 Red cell volume transfused (total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 2 Number of participants receiving a red cell transfusion (intraoperatively)." data-id="CD001884-fig-0024" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 2 Number of participants receiving a red cell transfusion (intraoperatively). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 3 Number of participants receiving a red cell transfusion (total)." data-id="CD001884-fig-0025" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 3 Number of participants receiving a red cell transfusion (total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 4 Blood loss (total)." data-id="CD001884-fig-0026" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 4 Blood loss (total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 5 Reoperation due to bleeding." data-id="CD001884-fig-0027" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 5 Reoperation due to bleeding. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 6 All‐cause mortality." data-id="CD001884-fig-0028" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 6 All‐cause mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 7 All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism)." data-id="CD001884-fig-0029" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 7 All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 8 Myocardial infarction." data-id="CD001884-fig-0030" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 8 Myocardial infarction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 9 Stroke." data-id="CD001884-fig-0031" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 9 Stroke.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-002-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-002-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 10 Venous thromboembolism." data-id="CD001884-fig-0032" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 10 Venous thromboembolism.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-002-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-002-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 11 Clinically important hypotension." data-id="CD001884-fig-0033" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2 Desmopressin vs placebo (platelet dysfunction), Outcome 11 Clinically important hypotension. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-002-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Desmopressin vs tranexamic acid, Outcome 1 Red cell volume transfused (total)." data-id="CD001884-fig-0034" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Desmopressin vs tranexamic acid, Outcome 1 Red cell volume transfused (total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Desmopressin vs tranexamic acid, Outcome 2 Number of participants receiving a red cell transfusion (total)." data-id="CD001884-fig-0035" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Desmopressin vs tranexamic acid, Outcome 2 Number of participants receiving a red cell transfusion (total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Desmopressin vs tranexamic acid, Outcome 3 Blood loss (total)." data-id="CD001884-fig-0036" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Desmopressin vs tranexamic acid, Outcome 3 Blood loss (total).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Desmopressin vs tranexamic acid, Outcome 4 Reoperation due to bleeding." data-id="CD001884-fig-0037" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Desmopressin vs tranexamic acid, Outcome 4 Reoperation due to bleeding.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Desmopressin vs tranexamic acid, Outcome 5 All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism)." data-id="CD001884-fig-0038" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Desmopressin vs tranexamic acid, Outcome 5 All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Desmopressin vs tranexamic acid, Outcome 6 Myocardial infarction." data-id="CD001884-fig-0039" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Desmopressin vs tranexamic acid, Outcome 6 Myocardial infarction.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Desmopressin vs tranexamic acid, Outcome 7 Stroke." data-id="CD001884-fig-0040" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Desmopressin vs tranexamic acid, Outcome 7 Stroke.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Desmopressin vs tranexamic acid, Outcome 8 Venous thromboembolism." data-id="CD001884-fig-0041" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Desmopressin vs tranexamic acid, Outcome 8 Venous thromboembolism.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Desmopressin vs aprotinin, Outcome 1 Number of participants receiving a red cell transfusion (total)." data-id="CD001884-fig-0042" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Desmopressin vs aprotinin, Outcome 1 Number of participants receiving a red cell transfusion (total). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Desmopressin vs aprotinin, Outcome 2 Reoperation due to bleeding." data-id="CD001884-fig-0043" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Desmopressin vs aprotinin, Outcome 2 Reoperation due to bleeding.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Desmopressin vs aprotinin, Outcome 3 All‐cause mortality." data-id="CD001884-fig-0044" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Desmopressin vs aprotinin, Outcome 3 All‐cause mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Desmopressin vs aprotinin, Outcome 4 All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism)." data-id="CD001884-fig-0045" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Desmopressin vs aprotinin, Outcome 4 All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Desmopressin vs aprotinin, Outcome 5 Myocardial infarction." data-id="CD001884-fig-0046" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Desmopressin vs aprotinin, Outcome 5 Myocardial infarction.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Desmopressin vs aprotinin, Outcome 6 Stroke." data-id="CD001884-fig-0047" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Desmopressin vs aprotinin, Outcome 6 Stroke.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Desmopressin vs aprotinin, Outcome 7 Venous thromboembolism." data-id="CD001884-fig-0048" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 Desmopressin vs aprotinin, Outcome 7 Venous thromboembolism.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001884-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/urn:x-wiley:14651858:media:CD001884:CD001884-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_t/tCD001884-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Desmopressin vs aprotinin, Outcome 8 Clinically significant hypotension." data-id="CD001884-fig-0049" src="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 Desmopressin vs aprotinin, Outcome 8 Clinically significant hypotension.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/media/CDSR/CD001884/image_n/nCD001884-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD001884-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">DDAVP vs placebo or standard care</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participant or population:</b> participants undergoing surgery<br/> <b>Intervention:</b> desmopressin<br/> <b>Comparison:</b> placebo or standard care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with desmopressin</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="4" valign="top"> <p><b>Red cell volume transfused (total)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Adult cardiac surgery:</b> red cell volume transfused in the desmopressin group was 0.52 units less (0.96 fewer to 0.08 fewer units, 14 RCTs, 957 participants) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1454<br/> (23 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Data not pooled due to clinical heterogeneity and reported as subgroups</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Orthopaedic surgery:</b> red cell volume transfused in the desmopressin group was 0.02 units less (0.67 less to 0.64 more units, 6 RCTs, 303 participants) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Vascular surgery:</b> red cell volume transfused in the desmopressin group was 0.06 units more (0.60 less to 0.73 more units, 2 RCTs, 135 participants) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Hepatic surgery:</b> red cell volume transfused in the desmopressin group was 0.47 units less (1.27 less to 0.33 more units, 1 RCT, 59 participants) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants receiving a red cell transfusion (total)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>450 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>436 per 1000<br/> (400 to 476) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.96<br/> (0.86 to 1.06) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1806<br/> (25 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Blood loss (total)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Cardiac surgery:</b> total blood loss in the desmopressin group was 135.24 mL less (210.8 mL to 59.68 mL less, 22 RCTs, 1358 participants). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>1643<br/> (28 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Data not pooled owing to clinical heterogeneity and reported as subgroups</p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Orthopaedic surgery:</b> total blood loss in the desmopressin group was 285.76 mL less (514.99 mL to 56.53 mL less, 5 RCTs, 241 participants) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Vascular surgery:</b> total blood loss in the desmopressin group was 582 mL less (1264.07 mL less to 100.07 mL more, 1 RCT, 44 participants) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1000<br/> (7 to 41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>pOR 1.09</p> <p>(0.51 to 2.34)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1631<br/> (22 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>34 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>44 per 1000<br/> (28 to 67) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>pOR 1.36</p> <p>(0.85 to 2.16)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1984<br/> (29 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(No studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <br/> CI: confidence interval; pOR: Peto odds ratio; RCT: randomised controlled trial; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to risk of bias: inadequate reporting of blinding and incomplete outcome data </p> <p><sup>b</sup>Downgraged one level for inconsistency: I<sup>2</sup> = 66% </p> <p><sup>c</sup>Downgraded one level for inconsistency: I<sup>2</sup> = 73% and sensitivity analysis unable to determine cause of heterogeneity </p> <p><sup>d</sup>Downgraded one level for suspected publication bias </p> <p><sup>e</sup>Downgraded one level due to imprecision, as confidence intervals include both clinically important benefit and clinically important harm </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">DDAVP vs placebo or standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001884-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">DDAVP vs placebo or standard care: platelet dysfunction subgroup</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participant or population:</b> participants with platelet dysfunction undergoing surgery<br/> <b>Intervention:</b> desmopressin<br/> <b>Comparison:</b> placebo or standard care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with desmopressin</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Red cell volume transfused (total)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Red cell volume transfused was 2.6 units</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Red cell volume transfused in the desmopressin group was 0.65 units less (1.16 less to 0.13 less) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>388<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants receiving a red cell transfusion (total)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>541 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>449 per 1000<br/> (357 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.83<br/> (0.66 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>258<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Blood loss (total)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean total blood loss was 1098 mL</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Total blood loss in the desmopressin group was 253.93 mL less (408.01 mL less to 99.85 mL less) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>422<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>All‐cause mortality</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>14 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>10 per 1000</p> <p>(2 to 59)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>pOR 0.72</p> <p>(0.12 to 4.22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>422<br/> (7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>32 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>51 per 1000<br/> (19 to 133) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>pOR 1.58<br/> (0.60 to 4.17) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>422<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(No studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <br/> CI: confidence interval; pOR: Peto odds ratio; RCT: randomised controlled trial; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias </p> <p><sup>b</sup>Downgraded one level for inconsistency due to variation in baseline level of transfusion and blood loss </p> <p><sup>c</sup>Downgraded two levels for imprecision, as confidence intervals include clinically important benefit and clinically important harm with low background event rate </p> <p><sup>d</sup>Downgraded one level for imprecision </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">DDAVP vs placebo or standard care: platelet dysfunction subgroup</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001884-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">DDAVP vs tranexamic acid</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participant or population:</b> participants undergoing surgery<br/> <b>Intervention:</b> desmopressin<br/> <b>Comparison:</b> tranexamic acid </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with tranexamic acid</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with desmopressin</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Red cell volume transfused (total)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean red cell volume transfused was 0.2 units</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Red cell volume transfused in the desmopressin group was 0.6 units more (0.09 more to 1.11 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants receiving a red cell transfusion (total)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>239 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>578 per 1000<br/> (248 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.42<br/> (1.04 to 5.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>135<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Blood loss (total)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean blood loss was 270 mL</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Total blood loss in the desmopressin group was 142.81 mL more (79.78 mL more to 205.84 mL more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>115<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(No studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>18 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>51 per 1000<br/> (6 to 471) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.92<br/> (0.32 to 26.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>115<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(No studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <br/> CI: confidence interval; RCT: randomised controlled trial; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias </p> <p><sup>b</sup>Downgraded one level for indirectness because most types of surgery or procedures were not represented by the included trials </p> <p><sup>c</sup>Downgraded one level for imprecision owing to wide confidence intervals </p> <p><sup>d</sup>Downgraded two levels for imprecision owing to very wide confidence intervals </p> <p><sup>e</sup>Outcome not downgraded for indirectness because already downgraded three levels for other reasons </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">DDAVP vs tranexamic acid</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001884-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">DDAVP vs aprotinin</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Participant or population:</b> participants undergoing surgery<br/> <b>Intervention:</b> desmopressin<br/> <b>Comparison:</b> aprotinin </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with aprotinin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with desmopressin</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Red cell volume transfused (total)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(No studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants receiving a red cell transfusion (total)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>265 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>639 per 1000<br/> (385 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.41<br/> (1.45 to 4.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Blood loss (total)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(No studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No deaths in either arm of the trial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>14 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>13 per 1000<br/> (1 to 206) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>pOR 0.98<br/> (0.06 to 15.89) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>a,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(No studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <br/> CI: confidence interval; pOR: Peto odds ratio; RCT: randomised controlled trial; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for risk of bias </p> <p><sup>b</sup>Downgraded one level for indirectness because most types of surgery or procedures were not represented by the included trials </p> <p><sup>c</sup>Downgraded two levels for imprecision (no deaths in either arm) </p> <p><sup>d</sup>Not downgraded for indirectness because already downgraded three levels for other reasons </p> <p><sup>e</sup>Downgraded two levels for imprecision (very wide confidence intervals) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">DDAVP vs aprotinin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001884-tbl-0005"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study characteristics</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Trial</b> </p> <p><b>(country)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Number of participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Surgery type</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Cases</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Antiplatelet agents <br/> or platelet dysfunction (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Anticoagulants (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Coagulopathy (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Thrombocytopenia (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Antifibrinolytics (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Transfusion protocol</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Timing of blood loss or transfusion assessment (hours)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0001" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass [membrane oxygenator]. Japanese Journal of Artificial Organs1991;20(2):2516‐20. "><b>Aida 1991a</b> </a> </p> <p><b>(Japan)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0002" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass. Japanese Journal of Artificial Organs1991;20(2):2516‐20. "><b>Aida 1991b</b> </a> </p> <p><b>(Japan)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0003" title="AcarogluE , AlanayA , SuratA . Desmopressin (DDAVP) in scoliosis surgery. Journal of Bone and Joint Surgery ‐ British Volume. 1997; Vol. 79:Abstract O343. AlanayA , AcarogluE , OzdemirO , ErçelenO , BulutçuE , SuratA . Effects of deamino‐8‐D‐arginin vasopressin on blood loss and coagulation factors in scoliosis surgery. A double‐blind randomized clinical trial. Spine1999;24(9):877‐82. "><b>Alanay 1999</b> </a> </p> <p><b>(Turkey)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0004" title="AnderssonTL , SolemJO , TengbornL , VingeE . Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation. Circulation1990;81(3):872‐8. "><b>Andersson 1990</b> </a> </p> <p><b>(Sweden)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. "><b>Ansell 1992</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 2‐4<sup>a</sup> </p> <p>Placebo: 0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. "><b>Bignami 2016</b> </a> </p> <p><b>(Italy)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>135</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 38<sup>b</sup> </p> <p>Placebo: 43<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 1‐5</p> <p>Placebo: 1‐5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. "><b>Brown 1989</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 60<sup>b</sup> </p> <p>Placebo: 50<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. "><b>Casas 1995</b> </a> </p> <p><b>(Spain)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>149</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 14<sup>b</sup> </p> <p>Placebo: 9‐8<sup>b</sup> </p> <p>Aprotinin: 14‐6<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 0</p> <p>Placebo: 0</p> <p>Aprotinin: 100<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0009" title="ChuangHI , HorngYJ , LiY , ChernFC , ShiehDY , ChiouIS , et al. [Clinical assessment of desmopressin to reduce blood loss in patients after cardiopulmonary bypass]. Ma Zui Xue Za Zhi1993;31(1):35‐42. "><b>Chuang 1993</b> </a> </p> <p><b>(China)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. "><b>Clagett 1995</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>91</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vascular</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0011" title="ProstD , Barbier‐BoehmG , HazebroucqJ , BielskyMC , HvassU . Effect of desmopressin on excessive postoperative bleeding and blood product requirements associated with cardiopulmonary bypass. Thrombosis Research. 1992; Vol. 65:Abstract C132. deProstD , Barbier‐BoehmG , HazebroucqJ , IbrahimH , BielskyMC , HvassU , et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thrombosis and Haemostasis1992;68(2):106‐10. "><b>de Prost 1992</b> </a> </p> <p><b>(France)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 4‐3<sup>d</sup> </p> <p>Placebo: 13‐3<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. "><b>Despotis 1999</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 52<sup>b</sup> </p> <p>Placebo: 66<sup>b</sup> </p> <p>100<sup>f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 6</p> <p>Placebo: 0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP 50<sup>a</sup> </p> <p>Placebo 61<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. "><b>Dilthey 1993</b> </a> </p> <p><b>(Germany)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. "><b>Ellis 2001</b> </a> </p> <p><b>(Israel)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 0</p> <p>TXA: 100<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. "><b>Flordal 1991</b> </a> </p> <p><b>(Sweden)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. "><b>Flordal 1992</b> </a> </p> <p><b>(Sweden)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. "><b>Frankville 1991</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. "><b>Gratz 1992</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. "><b>Guay 1992</b> </a> </p> <p><b>(Canada)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0020" title="GuyuronB , VaughanC , SchlecterB . The role of DDAVP (desmopressin) in orthognathic surgery. Annals of Plastic Surgery1996;37(5):516‐9. "><b>Guyuron 1996</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maxillofacial</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. "><b>Hackmann 1989</b> </a> </p> <p><b>(Canada)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 21‐6<sup>b</sup> </p> <p>Placebo: 14‐5<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0022" title="HajjarLA , GalasF , FortimM , Melo , R , FerreiraR , AulerJO . Desmopressin acetate reduces blood loss after cardiac surgery: a double‐bind randomized controlled trial. Circulation. 2007; Vol. 116, issue 16:396. "><b>Hajjar 2007</b> </a> </p> <p><b>(Brazil)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. "><b>Hedderich 1990</b> </a> </p> <p><b>(Canada)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 38‐7<sup>b</sup> </p> <p>Placebo: 41.9<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18 blood loss</p> <p>48 transfusion</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0024" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. "><b>Hemșinli 2012a</b> </a> </p> <p><b>(Turkey)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0025" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. "><b>Hemșinli 2012b</b> </a> </p> <p><b>(Turkey)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0026" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. "><b>Hemșinli 2012c</b> </a> </p> <p><b>(Turkey)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Emergency</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 0</p> <p>TXA: 100<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. "><b>Horrow 1991a</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. "><b>Horrow 1991b</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0029" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. "><b>Horrow 1991c</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 0</p> <p>TXA: 100<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0030" title="JiH , JinL . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Cardiology. 2013; Vol. 126:Abstract. JinL , JiHW . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Chinese Medical Journal2015;128(5):644‐7. "><b>Jin 2015</b> </a> </p> <p><b>(China)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. "><b>Karnezis 1994a</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. "><b>Karnezis 1994b</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0033" title="KobrinskyNL , IsraelisED , LettsM , PatelL , SchwertzN , CheangMS , et al. DDAVP shortens the bleeding time and decreases operative blood loss in hemostatically normal subjects undergoing spinal fusion surgery. Blood. 1985; Vol. 5:Abstract 1176. KobrinskyNL , LettsRM , PatelLR , IsraelsED , MonsonRC , SchwetzN , et al. 1‐Desamino‐8‐D‐arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double‐blinded, controlled trial.. Annals of Internal Medicine1987;107:446‐50. "><b>Kobrinsky 1987</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0034" title="KuitunenAH . Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery. Annals Chirurgiae et Gynaecologiae1992;81(1):11‐8. "><b>Kuitunen 1992</b> </a> </p> <p><b>(Finland)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0035" title="LazarchickJ , ConroyJM . The effect of 6% hydroxyethyl starch and desmopressin infusion on von Willebrand factor: ristocetin cofactor activity. Annals of Clinical and Laboratory Science1995;25(4):306‐9. "><b>Lazarchick 1995</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0036" title="LeeHK , KimYJ , JeongJU , ParkJS , ChiHS , KimSB . Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients. Nephron Clinical Practice2010;114(4):c248‐52. "><b>Lee 2010</b> </a> </p> <p><b>(South Korea)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dialysis catheter</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. "><b>Leino 2010</b> </a> </p> <p><b>(Finland)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0038" title="LethagenS , RugarnP , BergqvistD . Blood loss and safety with desmopressin or placebo during aorto‐iliac graft surgery. European Journal of Vascular Surgery1991;5(2):173‐8. "><b>Lethagen 1991</b> </a> </p> <p><b>(Sweden)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vascular</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0039" title="LettsM , PangE , D'AstousJ , JarvisJ , LawtonL , LukeB , et al. The influence of desmopressin on blood loss during spinal fusion surgery in neuromuscular patients. Spine1998;23(4):475‐8. "><b>Letts 1998</b> </a> </p> <p><b>(Canada)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intraoperative only</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. "><b>Manno 2011</b> </a> </p> <p><b>(Italy)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>162</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kidney biopsy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. "><b>Marquez 1992</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0041" title="Use of preoperative desmopressin in preventing bleeding in patients treated with SSRI's. International Standard Randomised Controlled Trial Number: ISRCTN10353850. MarczinskiSC , Van derMeerYG , Van derBeek enM , EgbertsAC . Use of preoperative desmopressin in preventing bleeding in patients treated with SSRIs [Desmopressine preoperatif vermindert bloedverlies bij SSRI‐gebruikers: gerandomiseerd placebogecontroleerd, dubbelblind onderzoek]. Wetenschappelijk Platform2007;1(3):60‐3. "><b>Marczinski 2007</b> </a> </p> <p><b>(Netherlands)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic/Breast/Abdominal</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. "><b>Mongan 1992a</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. "><b>Mongan 1992b</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>h</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. "><b>Oliver 2000</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Paediatric cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 9.7<sup>b</sup> </p> <p>Placebo: 3.4<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 6.5</p> <p>Placebo: 6.9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. "><b>Ozkisacik 2001</b> </a> </p> <p><b>(Turkey)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. "><b>Pleym 2004</b> </a> </p> <p><b>(Norway)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 6.5<sup>c</sup> </p> <p>Placebo: 17.4<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0048" title="ReichDL , HammerschlagBC , RandJH , Weiss‐BloomL , PeruchoH , GallaJ , et al. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):142‐5. "><b>Reich 1991</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 28.6<sup>b</sup> </p> <p>Placebo: 38.5<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0049" title="ReynoldsLM , NicolsonSC , JobesDR , StevenJM , NorwoodWI , McGonigleME , et al. Desmopressin does not decrease bleeding after cardiac operation in young children. Journal of Thoracic and Cardiovascular Surgery1993;106(6):954‐8. "><b>Reynolds 1993</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>95</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Paediatric cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. "><b>Rocha 1988</b> </a> </p> <p><b>(Spain)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. "><b>Rocha 1994</b> </a> </p> <p><b>(Spain)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>109</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP (1): 0</p> <p>DDAVP (2): 0</p> <p>Control: 0</p> <p>Aprotinin: 100<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0052" title="SalmenperaM , KuitunenA , HynynenM , HeinonenJ . Hemodynamic responses to desmopressin acetate after CABG: a double‐blind trial. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):146‐9. "><b>Salmenpera 1991</b> </a> </p> <p><b>(Finland)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. "><b>Salzman 1986</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. "><b>Schott 1995</b> </a> </p> <p><b>(Sweden)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0055" title="SeearM , WadsworthL , ShepsS , MontgomeryC , AshmoreP . The effect of desmopressin acetate (DDAVP) on post‐operative blood loss after open heart surgery in children. Blood. 1987; Vol. 5:Abstract 380a. SeearMD , WadsworthLD , RogersPC , ShepsS , AshmorePG . The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. Journal of Thoracic and Cardiovascular Surgery1989;98(2):217‐9. "><b>Seear 1989</b> </a> </p> <p><b>(Canada)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Paediatric cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. "><b>Shao 2015</b> </a> </p> <p><b>(China)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sinus</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intraoperative only</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. "><b>Sheridan 1994</b> </a> </p> <p><b>(Canada)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0058" title="SpytTJ , WeerasenaNA , BainWH , LoweGD , RumleyA . The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double‐blind trial. Perfusion1990;5(Suppl):57‐61. WeerasenaNA , SpytTJ , RumleyA , BainWH , LoweGD . Randomised, double‐blind, placebo‐controlled trial of desmopressin in routine coronary artery bypass surgery. British Journal of Haematology. 1990; Vol. 76:Abstract 38. "><b>Spyt 1990</b> </a> </p> <p><b>(UK)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 14.3<sup>b</sup> </p> <p>Placebo: 10.2<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>˜24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. "><b>Steinlechner 2011</b> </a> </p> <p><b>(Austria)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0060" title="TemeckBK , BachenheimerLC , KatzNM , CoughlinSS , WallaceRB . Desmopressin acetate in cardiac surgery: a double‐blind, randomized study. Southern Medical Journal1994;87(6):611‐5. "><b>Temeck 1994</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 20<sup>a</sup> </p> <p>Placebo: 30.2<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0061" title="TherouxMC , CorddryDH , TietzAE , MillerF , PeoplesJD , KettrickRG . A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double‐blinded study. Anesthesiology1997;87(2):260‐7. "><b>Theroux 1997</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0062" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores. Plastic and Reconstructive Surgery1992;89(2):279‐82. "><b>Wingate 1992a</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Plastic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0063" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores (low risk procedures only). Plastic and Reconstructive Surgery1992;89(2):279‐82. "><b>Wingate 1992b</b> </a> </p> <p><b>(USA)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Plastic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0064" title="WongAY , IrwinMG , HuiTW , FungSK , FanST , MaES . Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Canadian Journal of Anaesthesia2003;50(1):14‐20. "><b>Wong 2003</b> </a> </p> <p><b>(Hong Kong)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hepatic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intraoperative only</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0065" title="ZoharE , FredmanB , EllisMH , IfrachN , SternA , JedeikinR . A comparative study of the postoperative allogeneic blood‐sparing effects of tranexamic acid and of desmopressin after total knee replacement. Transfusion2001;41(10):1285‐9. "><b>Zohar 2001</b> </a> </p> <p><b>(Israel)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Orthopaedic</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP: 0</p> <p>TXA: 100<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="11"> <div class="table-footnote"> <p>Blank cells indicate that information was not reported in the original papers<br/> <sup>a</sup>Epsilon‐aminocaproic acid<br/> <sup>b</sup>Antiplatelet agents<br/> <sup>c</sup>Tranexamic acid<br/> <sup>d</sup>Aprotinin<br/> <sup>e</sup>Defined as bleeding time greater than 10 seconds<br/> <sup>f</sup>Defined as hemoSTATUS &lt; 60%<br/> <sup>g</sup>Defined as prolonged platelet function analyser‐100 closure time<br/> <sup>h</sup>Defined as thromboelastography maximum clot amplitude &lt; 50 mm </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study characteristics</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001884-tbl-0006"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Intervention characteristics</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> DDAVP dose(s) (μg/kg)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Timing of dose</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Timing summary</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Comparator(s)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Preoperative DDAVP</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0003" title="AcarogluE , AlanayA , SuratA . Desmopressin (DDAVP) in scoliosis surgery. Journal of Bone and Joint Surgery ‐ British Volume. 1997; Vol. 79:Abstract O343. AlanayA , AcarogluE , OzdemirO , ErçelenO , BulutçuE , SuratA . Effects of deamino‐8‐D‐arginin vasopressin on blood loss and coagulation factors in scoliosis surgery. A double‐blind randomized clinical trial. Spine1999;24(9):877‐82. "><b>Alanay 1999</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Induction of anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. "><b>Flordal 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 (× 2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At start of surgery and again after 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0016" title="FlordalPA , LjungstromKG , EkmanB , NeanderG . Effects of desmopressin on blood loss in hip arthroplasty. Controlled study in 50 patients. Acta Orthopaedica Scandinavica1992;63(4):381‐5. "><b>Flordal 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 (× 2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At start of surgery and again after 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0019" title="GuayJ , ReinbergC , PoitrasB , DavidM , MathewsS , LortieL , et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesthesia and Analgesia1992;75(3):405‐10. GuayJ , ReinbergC , RivardGE , PoitrasB , MathewsS , DavidM . DDAVP does not reduce bleeding during spinal fusion for idiopathic scoliosis. Canadian Journal of Anaesthesia. 1990; Vol. 37:Abstract S14. "><b>Guay 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 μg/m<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At time of first skin incision</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0020" title="GuyuronB , VaughanC , SchlecterB . The role of DDAVP (desmopressin) in orthognathic surgery. Annals of Plastic Surgery1996;37(5):516‐9. "><b>Guyuron 1996</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 minutes preoperatively</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0033" title="KobrinskyNL , IsraelisED , LettsM , PatelL , SchwertzN , CheangMS , et al. DDAVP shortens the bleeding time and decreases operative blood loss in hemostatically normal subjects undergoing spinal fusion surgery. Blood. 1985; Vol. 5:Abstract 1176. KobrinskyNL , LettsRM , PatelLR , IsraelsED , MonsonRC , SchwetzN , et al. 1‐Desamino‐8‐D‐arginine vasopressin (desmopressin) decreases operative blood loss in patients having Harrington rod spinal fusion surgery. A randomized, double‐blinded, controlled trial.. Annals of Internal Medicine1987;107:446‐50. "><b>Kobrinsky 1987</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 μg/m<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after induction of anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0035" title="LazarchickJ , ConroyJM . The effect of 6% hydroxyethyl starch and desmopressin infusion on von Willebrand factor: ristocetin cofactor activity. Annals of Clinical and Laboratory Science1995;25(4):306‐9. "><b>Lazarchick 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After anaesthetic induction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0036" title="LeeHK , KimYJ , JeongJU , ParkJS , ChiHS , KimSB . Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients. Nephron Clinical Practice2010;114(4):c248‐52. "><b>Lee 2010</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. "><b>Leino 2010</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>0.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>At start of surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP 0.2 μg/kg</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0038" title="LethagenS , RugarnP , BergqvistD . Blood loss and safety with desmopressin or placebo during aorto‐iliac graft surgery. European Journal of Vascular Surgery1991;5(2):173‐8. "><b>Lethagen 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately before start of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0039" title="LettsM , PangE , D'AstousJ , JarvisJ , LawtonL , LukeB , et al. The influence of desmopressin on blood loss during spinal fusion surgery in neuromuscular patients. Spine1998;23(4):475‐8. "><b>Letts 1998</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 μg/m<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after induction of anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0040" title="MannoC , BonifatiC , TorresDD , CampobassoN , SchenaFP . Desmopressin acetate in percutaneous ultrasound‐guided kidney biopsy: a randomized controlled trial. American Journal of Kidney Diseases2011;57(6):850‐5. "><b>Manno 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 hour before biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0041" title="Use of preoperative desmopressin in preventing bleeding in patients treated with SSRI's. International Standard Randomised Controlled Trial Number: ISRCTN10353850. MarczinskiSC , Van derMeerYG , Van derBeek enM , EgbertsAC . Use of preoperative desmopressin in preventing bleeding in patients treated with SSRIs [Desmopressine preoperatif vermindert bloedverlies bij SSRI‐gebruikers: gerandomiseerd placebogecontroleerd, dubbelblind onderzoek]. Wetenschappelijk Platform2007;1(3):60‐3. "><b>Marczinski 2007</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 μg to 45 μg depending on weight</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0054" title="SchottU , SollenC , AxelssonK , RugarnP , AllvinI . Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiolica Scandinavica1995;39(5):592‐8. "><b>Schott 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 (× 2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Post induction of anaesthesia and again after 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0056" title="Effects of desmopressin on blood loss and the quality of the surgical field during endoscopic sinus surgery. ClinicalTrials.gov number: NCT02125188 (accessed 23 May 2017). ShaoH , KuangLT , HouWJ , ZhangT . Effect of desmopressin administration on intraoperative blood loss and quality of the surgical field during functional endoscopic sinus surgery: a randomized, clinical trial. BMC Anesthesiology2015;15:53. "><b>Shao 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After induction of anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0059" title="SteinlechnerB , SpannaglM , QuehenbergerP , ZeidlerP , JilmaB . Patients with severe aortic valve stenosis and impaired platelet function benefit from pre‐operative desmopressin infusion. Journal of Thrombosis and Haemostasis. 2011; Vol. 9:Abstract P‐MO‐530. SteinlechnerB , ZeidlerP , BaseE , BirkenbergB , AnkersmitHJ , SpannaglM , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Annals of Thoracic Surgery2011;91(5):1420‐6. "><b>Steinlechner 2011</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After induction of anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0061" title="TherouxMC , CorddryDH , TietzAE , MillerF , PeoplesJD , KettrickRG . A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double‐blinded study. Anesthesiology1997;87(2):260‐7. "><b>Theroux 1997</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0062" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores. Plastic and Reconstructive Surgery1992;89(2):279‐82. "><b>Wingate 1992a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After induction of anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0063" title="WingateGF , LewisVLJr , GreenD , WiedrichTA , KoenigWJ . Desmopressin decreases operative blood loss in spinal cord injury patients having flap reconstruction of pelvic pressure sores (low risk procedures only). Plastic and Reconstructive Surgery1992;89(2):279‐82. "><b>Wingate 1992b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After induction of anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0064" title="WongAY , IrwinMG , HuiTW , FungSK , FanST , MaES . Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Canadian Journal of Anaesthesia2003;50(1):14‐20. "><b>Wong 2003</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After induction of anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Preoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>DDAVP administered at end of operation</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0001" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass [membrane oxygenator]. Japanese Journal of Artificial Organs1991;20(2):2516‐20. "><b>Aida 1991a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 minutes after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0002" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass. Japanese Journal of Artificial Organs1991;20(2):2516‐20. "><b>Aida 1991b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 minutes after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0004" title="AnderssonTL , SolemJO , TengbornL , VingeE . Effects of desmopressin acetate on platelet aggregation, von Willebrand factor, and blood loss after cardiac surgery with extracorporeal circulation. Circulation1990;81(3):872‐8. "><b>Andersson 1990</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 minutes after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0005" title="AnsellJ , KlassenV , LewR , BallS , WeinsteinM , VanderSalmT , et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double‐blind study. Journal of Thoracic and Cardiovascular Surgery1992;104(1):117‐23. "><b>Ansell 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. "><b>Bignami 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In event of excessive bleeding, after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation/postoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0007" title="BrownMR , SwygertTH , WhittenCW , HebelerR . Desmopressin acetate following cardiopulmonary bypass: evaluation of coagulation parameters. Journal of Cardiothoracic Anesthesia1989;3(6):726‐9. "><b>Brown 1989</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. "><b>Casas 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aprotinin<sup>a</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0009" title="ChuangHI , HorngYJ , LiY , ChernFC , ShiehDY , ChiouIS , et al. [Clinical assessment of desmopressin to reduce blood loss in patients after cardiopulmonary bypass]. Ma Zui Xue Za Zhi1993;31(1):35‐42. "><b>Chuang 1993</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 minutes after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0010" title="ClagettGP , ValentineRJ , MyersSI , ChervuA , HellerJ . Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double‐blind study. Journal of Vascular Surgery1995;22(3):223‐9. "><b>Clagett 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 minutes after heparinisation and before aortic cross‐clamp application</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0012" title="DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new point‐of‐care test. Blood. 1998; Vol. 92:Abstract 189. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . DDAVP reduces blood loss and blood component transfusion in cardiac surgery patients with impaired platelet function identified with a new‐point‐of‐care test. Annals of Hematology. 1999; Vol. 78:Abstract P054. DespotisGJ , LevineV , SaleemR , SpitznagelE , JoistJH . Use of point‐of‐care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet1999;354(9173):106‐10. "><b>Despotis 1999</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. "><b>Dilthey 1993</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 minutes after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. "><b>Ellis 2001</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Before removal of tourniquet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tranexamic acid<sup>b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. "><b>Frankville 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 minutes after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0018" title="GratzI , KoehlerJ , OlsenD , AfsharM , DeCastroN , SpagnaPM , et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. Journal of Thoracic and Cardiovascular Surgery1992;104(5):1417‐22. KoehlerJ , GratzI , LarijaniGE , SpagnaP , GomezF , KarayannisB , et al. The use of desmopressin to decrease bleeding in patients on aspirin therapy undergoing uncomplicated coronary artery bypass surgery (CABG). Clinical Pharmacology and Therapeutics. 1990; Vol. 47:Abstract PIII‐107. "><b>Gratz 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. "><b>Hackmann 1989</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0022" title="HajjarLA , GalasF , FortimM , Melo , R , FerreiraR , AulerJO . Desmopressin acetate reduces blood loss after cardiac surgery: a double‐bind randomized controlled trial. Circulation. 2007; Vol. 116, issue 16:396. "><b>Hajjar 2007</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0023" title="HedderichGS , PetsikasDJ , CooperBA , LeznoffM , GuerratyAJ , PoirierNL , et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomized clinical trial. Canadian Journal of Surgery1990;33(1):33‐6. "><b>Hedderich 1990</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0027" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. "><b>Horrow 1991a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0028" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. "><b>Horrow 1991b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0029" title="HorrowJC , VanRiperDF , StrongMD , BrodskyI , ParmetJL . Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation1991;84(5):2063‐70. "><b>Horrow 1991c</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tranexamic acid<sup>c</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0030" title="JiH , JinL . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Cardiology. 2013; Vol. 126:Abstract. JinL , JiHW . Effect of desmopressin on platelet aggregation and blood loss in patients undergoing valvular heart surgery. Chinese Medical Journal2015;128(5):644‐7. "><b>Jin 2015</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Before cardiac rewarming</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0031" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. "><b>Karnezis 1994a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 minutes before closure of wound</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0032" title="KarnezisTA , StulbergSD , WixsonRL , ReillyP . The hemostatic effects of desmopressin on patients who had total joint arthroplasty. A double‐blind randomized trial. Journal of Bone and Joint Surgery. American Volume1994;76(10):1545‐50. "><b>Karnezis 1994b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 minutes before closure of wound</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. "><b>Marquez 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP 0.3 μg/kg × 2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. "><b>Mongan 1992a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After reversal of heparin and before chest closure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. "><b>Mongan 1992b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After reversal of heparin and before chest closure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. "><b>Oliver 2000</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 minutes after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0046" title="OzkisacikE , IslamogluF , PosaciogluH , YagdiT , BasarirS , OmaySB , et al. Desmopressin usage in elective cardiac surgery. Journal of Cardiovascualr Surgery (Torino)2001;42(6):741‐7. "><b>Ozkisacik 2001</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After reversal of heparin (timing unclear)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0047" title="PleymH , StensethR , WahbaA , BjellaL , TromsdalA , KarevoldA , et al. Prophylactic treatment with desmopressin does not reduce postoperative bleeding after coronary surgery in patients treated with aspirin before surgery. Anesthesia and Analgesia2004;98(3):578‐84. "><b>Pleym 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0048" title="ReichDL , HammerschlagBC , RandJH , Weiss‐BloomL , PeruchoH , GallaJ , et al. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):142‐5. "><b>Reich 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 minutes after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0049" title="ReynoldsLM , NicolsonSC , JobesDR , StevenJM , NorwoodWI , McGonigleME , et al. Desmopressin does not decrease bleeding after cardiac operation in young children. Journal of Thoracic and Cardiovascular Surgery1993;106(6):954‐8. "><b>Reynolds 1993</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 minutes after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. "><b>Rocha 1988</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. "><b>Rocha 1994</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aprotinin<sup>d</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DDAVP 0.3 μg/kg × 2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0052" title="SalmenperaM , KuitunenA , HynynenM , HeinonenJ . Hemodynamic responses to desmopressin acetate after CABG: a double‐blind trial. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):146‐9. "><b>Salmenpera 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Via pulmonary artery catheter immediately after sternal closure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0053" title="MillardF , AllenG , SalzmanEW . Desmopressin acetate to reduce blood loss after cardiac surgery. New England Journal of Medicine1986;315(13):834‐5. SalzmanEW , WeinsteinMJ , WeintraubRM , WareJA , ThurerRL , RobertsonL , et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double‐blind randomized trial. New England Journal of Medicine1986;314(22):1402‐6. WeinsteinM , WareJA , TrollJ , SalzmanE . Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate. Blood1988;71(6):1648‐55. "><b>Salzman 1986</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after reversal of heparin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0055" title="SeearM , WadsworthL , ShepsS , MontgomeryC , AshmoreP . The effect of desmopressin acetate (DDAVP) on post‐operative blood loss after open heart surgery in children. Blood. 1987; Vol. 5:Abstract 380a. SeearMD , WadsworthLD , RogersPC , ShepsS , AshmorePG . The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. Journal of Thoracic and Cardiovascular Surgery1989;98(2):217‐9. "><b>Seear 1989</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After reversal of heparin (timing unclear)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0057" title="SheridanDP , CardRT , PinillaJC , HardingSM , ThomsonDJ , GauthierL , et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic‐acid‐induced platelet dysfunction. Canadian Journal of Surgery1994;37(1):33‐6. "><b>Sheridan 1994</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 μg/m<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After reversal of heparin (timing unclear)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0058" title="SpytTJ , WeerasenaNA , BainWH , LoweGD , RumleyA . The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double‐blind trial. Perfusion1990;5(Suppl):57‐61. WeerasenaNA , SpytTJ , RumleyA , BainWH , LoweGD . Randomised, double‐blind, placebo‐controlled trial of desmopressin in routine coronary artery bypass surgery. British Journal of Haematology. 1990; Vol. 76:Abstract 38. "><b>Spyt 1990</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After reversal of heparin (timing unclear)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0060" title="TemeckBK , BachenheimerLC , KatzNM , CoughlinSS , WallaceRB . Desmopressin acetate in cardiac surgery: a double‐blind, randomized study. Southern Medical Journal1994;87(6):611‐5. "><b>Temeck 1994</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After reversal of heparin (timing unclear)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0065" title="ZoharE , FredmanB , EllisMH , IfrachN , SternA , JedeikinR . A comparative study of the postoperative allogeneic blood‐sparing effects of tranexamic acid and of desmopressin after total knee replacement. Transfusion2001;41(10):1285‐9. "><b>Zohar 2001</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 minutes before deflation of tourniquet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>End of operation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tranexamic acid<sup>b</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>DDAVP administered postoperatively</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0011" title="ProstD , Barbier‐BoehmG , HazebroucqJ , BielskyMC , HvassU . Effect of desmopressin on excessive postoperative bleeding and blood product requirements associated with cardiopulmonary bypass. Thrombosis Research. 1992; Vol. 65:Abstract C132. deProstD , Barbier‐BoehmG , HazebroucqJ , IbrahimH , BielskyMC , HvassU , et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thrombosis and Haemostasis1992;68(2):106‐10. "><b>de Prost 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Between end of operation and 6 hours postoperatively</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0034" title="KuitunenAH . Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery. Annals Chirurgiae et Gynaecologiae1992;81(1):11‐8. "><b>Kuitunen 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after sternal closure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postoperative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Timing of DDAVP administration unclear</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0024" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. "><b>Hemșinli 2012a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0025" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. "><b>Hemșinli 2012b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard care</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0026" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. "><b>Hemșinli 2012c</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tranexamic acid<sup>c</sup> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>Aprotinin 2 million KIU in 200 mL preoperatively, 2 million KIU in 200 mL in fluid prime, 500,000 KIU in 50 mL/h from skin incision to skin closure<br/> <sup>b</sup>Tranexamic acid 15 mg/kg 30 minutes before tourniquet removed over 30 minutes, then 10 mg/kg/h until 12 hours after tourniquet deflated<br/> <sup>c</sup>Tranexamic acid 10 mg/kg loading dose after induction of anaesthesia and before first skin incision over 30 minutes, then 1 mg/kg/h for 10 hours<br/> <sup>d</sup>Aprotinin 2 million KIU within 30 minutes after induction of anaesthesia followed by a continuous infusion of 500,000 KIU/h until the patient left the operating room, plus an additional bolus of 2 million KIU aprotinin in the pump prime by replacement of crystalloid solution </p> <p><b>Abbreviation</b> </p> <p>KIU: kilounits</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Intervention characteristics</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001884-tbl-0007"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">DDAVP vs placebo: intraoperative volume of red cells transfused</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reason not included in meta‐analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DDAVP arm</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo arm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Orthopaedic surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. "><b>Leino 2010</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (no standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.3 units</p> <p>(n = 23)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5 units</p> <p>(n = 24)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0039" title="LettsM , PangE , D'AstousJ , JarvisJ , LawtonL , LukeB , et al. The influence of desmopressin on blood loss during spinal fusion surgery in neuromuscular patients. Spine1998;23(4):475‐8. "><b>Letts 1998</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (no standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.6 units</p> <p>(n = 16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.0 units</p> <p>(n = 14)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0061" title="TherouxMC , CorddryDH , TietzAE , MillerF , PeoplesJD , KettrickRG . A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double‐blinded study. Anesthesiology1997;87(2):260‐7. "><b>Theroux 1997</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median and range</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51.5 (24 to 98.6) mL/kg</p> <p>(n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48.3 (24.5 to 96) mL/kg</p> <p>(n = 11)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">DDAVP vs placebo: intraoperative volume of red cells transfused</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001884-tbl-0008"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">DDAVP vs placebo: total volume of red cells transfused</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reason not included in meta‐analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DDAVP arm</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo arm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Adult cardiac surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0001" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass [membrane oxygenator]. Japanese Journal of Artificial Organs1991;20(2):2516‐20. "><b>Aida 1991a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/kg (mean ± standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.3 ± 5.6 mL/kg</p> <p>(n = 5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.8 ± 6.3 mL/kg</p> <p>(n = 4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0002" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass. Japanese Journal of Artificial Organs1991;20(2):2516‐20. "><b>Aida 1991b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/kg (mean ± standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.2 ± 6.4 mL/kg</p> <p>(n = 5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.2 ± 6.6 mL/kg</p> <p>(n = 6)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0003" title="AcarogluE , AlanayA , SuratA . Desmopressin (DDAVP) in scoliosis surgery. Journal of Bone and Joint Surgery ‐ British Volume. 1997; Vol. 79:Abstract O343. AlanayA , AcarogluE , OzdemirO , ErçelenO , BulutçuE , SuratA . Effects of deamino‐8‐D‐arginin vasopressin on blood loss and coagulation factors in scoliosis surgery. A double‐blind randomized clinical trial. Spine1999;24(9):877‐82. "><b>Alanay 1999</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (interquartile range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7 (2.3) units</p> <p>(n = 18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.6 (1.3) units</p> <p>(n = 22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. "><b>Bignami 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (interquartile range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (1 to 4) units</p> <p>(n = 68)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (1 to 3) units</p> <p>(n = 67)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0017" title="FrankvilleDD , HarperGB , LakeCL , JohnsRA . Hemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology1991;74(6):988‐96. "><b>Frankville 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (no standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4 units</p> <p>(n = 15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 units</p> <p>(n = 15)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. "><b>Hackmann 1989</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (90% confidence interval)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (1 to 8.5) units</p> <p>(n = 74)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (1 to 9.8) units</p> <p>(n = 76)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0034" title="KuitunenAH . Haemostatic responses to desmopressin acetate after primary coronary artery bypass surgery. Annals Chirurgiae et Gynaecologiae1992;81(1):11‐8. "><b>Kuitunen 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.3 (0 to 2) units</p> <p>(n = 15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.1 (0 to 3) units</p> <p>(n = 15)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. "><b>Marquez 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 units</p> <p>(n = 21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 units</p> <p>(n = 22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0043" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992b;77(1):38‐46. "><b>Mongan 1992a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.86 units</p> <p>(n = 44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.79 units</p> <p>n = 42)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0044" title="MonganPD , HoskingMP . The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology1992;77(1):38‐46. "><b>Mongan 1992b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4 units</p> <p>(n = 13)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.2 units</p> <p>(n = 16)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. "><b>Rocha 1994</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> (mean ± standard deviation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>740.4 ± 416.3 mL/m<sup>2</sup> </p> <p><sup>(n = 25)</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>662.8 ± 380.7 mL/m<sup>2</sup> </p> <p><sup>(n = 28)</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0058" title="SpytTJ , WeerasenaNA , BainWH , LoweGD , RumleyA . The effects of desmopressin acetate (DDAVP) on haemostasis and blood loss in routine coronary artery bypass surgery: a randomized, double‐blind trial. Perfusion1990;5(Suppl):57‐61. WeerasenaNA , SpytTJ , RumleyA , BainWH , LoweGD . Randomised, double‐blind, placebo‐controlled trial of desmopressin in routine coronary artery bypass surgery. British Journal of Haematology. 1990; Vol. 76:Abstract 38. "><b>Spyt 1990</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.38 units</p> <p>(n = 49)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.30 units</p> <p>(n = 49)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Orthopaedic surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. "><b>Ellis 2001</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7 units</p> <p>(n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.1 units</p> <p>(n = 10)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0061" title="TherouxMC , CorddryDH , TietzAE , MillerF , PeoplesJD , KettrickRG . A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double‐blinded study. Anesthesiology1997;87(2):260‐7. "><b>Theroux 1997</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median and range</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.8 (30.3 to 123.6) mL/kg</p> <p>(n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.9 (33.8 to 110) mL/kg</p> <p>(n = 11)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Maxillofacial surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0020" title="GuyuronB , VaughanC , SchlecterB . The role of DDAVP (desmopressin) in orthognathic surgery. Annals of Plastic Surgery1996;37(5):516‐9. "><b>Guyuron 1996</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (no standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.6 units</p> <p>(n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.9 units</p> <p>(n = 10)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">DDAVP vs placebo: total volume of red cells transfused</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001884-tbl-0009"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">DDAVP vs placebo: intraoperative blood loss</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reason not included in meta‐analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DDAVP arm</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo arm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Adult cardiac surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. "><b>Hackmann 1989</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (90% confidence interval)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>200 (0 to 1150) mL</p> <p>(n = 74)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>200 (0 to 1013) mL</p> <p>(n = 76)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. "><b>Rocha 1988</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> body surface area </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>131 ± 106 mL/m<sup>2</sup> </p> <p>(n = 50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>193 ± 137 mL/m<sup>2</sup> </p> <p>(n = 50)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Paediatric cardiac surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0045" title="OliverWCJr , SantrachPJ , DanielsonGK , NuttallGA , SchroederDR , ErethMH . Desmopressin does not reduce bleeding and transfusion requirements in congenital heart operations. Annals of Thoracic Surgery2000;70(6):1923‐30. "><b>Oliver 2000</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49.3 ± 43.7 mL/m<sup>2</sup> </p> <p>(n = 31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73.6 ± 71.1 mL/m<sup>2</sup> </p> <p>(n = 29)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Orthopaedic surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0037" title="LeinoKA , PalveHK , TiusanenHT , TuppurainenTT . The effect of desmopressin on blood loss in patients with rheumatoid arthritis undergoing hip arthroplasty. Acta Anaesthesiolica Scandinavica2010;54(7):863‐70. "><b>Leino 2010</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (no standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1200 mL</p> <p>(n = 23)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1463 mL</p> <p>(n = 24)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Hepatic surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0064" title="WongAY , IrwinMG , HuiTW , FungSK , FanST , MaES . Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Canadian Journal of Anaesthesia2003;50(1):14‐20. "><b>Wong 2003</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>832.5 (350 to 2955) mL</p> <p>(n = 30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>800 mL (250 to 7128) mL</p> <p>(n = 29)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Other surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0041" title="Use of preoperative desmopressin in preventing bleeding in patients treated with SSRI's. International Standard Randomised Controlled Trial Number: ISRCTN10353850. MarczinskiSC , Van derMeerYG , Van derBeek enM , EgbertsAC . Use of preoperative desmopressin in preventing bleeding in patients treated with SSRIs [Desmopressine preoperatif vermindert bloedverlies bij SSRI‐gebruikers: gerandomiseerd placebogecontroleerd, dubbelblind onderzoek]. Wetenschappelijk Platform2007;1(3):60‐3. "><b>Marczinski 2007</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean and range</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>251 (2 to 1330) mL</p> <p>(n = 14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>504 (50 to 2100) mL</p> <p>(n = 14)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">DDAVP vs placebo: intraoperative blood loss</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001884-tbl-0010"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">DDAVP vs placebo: total blood loss</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reason not included in meta‐analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DDAVP arm</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo arm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Adult cardiac surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0001" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass [membrane oxygenator]. Japanese Journal of Artificial Organs1991;20(2):2516‐20. "><b>Aida 1991a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/kg (mean ± standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.0 ± 1.4 mL/kg</p> <p>(n = 5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.9 ± 1.5 mL/kg</p> <p>(n = 4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0002" title="AidaH , KuribayashiR , SakuradaT , SekineS , GotohH , SekiK , et al. A study of desmopressin to reduce blood loss after surgery in patients on cardiopulmonary bypass. Japanese Journal of Artificial Organs1991;20(2):2516‐20. "><b>Aida 1991b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/kg (mean ± standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.3 ± 10 mL/kg</p> <p>(n = 5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.5 ± 4 mL/kg</p> <p>(n = 6)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0003" title="AcarogluE , AlanayA , SuratA . Desmopressin (DDAVP) in scoliosis surgery. Journal of Bone and Joint Surgery ‐ British Volume. 1997; Vol. 79:Abstract O343. AlanayA , AcarogluE , OzdemirO , ErçelenO , BulutçuE , SuratA . Effects of deamino‐8‐D‐arginin vasopressin on blood loss and coagulation factors in scoliosis surgery. A double‐blind randomized clinical trial. Spine1999;24(9):877‐82. "><b>Alanay 1999</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (interquartile range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>950 (950) mL</p> <p>(n = 18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>975 (811) mL</p> <p>(n = 22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0006" title="Desmopressin in Cardiac Surgery. Clinicaltrials.gov number: NCT00337766 (accessed 23 May 2017). Efficacy of desmopressin in patient with active bleeding after heart surgery. EudraCT Number: 2005‐005199‐33 (accessed 23 May 2017). BignamiE , CattaneoM , CrescenziG , RanucciM , GuarracinoF , CarielloC , et al. Desmopressin after cardiac surgery in bleeding patients. A multicenter randomized trial. Acta Anesthesiological Scandinavica2016;60(7):892‐900. "><b>Bignami 2016</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (interquartile range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>575 (422.5 to 770) mL</p> <p>(n = 68)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>590 (476.25 to 1013.75) mL</p> <p>(n = 67)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. "><b>Casas 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> body surface area (mean ± standard deviation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>400 ± 192 mL/m<sup>2</sup> </p> <p>(n = 50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>489 ± 361 mL/m<sup>2</sup> </p> <p>(n = 51)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0011" title="ProstD , Barbier‐BoehmG , HazebroucqJ , BielskyMC , HvassU . Effect of desmopressin on excessive postoperative bleeding and blood product requirements associated with cardiopulmonary bypass. Thrombosis Research. 1992; Vol. 65:Abstract C132. deProstD , Barbier‐BoehmG , HazebroucqJ , IbrahimH , BielskyMC , HvassU , et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thrombosis and Haemostasis1992;68(2):106‐10. "><b>de Prost 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> body surface area (mean ± standard deviation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>582 ± 410 mL/m<sup>2</sup> </p> <p>(n = 44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>465 ± 303 mL/m<sup>2</sup> </p> <p>(n = 37)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0013" title="DiltheyG , DietrichW , SpannaglM , RichterJA . Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. Journal of Cardiothoracic and Vascular Anesthesia1993;7(4):425‐30. "><b>Dilthey 1993</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1000 (600 to 1800) mL</p> <p>(n = 19)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1075 (400 to 1740) mL</p> <p>(n = 20)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0021" title="HackmanT , GroweGH , NaimanSC , TownsendG , GascoyneRD , JamiesonWR , et al. 1‐Desamino‐8‐D‐Arginine‐Vasopressin (DDAVP) does not reduce blood loss in open‐heart surgery. Canadian Journal of Surgery. 1988; Vol. 31:Abstract R63. HackmanT , GroweGH , NaimanSC , TownsendRD , GascoyneWR , JamiesonS , et al. Lack of effect of DDAVP in open heart surgery. Circulation. 1988; Vol. 78:Abstract 2102. HackmannT , GascoyneRD , NaimanSC , GroweGH , BurchillLD , JamiesonWR , et al. A trial of desmopressin (1‐desamino‐8‐D‐arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New England Journal of Medicine1989;321(21):1437‐43. "><b>Hackmann 1989</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (90% confidence interval)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>865 (358 to 2495) mL</p> <p>(n = 74)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>783 (300 to 2219) mL</p> <p>(n = 76)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0022" title="HajjarLA , GalasF , FortimM , Melo , R , FerreiraR , AulerJO . Desmopressin acetate reduces blood loss after cardiac surgery: a double‐bind randomized controlled trial. Circulation. 2007; Vol. 116, issue 16:396. "><b>Hajjar 2007</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> (mean ± standard deviation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>258 ± 106 mL/m<sup>2</sup> </p> <p>(n = 75)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>526 ± 314 mL/m<sup>2</sup> </p> <p>(n = 75)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0024" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. "><b>Hemșinli 2012a</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (no standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1430 mL</p> <p>(n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1767 mL</p> <p>(n = 10)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0025" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. "><b>Hemșinli 2012b</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (no standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>574 mL</p> <p>(n = 16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>535 mL</p> <p>(n = 18)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0042" title="MarquezJ , KoehlerS , StrelecSR , BenckartDH , SperoJA , CottingtonEM , et al. Repeated dose administration of desmopressin acetate in uncomplicated cardiac surgery: a prospective, blinded, randomized study. Journal of Cardiothoracic and Vascular Anesthesia1992;6(6):674‐6. "><b>Marquez 1992</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1157 mL</p> <p>(n = 21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1180 mL</p> <p>(n = 22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0050" title="RochaE , CuestaB , ParamoJA , FernandezJ , HernandezM , PalomaMJ , et al. Can desmopressin acetate reduce bleeding in cardiac surgery with extracorporeal circulation?.. Sangre. 1987; Vol. 32:Abstract 74. RochaE , LlorensR , ParamoJA , ArcasR , CuestaB , TrenorAM . Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass?. Circulation1988;77(6):1319‐23. "><b>Rocha 1988</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> body surface area (mean ± standard deviation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>458 ± 206 mL/m<sup>2</sup> </p> <p>(n = 50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>536 ± 304 mL/m<sup>2</sup> </p> <p>(n = 50)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. "><b>Rocha 1994</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> body surface area (mean ± standard deviation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>551.8 ± 324.1 mL/m<sup>2</sup> </p> <p>(n = 28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>438.7 ± 228.1 mL/m<sup>2</sup> </p> <p>(n = 25)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0052" title="SalmenperaM , KuitunenA , HynynenM , HeinonenJ . Hemodynamic responses to desmopressin acetate after CABG: a double‐blind trial. Journal of Cardiothoracic and Vascular Anesthesia1991;5(2):146‐9. "><b>Salmenpera 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as median (range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1020 (530 to 1155) mL</p> <p>(n = 15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1100 (425 to 1720) mL</p> <p>(n = 15)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Orthopaedic surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0015" title="FlordalPA , LjungstromKG , SvenssonJ , EkmanB , NeanderG . Effects on coagulation and fibrinolysis of desmopressin in patients undergoing total hip replacement. Thrombosis and Haemostasis1991;66(6):652‐6. "><b>Flordal 1991</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (no standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1320 mL</p> <p>(n = 6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1380 mL</p> <p>(n = 6)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0061" title="TherouxMC , CorddryDH , TietzAE , MillerF , PeoplesJD , KettrickRG . A study of desmopressin and blood loss during spinal fusion for neuromuscular scoliosis: a randomized, controlled, double‐blinded study. Anesthesiology1997;87(2):260‐7. "><b>Theroux 1997</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as estimated percentage blood loss: median (range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>147.8% (57% to 428.8%)</p> <p>(n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111.2% (65% to 239.5%)</p> <p>(n = 11)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Maxillofacial surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0020" title="GuyuronB , VaughanC , SchlecterB . The role of DDAVP (desmopressin) in orthognathic surgery. Annals of Plastic Surgery1996;37(5):516‐9. "><b>Guyuron 1996</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (range)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>675 (380 to 1330) mL</p> <p>(n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>819 (200 to 1600) mL</p> <p>(n = 10)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">DDAVP vs placebo: total blood loss</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001884-tbl-0011"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">DDAVP vs tranexamic acid: total volume of red cells transfused</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reason not included in meta‐analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DDAVP arm</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Tranexamic acid arm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Orthopaedic surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0014" title="EllisMH , FredmanB , ZoharE , IfrachN , JedeikinR . The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia2001;13(7):509‐13. "><b>Ellis 2001</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.7 units</p> <p>(n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.1 units</p> <p>(n = 10)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">DDAVP vs tranexamic acid: total volume of red cells transfused</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001884-tbl-0012"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">DDAVP vs tranexamic acid: total blood loss</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reason not included in meta‐analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DDAVP arm</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Tranexamic acid arm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Adult cardiac surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0026" title="HemşinliD , PulathanZ , AltunG , GűvenKY , CivelekA . The effect of tranexamic acid and desmopressin acetate infusion on coagulation parameters in patients operated under dual antiplatelet therapy. Heart Surgery Forum. 2012; Vol. 15 Suppl 1:Abstract OP‐088. "><b>Hemșinli 2012c</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mean (no standard deviation)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1430 mL</p> <p>(n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>535 mL</p> <p>(n = 18)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">DDAVP vs tranexamic acid: total blood loss</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001884-tbl-0013"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">DDAVP vs aprotinin: total volume of red cells transfused</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reason not included in meta‐analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DDAVP arm</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Aprotinin arm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Adult cardiac surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. "><b>Rocha 1994</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> body surface area (mean ± standard deviation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>740.4 ± 416.3 mL/m<sup>2</sup> </p> <p>(n = 25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>366.1 ± 331.9 mL/m<sup>2</sup> </p> <p>(n = 28)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">DDAVP vs aprotinin: total volume of red cells transfused</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001884-tbl-0014"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">DDAVP vs aprotinin: total blood loss</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reason not included in meta‐analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DDAVP arm</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Aprotinin arm</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Adult cardiac surgery</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0008" title="CasasJI , Zuazu‐JausoroI , MateoJ , OliverA , LitvanH , Muniz‐DiazE , et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double‐blind placebo‐controlled study. Journal of Thoracic and Cardiovascular Surgery1995;110(4 Pt 1):1107‐17. Zuazu‐JausoroI , OliverA , CasasI , RodriguezA , CaralpsJM , ArisA , et al. Aprotinin or desmopressin, which is the best one to control bleeding associated to cardiopulmonary bypass (CPB)? A prospective randomized double blind trial. Thrombosis and Haemostasis. 1993; Vol. 69:Abstract 2671. "><b>Casas 1995</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> body surface area (mean ± standard deviation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>400 ± 192 mL/m<sup>2</sup> </p> <p>(n = 50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>195 ± 146 mL/m<sup>2</sup> </p> <p>(n = 48)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001884-bbs2-0051" title="HidalgoF , LlorensR , MeleroJM , ArroyoJL , RochaE . Influence of the administration of DDAVP versus aprotinin in the prevention of bleeding after cardiac surgery. Thrombosis Research. 1993; Vol. 70:Abstract C120. RochaE , HidalgoF , LlorensR , MeleroJM , ArroyoJL , ParamoJA . Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation1994;90(2):921‐7. "><b>Rocha 1994</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported as mL/m<sup>2</sup> body surface area (mean ± standard deviation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>551.8 ± 324.1 mL/m<sup>2</sup> </p> <p>(n = 25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>358.5 ± 156.3 mL/m<sup>2</sup> </p> <p>(n = 28)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">DDAVP vs aprotinin: total blood loss</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/full#CD001884-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001884-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Desmopressin vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Red cell volume transfused (intraoperatively) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Adult cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐1.22, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Paediatric cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐0.87, 1.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.50 [‐0.89, ‐0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Vascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.20 [‐2.55, 0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Plastic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.75 [‐1.23, ‐0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Red cell volume transfused (total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>957</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.52 [‐0.96, ‐0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.67, 0.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Vascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.60, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Hepatic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.47 [‐1.27, 0.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Red cell volume transfused (children only, total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Number of participants receiving a red cell transfusion (intraoperatively) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>349</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.50, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.43, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Plastic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.45, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Kidney biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 Other</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Number of participants receiving a red cell transfusion (total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1806</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.86, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.82, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.45, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Vascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.83, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 Paediatric cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.66, 2.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5 Plastic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.45, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6 Hepatic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.15, 2.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.7 Kidney biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.8 Maxillofacial surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.88, 4.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Blood loss (intraoperative) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐138.20 [‐623.40, 347.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>224</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐118.24 [‐278.43, 41.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Vascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐525.0 [‐1177.34, 127.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 Sinus surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐28.0 [‐31.70, ‐24.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5 Plastic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐146.02 [‐487.86, 195.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Blood loss (total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Adult cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1358</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐135.24 [‐210.80, ‐59.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐285.76 [‐514.99, ‐56.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Vascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐582.0 [‐1264.07, 100.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Blood loss (children only, total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Paediatric cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [‐12.92, 15.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Number of participants with any bleeding (intraoperatively) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Dialysis catheter</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Number of participants with any bleeding (total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Kidney biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Reoperation due to bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1783</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.40, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1483</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.38, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3 Paediatric cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.93 [0.14, 349.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.4 Dialysis catheter insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.5 Kidney biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1631</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.51, 2.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1239</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.48, 2.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 Vascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.50 [0.52, 138.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.4 Paediatric cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.01, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1984</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.36 [0.85, 2.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [0.88, 2.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>280</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.21 [0.14, 363.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3 Vascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.23, 2.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.4 Sinus surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.5 Kidney biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1704</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.70, 2.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1031</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.52 [0.77, 3.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>280</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.3 Vascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.11, 2.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.4 Kidney biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.5 Sinus surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.95 [0.94, 9.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>733</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.95 [0.94, 9.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.3 Vascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.4 Kidney biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.5 Sinus surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Venous thromboembolism <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1377</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.17, 3.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>754</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.11, 2.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>280</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.21 [0.14, 363.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.3 Vascular surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.4 Kidney biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.5 Sinus surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Clinically important hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.32 [1.37, 3.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>762</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.88 [1.32, 6.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.05 [0.99, 4.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.3 Paediatric cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.06, 14.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.4 Sinus surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.5 Kidney biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Desmopressin vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001884-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Desmopressin vs placebo (platelet dysfunction)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Red cell volume transfused (total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>388</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.65 [‐1.16, ‐0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Number of participants receiving a red cell transfusion (intraoperatively) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Number of participants receiving a red cell transfusion (total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.66, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Blood loss (total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐253.93 [‐408.01, ‐99.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Reoperation due to bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>413</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.18, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.12, 4.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.58 [0.60, 4.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.72 [0.60, 12.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Venous thromboembolism <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.06, 5.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Clinically important hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>315</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.58 [1.18, 36.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Desmopressin vs placebo (platelet dysfunction)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001884-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Desmopressin vs tranexamic acid</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Red cell volume transfused (total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Number of participants receiving a red cell transfusion (total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.42 [1.04, 5.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [0.82, 2.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.15 [1.58, 10.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Blood loss (total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>142.81 [79.78, 205.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>115.0 [35.38, 194.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>180.0 [86.82, 273.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Reoperation due to bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Venous thromboembolism <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Orthopaedic surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Desmopressin vs tranexamic acid</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001884-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Desmopressin vs aprotinin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Number of participants receiving a red cell transfusion (total) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Reoperation due to bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 All thrombotic events (including myocardial infarction, ischaemic stroke, other arterial thromboembolism, and venous thromboembolism) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Myocardial infarction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Stroke <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Venous thromboembolism <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Clinically significant hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Cardiac surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Desmopressin vs aprotinin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001884.pub3/references#CD001884-tbl-0018">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD001884.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD001884-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD001884-note-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD001884-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD001884-note-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD001884-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD001884-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001884\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001884\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001884\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001884\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001884\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001884\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001884\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001884\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001884\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001884\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001884\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001884\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001884\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001884\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001884\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001884\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001884\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001884\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=dLyXbLct&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001884.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001884.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD001884.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD001884.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001884.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718702101"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001884.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718702104"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001884.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dd6c43e5ff47a',t:'MTc0MDcxODcwMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 